Mechanistic studies on glutamate mutase by Hartzoulakis, Basil
  
 
MECHANISTIC STUDIES ON GLUTAMATE MUTASE 
 
Basil Hartzoulakis 
 
A Thesis Submitted for the Degree of PhD 
at the 
University of St Andrews 
 
 
  
1994 
Full metadata for this item is available in                                                                           
St Andrews Research Repository 
at: 
http://research-repository.st-andrews.ac.uk/ 
 
 
 
Please use this identifier to cite or link to this item: 
http://hdl.handle.net/10023/14380  
 
 
 
 
This item is protected by original copyright 
 
MECHANISTIC STUDIES ON 
GLUTAMATE MUTASE
a thesis presented by 
Basil Hartzoulakis 
to the
University of St. Andrews 
in application for
THE DEGREE OF DOCTOR OF PHILOSOPHY
St. Andrews March 1994
ProQuest Number: 10167135
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is d e p en d en t upon the quality of the copy submitted.
In the unlikely eve n t that the author did not send a c o m p le te  manuscript 
and there are missing pages, these will be noted. Also, if m aterial had to be rem oved,
a no te  will indicate the deletion.
uest
ProQuest 10167135
Published by ProQuest LLO (2017). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C o d e
Microform Edition ©  ProQuest LLO.
ProQuest LLO.
789 East Eisenhower Parkway 
P.Q. Box 1346 
Ann Arbor, Ml 4 8 1 0 6 - 1346
îi
i
y.'
I
DECLARATION
I, Basil Hartzoulakis, hereby certify that this thesis has been composed by myself, 
that is a record of my own work, and that it has not been accepted in partial or 
complete fulfilment of any other degree or professional qualification.
Signe(d Date
I was admitted to the Faculty of Science of the University of St.Andrews under 
Ordinance General No. 12 on .^^ .LQ.çfebf.v....!.3.-?.P... and as a candidate for the degree 
of Ph.D. on ....... .............
Signée Date  / 5 3 'V
I hereby certify that the candidate has fulfilled the conditions of the Resolution and 
Regulations appropriate to the degree of Ph.D.
Signature of Supervisor ...(
Date ........................
Copyright
In submitting this thesis to the University of St.Andrews I understand that I am 
giving permission for it to be made available for use In accordance with the 
regulations of the University library for the time being in force, subject, to any 
copyright vested in the work not being affected thereby. I also understand that the 
title and abstract will be published, and that a copy of my work may be made and 
supplied to any bona fide library or research worker.
TO THE MEMORY OF MY FATHER
TO MY MOTHER
For Their 
Will, Integrity, Courage 
and Love
"It is not our part to master all the tides of the world, 
but to do what is in us for the succour 
of those years wherein we are set, 
uprooting the evil in the fields that we know, 
so that those who live after may have a clean earth to tiU. 
What weather they shall have is not ours to rule."
J.R.R.Tolkien
Acknowledgements
I would like to thank my friend and supervisor, Professor David Gani for his 
support and encouragement throughout the course of this work. His help is deeply 
appreciated.
Many thanks to Mahmoud Akhtar, for his friendship, help in the lab, and proof­
reading. Most of all, however, I would like to thank him for being patient when I 
argued with him.
I will be always grateful to Paul Hawkins, for his most stimulating friendship.
Special thanks to the "GM" boys, Saeed Gulzar, and Kamal Badiani. Their 
presence and encouragement in the lab, made my hectic last months more 
tolerable.
To Hylarie,
To all the friends I made in St. Andrews.
Finally, a million thanks to my mother and sister. Thought of them kept me going 
through all of the difficulties I came up against.
Abstract
The coenzyme B i2-dependent enzyme glutamate mutase (E.G. 5.4.99.1) 
catalyses the rearrangement of (2S)-glutamlc acid to (2S,3S)-3-methylaspartic 
acid. Each of the two components of the enzyme was purified to homogeneity using 
a combination of low and high performance chromatographic techniques. 
Component E and S displayed molecular weights of 53 KDa and 13 KDa 
respectively as determined by gel electrophoresis, contrary to literature reports.
A large number of glutamate and 3-methylaspartate analogues were 
synthesised and tested as substrates for the enzyme from Clostridium  
tetanomorphum. No rearrangement products could be detected for (2S,3R)-3- 
methylaspartic acid, (2S,3S)-3-ethylaspartic acid, 3-methylglutamic acid, (2S,3R)- 
3-methylsuccinic acid or N-methyl-3-methylaspartic acid. Five inhibitors were 
discovered for the enzyme. Four of them were typical competitive inhibitors: 
(2S,3S)- and (2S,3R)-3-methylglutamates (Kj = 1.0 mM and K; = 1.5 mM 
respectively); (2S)-homocysteic acid, K| = 5 mM; and 1-bromo-c/s-1,2 - 
cyclopropanedicarboxylic acid (K|= 2.2±0.2 mM). Finally l-bromo-frans-l ,2- 
cyclopropanedicarboxylic acid prevented the enzyme from processing (2S)- 
glutamic acid for periods of times proportional to its concentration. Our results 
support a radical mechanism with a protein bound glycyl radical as an 
intermediate, and provide evidence for the existence of two distinct conformations 
of the holoenzyme, prior to and after the activation of the cofactor.
(2S,3R)-3- and (2S,3S)-3-Methylglutamic acids were synthesised 
stereospecifically by extending Schollkopf's b/s-lactim ether methodology. The 
attack of various carbon anions at 0-5 of isopropyl A/-benzyl-(4S,5R)-1,2 ,3- 
oxathiazolidone-5-methyl-4-carboxylate S,S-dioxide was not a versatile pathway. 
Nevertheless, the reaction of the oxathiazolldone with an aliylmagnesium lithium 
cuprate complex gave some promising results, but more research is necessary to 
optimise certain problematic steps. Several different routes were evaluated for the 
preparation of 1-amino-1,2-cyclopropanedicarboxylic acid, but either low yields or 
instability of intermediates thwarted any attempts to achieve this goal. Finally 1- 
bromo-c/s- and frans-1,2-cyclopropanedicarboxylic acids were synthesised by 
reacting methyl acrylate with methyl dibromoacetate in the presence of sodium 
hydride. The two pairs of enantiomers, c/s- ((28,38) and (2R,3R)) and trans- 
((2R,38) and (28,3R)) were separated by selective ester formation.
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Glutamate Mutase
Chapter 1 : Introduction________________________________________________ 1
1.0 Introduction
Nature's ability to accomplish an immense variety of catalytic events relies 
primarily on two evolutionary achievements. The development of a large number of 
alternative protein structures and the use of cofactors.
The conformations of polypeptide chains, selected from the pool of an infinite 
possible number, are necessary to establish the vital element of selectivity. In the 
cases where binding of the transition state (TS) is sufficient for catalysis, a protein 
(or even an RNA molecule'*) can be synthesised by the cell that will perform the 
task. However, many processes in living organisms would be impossible to realise 
with the intervention of a protein structure alone. Many "difficult" key 
transformations, oxygen transport, and energy transfer require a cofactor.
In this context, the term "cofactor" includes metals (Zn, M g ), metal clusters (Fe- 
S) and coenzymes. Coenzymes are defined as "small" thermostable molecules 
necessary for enzymatic activity ( CoA, NADH, NAD, ATP, flavins eta). One family 
of coenzymes is characterised by a tetrapyrole macrocycle with a metal 
coordinated in its centre and includes haem (Fe), chlorophylls (Mg), coenzyme 
F430 (Ni) and coenzyme B12 (Co).2 The larger and structurally more complicated 
member of this family is 5'-deoxyadenosylcobalamin (adenosyIcobalamin, AdoCbl) 
(Fig. 1.1). Its de novo synthesis is restricted to bacteria. The concentrations of the 
coenzyme in the environment are very low ([AdoCbl] < InM), so all the higher 
mammals have evolved very sophisticated systems in order to absorb, store and 
utilise it. The task of unravelling the secrets of coenzyme B12 chemistry has been a 
target for scientists for the last 50 years. While the elucidation of the biosynthetic 
pathway to vitamin B12 has almost been completed,^ chemists are not in a position 
to claim sufficient understanding of the mechanistic details of its enzymatic action. 
The consensus is that it serves as a reversible carrier of free radicals in the same 
way that myoglobin/haemoglobin can bind and release molecular oxygen. 
Homolysis of the unique o Co-C bond affords cob(ll)alamin and 5'-adenosyl 
radical. The latter gives rise to a range of new radicals derived from the appropriate 
substrates. The special properties of the coenzyme that make this process possible 
will be discussed. The structural and mechanistic aspects of the protein's
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involvement in the individual steps will be evaluated. Finally the chemical models 
of the rearrangement process will be reviewed.
1.0.1 Discovery of Gobalamins
Living organisms contain, in addition to the biosynthetic intermediates, four 
related cobalamin structures, namely 5'-adenosyl-, cyano-, methyl-, and hydroxyl- 
cobalamin. The corresponding group occupies in each case the p-axial position 
(Fig. 1.1 ).3 Cyanocobalamin functions as the metabolic precursor for AdoCbl, and 
MeCbl. The two latter molecules are the only ones that are used as cofactors in 
various biochemical systems. There is evidence to support the existence of specific 
enzymes that can add or remove the axial cobalamin substituents.^ However, our 
understanding in this area is poor.
a-Side <
R=-CH2C0 NH2
CHoOH
1  »
Figure 1.1 5'-Adenosylcobalamin (Coenzyme B j2 )
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The first cobalamin to be isolated® and characterised® was cyanocobalamin. 
AdoCbl (Fig. 1.1) was crystallised in 1959 by Barker et al.7  and characterised by 
Lenhert and Hodgkin® in 1961. The discovery of the stable C-Co bond in AdoCbl 
provoked a considerable amount of research. Nevertheless, the mode(s) of action 
of cobalamins still provoke much speculation.
1.0.2 Biological Function of Cobalamins
Methyl- and 5‘-adenosyl-cobalamin serve as coenzymes for a variety of unusual 
catalytic processes:
1) Methyl group transfers (synthesis of methionine).
2) Isomérisations.
3) Reduction of ribonucleotides to deoxyribonucleotides.
The ten apoenzymes which require AdoCbl, In order to catalyse the 
rearrangements, are listed in Table 1.
There is a small number of systems which catalyse reactions which appear to 
be similar to Bi2-dependent isomérisations. For example lysine 2,3-aminomutase 
(E.C. S.4.3.2) is not AdoCbl dependent but catalyses the interconversion of (S)- 
lysine to (3S)-p-lysine. This reaction is very similar to the lysine 5,6-aminomutase 
reaction which is dependent on the coenzyme (entry 7, Table 1.1). For the 2,3- 
aminomutase iron, cobalt(lll), S-adenosylmethionine, and pyridoxal phosphate are 
necessary for activity. It is believed that a radical is generated on an iron/sulphur 
cluster, and then transferred to the adenine part of S-adenosylmethionine.® The 
role of the Co(lll) ions is yet to be established.
Another case worthy of mention is ribonucleotide reductase.^® This enzyme 
uses different cofactors in different species, either an ion cluster or AdoCbl. 
Ribonucleotide reductases are important enzymes which play a central role in DNA 
biosynthesis in catalysing the conversion of GTP, ATP, ITP, and UTP to the 
corresponding deoxyribonucleotides. The protein from E. coli is the prototype for 
the enzyme present in mammals, yeast and herpes simplex virus. Mechanistic 
studies have shown that the adenosyl radical abstracts a hydrogen from an amino 
acid at the active site and is thus how the protein itself is involved in the chemical 
changes during the catalytic cycle.
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Table 1. B 12 '  Dependent enzymes catalysing rearrangements
Enzyme Substrate Product E.C. Number
1) (S)-Glutamate Mutase HzN m  H GH3 
HOgC CO2H 5.4.99.1
2) (R)-Methylmalonyl"CoA 
mutase
O
CoA-S COgH CoA-S'^^^COgH
HoC
5.4.99.2
3) Isobutyryl-CoA mutase
CoA-S CH. CoA-S
O
CH.
CH.
5.4.99.3
4) a-Methyleneglutarate 
mutase HOgC
H .CH.
H02C C02H 5.4.99.4
5) (S)-Leucine 2,3- 
aminomutase
HgN CHg CH.
CH. HOgC" y  CHg
NHg
5.4.3.7
6) (R)-Omithlne 4,5- 
aminomutase
HgN
H02C^'g|s^/S^NH2
H HOgC
HgN NHg
CH. 5.4.3.5
7) (R)- a-Lysine 5,6- 
aminomutase
HgN
NHg
((S)- P-Lysine mutase)
HOgC" ^  ^ NH2
H NHg
HgN NHg
HOgC-^—
H
H NHg NH2
5.3.3.3
8) Diol dehydrase HO OH 
R
4.2.1.28
9) Glycerol dehydrase HO ^  ’ OH 
OH
4.2.1.30
10) Ethanolamine ammonia 
lyase HoN' ,0H XHgO'^H
4.3.1.7
Reaction reversibility under physiological conditions is also indicated.
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Ribonucleotide reductase is characterised by the presence of two catalytically 
significant thiol groups in the active sitejo This is another common feature of all 
coenzyme Bi2-dependent enzymes (see § 1.13)JT12
1.1 Structure of Goenzyme B^2
Goenzyme B12 belongs to a specific group of corrinoids called cobalamins. A 
nitrogen containing macrocycle known as a corrin forms the core of the coenzyme 
(Fig. 1.2.8). There are two main differences between corrins and the more widely 
distributed porphyrins (Fig. 1.2.b). First, corrins exist in a highly reduced state, there 
are only six double bonds instead of the eieven present in porphyrins. Corrins also 
incorporate a characteristic linkage between rings A and D. Halpern^^ provided 
evidence to support the view that corrins, display greater flexibility than porphyrins 
and therefore respond more efficiently to steric pressures induced by bulky ligands. 
The rigid structure of the fuily aromatic porphyrins does not allow such flexibility. It 
has to be stressed, however, that despite the abiiity of the corrin to change its 
conformation, it is, on the basis of X-ray crystal data, extremely reluctant to do so. 
Nevertheless, severe interactions with the axial ligands, (Fig.1.1), are able to push 
the cobalt atom out of the corrin plane and distort the ring.i^
20
(a) Corrin (b) Porphyrin
Figure 1.2 The corrin and the porphyrin nucleus
Seven amide chains are attached to the corrin ring. One of them, a propanoate 
side-chain on ring D (C-17), is bonded through amidation with a (2R)-1- 
aminopropan-2-ol phosphodiester, to the 3'-hydroxyl group of a 5,6-dimethyl-
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benzimidazolyi a-ribofuranoside. The 5,6-dlmethylbenzimidazole is coordinated 
through N-3 to the cobalt's a-axial position (Fig. 1.1) and thus forms a loop.
This highly functionalized ring D to Co(lll) loop bears many groups that can 
interact with the environment of the active site. In fact, recent datais point to a 
significant role for this loop during the initial catalytic steps when the radical 
species are formed. In solution the coenzyme exists in an equilibrium in which 5,6- 
dimethylbenzimidazole is either coordinated (base-on) or not (base-off) at the a- 
position of the coenzyme. A water molecule occupies the a-axial position in the 
base-off form to provide a yellow‘d® rather than a red-orange colour. There is no firm 
evidence supporting the involvement of the base-off form in the catalytic events. 
The other chains attached to the corrin ring interact with the environment of the 
active site and together with eleven methyl substituents stabilise the important Co- 
C bond by preventing the approach of other molecules.''®
The Co(lll) atom is octahedrally coordinated in the centre of the macrocycle. It is 
very tightly bound in this position such that any efforts to remove it, result in the 
destruction of the corrinoid ring.''^ Its coordination sphere is slightly, but 
significantly distorted due to the direct linkage between rings A and D. The field 
provided by the unsaturated nitrogen-containing ligand induces very strong 
changes in the energy levels of cobalt's orbitals."i® This affects the nature of the Co- 
C bond and the stability of intermediates. For example cob(ll)aIamin radical is 
stable and has been crystallised and fully characterised.
The a Co-C bond is stable to water and oxygen, and was the first stable 
organometallic bond to be discovered.® The ability of cobalt to form this 
thermodynamically and kinetically stable bond is not matched by any other 
m e t a l . The bond dissociation energy (BDE) for the Co-C bond was 
calculated from kinetic data^® to be 109±8 kJ mol-T Finke^i reported a slightly 
higher value of 126+8 kJ mol'\ The "base-off" form in models has a higher BDE by 
about 17 kJ mol"''. The stability of the bond depends on electronic as well as steric 
factors. Indeed the BDE is substantially affected by the nature {e.g. electron 
donating or neutral) of the ligand on the a-position (this is the so called "trans 
effect"''®) and the steric interactions between the adenosine and the substituents on 
the corrin ring.''4
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1.2 3-Dimensional Structure of Coenzyme Big and Analogues
The major features of the three dimensional structure of the coenzyme are the a 
Co-C bond, the ioop connecting ring D with the 5,6-dimethylbenzimidazoiyl iigand, 
the extended substitution on the corrin ring, and the ribose moiety which neatiy 
caps the Co-atom.
The iength of the Co-C is 2.03 Â, siightiy ionger than the Co-CN bond in vitamin 
Bi2 (1.92 Â). The steric compression that occurs between the adenosine and the 
corrin substituents is reveaied by the distorted (Co-CHg-C) bond angie of 124.4°, 
15° larger than normal.22
(a) (b)
OH OH
HO,
ÇH2
ÇH2
Co
CH2
CoCo
Figure 1.3 Analogues o f AdoCbl
The number of coenzyme B12 analogues in which the adenosine moiety is 
repiaced by another group has been only recently extended sufficiently to allow 
comparative studies. Golding et al.^  ^ analysed the structure of (R)- and (S)- 
dihydroxypropyl-cobalamin (Fig. 1.3.a and b). Careful examination confirmed that 
the (R)-anaiogue could not accommodate itself very well between the substituents 
on the corrin ring. On the other hand the (S)-analogue (Fig. 1.3.b) positions its 
hydroxy methyl group between rings C and D (the same position AdoCbi nests the 
ribose ring oxygen, (Fig. 1.1)) and forms a hydrogen bond, with one of the 
acetamido ligands releasing thereby much of the strain. The (Co-CHg-C) bond 
angie in this casé is only 113°. in a similar study Marzilli and Glusker24 presented 
data on adeninyipropyl-cobalamin (Ade(CH2)3-cobalamin) (Fig 1.3.C). By 
comparison, no important differences were found in the conformation of corrin
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nucleus in the analogue, and in AdoCbl and MeCbl. The most important structurai 
properties for some analogues are summarised in Table 1.2.
Table 1.2. Structural characteristics o f AdoCbl analogues with various f-ax ia l
R Co-C
(Â)
Co-N(ax)
(Â)
Co-N(eq)
(A)
Co-Ca-Cb
(°)
1) Ado22 2.03 2.24 1.87-1.91 124.4
2) Ade-(CH2)3-24 1.96 2.12 1.85-1.88 119
3) Me25 1.99 2.19 1.88-1.97 -
4) fR)-2,3-dihydroxvDroDv|23 2.00 2.27 1.84-1.95 120
5) (S)-2,3-dihydroxvDroDyl2^ 2.08 2.36 1.89-1.98 114
6) CN26 1.91 2.03 1.91-1.94 175.0
1.3 Coenzyme Big Models
Many groups have attempted to use model systems to gain an understanding of 
the chemistry of AdoCbl. Typically, a model for the coenzyme is constructed when 
large, electron rich (nitrogen or oxygen containing) molecules, are compiexed with 
a Co(lil)-atom. The two remaining axial positions of the Co(lli) atom are then 
available to coordinate with an alkyl group at the |3-axiai position, or Lewis bases at 
the a-axial position. The most popular ligand for cobait's equatorial coordination 
sphere has been b/s-(dimethyi giyoximato), (DH)2, and a number of its substituted 
derivatives (Fig. 1.4.a, X=H, CH3, Ph ). The chemistry of these systems has been 
extensively re v ie w e d . 17,19,27,28 other coenzyme models include the mixed oxime- 
Schiff bases, [(DO)(DOH)pn] (Fig. 1.4.b), bis(acetylacetone)ethylenediimine (BEA) 
(Fig. 1.4.0), and bis-(salicyiaidehydo hydroethylenediimine) (SALEN) (Fig. 1.4.d).
Cobaloximes (Fig. 1.4.a) have been successfully used to support predictions 
concerning the properties of cobalamins made nearly three decades ago.29 An 
increase in the buikiness of the R or the L iigand would elongate the Co-C bond 
and decrease the BDE. For example pyCo(DH)2CH3 has a BDE of 143±4 kJ moLL 
This value is significantly higher than the 89.5±6 kJ mol-i obtained for the 
pyCo(DH)2'Pr analogue. Additionally the presence of any steric compression is 
typically reflected in the C-CHg-C-S' bond angie. For example the introduction of a
Chapter 1 : Structure and Models
methylene bridge (Fig. 1.4.b, oxime-Schiff base) reduced the flexibility of the 
equatorial iigand and subsequently a value of 130° for the Co-CHg-C bond angle 
was observed, when R= CH2C(CH3)3. The distortion of the Co-CHg-C bond angle is 
even more pronounced when the other axial ligand B is also bulky. The importance 
of this kind of distortion in the enzymatic catalysed activation of the Co-C bond is, 
however, ambiguous since obviously it is not connected with the stability of the Co- 
C bond. Neopentyl cobaloximes with a distorted angie of 130° are particularly 
stable.
I R I X
X
a
B
X
X
H" .0
O
(a) [R-Co(DH) 2B] (b) [R-Co{(DO)(DOH) B] +11-R-l l-B-4,10-diaIkyl-5,9-diazatrideca 
4,9-diene-3-one oximato (2-)
c R — Co
(C) |R-Co(BAE) B] X=H, Y=-CH2CH2-, [R-Co(SALEN)B]X=CH3, Y=-CH2CH2-, [R-Co{7,7’(CH3)2(SALEN)} B] 
X=H, Y=-Ph , [R-Co(SALOPH) B]
Figure 1,4 Models fo r  coenzyme B j2
When a bulky, "electron rich", Schiff base (Fig. 1.4.c,d) is the equatorial ligand 
donor, the complexes display Co-R distances more similar to cobalamins than the 
previously discussed models. These large complexes, in contrast with the "electron 
poor" cobaloximes, have similar properties to corrins, but are difficult to prepare
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and study. All the models mentioned above display similar trends in the 
dependency of the BDE on steric and electronic factors.
A new of generation of model compounds, with structural characteristics very 
similar to cobalamins, has recently appeared in the literature (Fig. 1.5).3° Whether 
these structures will be of any practical importance remains to be seen.
Figure 1,5 Model with a Co-C-eqmtorial ligand bridge
1.4 Properties of Cobaiamlns
Cobalamins owe their unique properties to cobalt. Co is the only metal that can 
form stable a M-Co(lll) bonds and the same time retain easy access to its range of 
oxidation states (Co(l), Co(ll)).i4 Therefore, not only can the Co-C bond be 
synthesised and preserved efficiently in biochemical systems, but more importantly 
it can be manipulated during catalysis to afford the kinetically competent species 
(5'-adenosyl radical and cob(ll)alamin). This interplay of oxidation states offers the 
means for observing coenzyme Big-dependent reactions in real time, since there 
are very characteristic differences between the U.V./ visible spectra of cob(l)-, 
cob(ll)- and cob(III)-alamin.3'i
Cyclic voltametry, and other spectroelectrochemical methods are usually 
applied to study the redox properties of AdoCbl and its a n a l o g u e s . 3 2 , 3 3  These 
methods can simplify (in an electrochemical cell) comparisons between models 
and the naturally occurring cobalamins. In some cases important findings have 
emerged, some of which allowed the identification of compounds with potentially
useful properties.34
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The tetrapyrrole ring and the side chains of cobalamins have been derivatised 
or transformed using a variety of chemical means.^s The products of these 
reactions are coenzyme analogues that provided useful information about the 
interactions between the side chains and the protein enviroment of the active site 
(see § 1.7). The formation of the Co-C bond is another important reaction. This can 
be easily achieved by reacting alkyl halides with Co(l) or C o ( l  1 )3 5 ,3 6  species. Many 
organocobalt complexes have been synthesised in this manner.
Once formed the Co-C bond is rather inert under a variety of conditions. 
Heterolytic cleavage was achieved only under relatively forcing conditioned  ^ (e,g. 
CN-, H+, HO"» Hg), and formation of degradation products (cob(l)alamin, 
hydroxycob(lll)alamins, elimination products of the adenosyl moiety) was 
commonly observed. The mild homolytic cleavage of the Co-C bond seems to be 
the only alternative left to the apoenzyme as the first step of the coenzyme 
activation.
1.5 Radical Intermediates; Structure and Properties
Abeles and coworkers suggested in 1972 the involvement of highly reactive 
radical intermediates in the mechanism of the coenzyme dependent dehydration of 
ethanediol by diol dehydrase.38 The presence of enzyme bound radical species in 
the AdoCbl-dependent rearrangements is now supported by a large body of 
evidence (see §1.8).i3,39
Since cob(ll)alamin radical appears to be the active form of the coenzyme 
during catalysis, its structural characteristics are of particular interest. Recent 
EXAFS studies^® of cob(ll)alamin showed that the axial Co-N-3 bond becomes 
shorter while the equatorial Co-N distances display only minimal changes, 
implying that upon homolysis the cobalt atom moves towards the a-axial nitrogen. 
This movement is not very important in solution due to the very low energy barrier 
for the recombination of the Co(ll) and the organic radical. In the active site, 
however, maintaining the distance between the Co(ll) radical and the enzyme 
bound 5'-adenosyl radical may be necessary for the propagation of the reaction. 
One of the enzyme's tasks must be to prevent the immediate reverse reaction (eq. 
1, Fig. 1.6) by holding the two radicals as far apart as possible.
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Enzyme \
Figure 1.6 Activation o f the coenzyme
Krautler and c o w o r k e r s ^ s  published a crystal structure of cob(ll)aiamin which 
was found to be remarkably similar to the intact coenzyme. An upward movement 
of the substituents on ring D, including the functionalized, ribonucleotide containing 
loop, were the only differences observed. These two conformational changes are 
probably related to the repositioning of Co(II) towards the 5,6-dimethyi- 
benzimidazolyl base.
Many studies have probed the mechanism of alkylcobalamins photolysis. 
Elaboration of radical-trapping experiments afforded methods to measure the BDE 
of organocobalt complexes free in solution^i and bound by e n z y m e s . ^ ^
Lowe et al. reported in 1978 that photolysis of AdoCbl in aqueous propan-1,2- 
diol produced a small cob(ll)alamin signal detectable by EPR.43 Upon warming up 
and re-freezing the samples, without further irradiation, the EPR signal increased 
substantially up to six times. A likely explanation seemed to be that the coenzyme, 
after irradiation either in solution or in the active site, existed in a peculiar state of 
"incipient "homoiysis. This state might have arisen from either i) a hetero lytic 
cleavage of the Co-C bond to form diamagnetic products, which on warming up 
afforded the radicals, or, ii) from a state in which the electrons of the bond were 
unpaired but EPR-silent as a result of dipole-dipole interactions in the triplet state. 
A similar behaviour was observed for the coenzyme compiexed with diol 
dehydrase/holoenzyme {§ 1.7.3). Although the coenzyme was EPR silent, 
irreversible deactivation of the enzyme system was observed.^^ It was clear that the 
Co-C bond was not cleaved, but the coenzyme was not in the ground state either.
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1.6 Radicals In Biological Systems
The fact that Nature uses radical intermediates to achieve a remarkable variety 
of tasks is well documented^® Photosynthetic Og-evolving systems, isopenicillin N 
synthase, and lipoxygenases are just three cases, chosen from a wide variety of 
available examples. In biological systems radicals are commonly employed in 
redox reactions or as intermediates in "difficult" transformations. Radicals can be 
generated by the photo irradiation of semiquinones, from Fe-S clusters, or by the 
"manipulation" of AdoCbl. Over the last few years the generation and use of high 
energy intermediates in enzymatic systems has been the focus of considerable 
research activity."'®
The study of enzyme bound radical intermediates is complicated by the fast 
appearance and disappearance of the species involved. EPR or stopped-flow 
visible spectroscopy are the methods of choice. If, however, the concentration of 
the active species is not high enough then "spin traps", can be useful, if the enzyme 
allows the spin trap access in the active site. In the case of the Big-dependent 
rearrangements (and MeCbl mediated methyl transfers) all of these methods have 
been used to try to elucidate the details of the catalytic steps.®,12
It is generally accepted that in the first catalytic event the apoenzyme binds the 
coenzyme and the other cofactors necessary for catalysis e.g. a metal for diol 
dehydrase, or pyridoxal phosphate for the aminomutases. The protection of the Co- 
C bond in the holoenzyme is an important task of the protein. The binding of the 
appropriate substrate triggers the homolytic cleavage of the Co-C bond. All the 
highly reactive radical intermediates are protected by the protein and after the 
rearrangement of the substrate to the product the coenzyme is regenerated. The 
Co-C bond activation step is not fully understood despite the extended literature on 
the subject. Finke and coworkers^s found that diol dehydrase and ethanolamine 
ammonia lyase accelerate the homolysis of the AdoCbl Co-C bond by a factor of 
1012±1| For such a high acceleration to be rationalised two major issues have to be 
dealt with. First, what tertiary and quaternary structures can establish the ability of 
these enzymes to control so many remarkable steps and second how is the binding 
energy converted to catalysis along the Co-C bond cleavage co-ordinate profile?
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1.7 Co-C Bond Homolysis Induced by the Protein
Considerations on how the protein facilitates the Co-C bond activation should 
take into account the following useful facts.
1) Modifications of the amide side chains of the coenzyme caused partial or 
complete loss of the coenzymatic activity in several AdoCbl-dependent systems, 
including ribonucleotide reductase, 6^ diol d e h y d r a s e ,"^ 7 ethanolamine ammonia 
lyase,47 and glutamate mutase.4® The EPR signal for the inactive coenzyme analo­
gues was, in the presence of the protein, either missing or reduced (see § 1.21).
2) The adenine moiety is necessary for activity, although small alterations can 
be tolerated.4® Ichikawa and To raya synthesised a series of coenzyme analogues 
(Fig. 1.7) incorporating various changes at the ribose ring.so
HO H H ?" HO H ?^
CHo ptT* CHo\^ xi2 Y ^
T 0 ' ^ '  IB (a) B ( b )  B (C)
Figure I J  Analogues of AdoCbl; importance o f the two 
hydroxyl groups and the ribose ring
The coenzyme analogues (a, b, Fig. 1.7) lacking the 2' and 3' hydroxyl group 
respectively, retained a percentage of activity with diol dehydrase (a, 31%; b, 
19%). The open-ring form (c) was inactive.®® The importance of the nitrogens on 
the adenine, the two hydroxyl groups and the ribose ring®i probably arise from their 
ability to keep the 5’-adenosyl radical in a very specific and restricted orientation in 
the active site, thus minimising harmful side reactions.
3) The Co-C bond seems to be under severe strain even without the presence 
of substrate. An interesting finding by Krouwer et a/.®^  was that longer alkyl chain 
AdoCbl analogues, (Fig. 1.3.0, p. 7) despite being inactive and photostable, 
showed, in the presence of ethanolamine ammonia lyase, changes in their CD
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spectra. On the other hand AdoCbl is photolabiie and no changes were observed 
in its corresponding CD spectrum after binding on the enzyme. More elaborate 
studies have dismissed the suggestion that the changes in the CD spectra were 
due to changes in the conformation of the corrin ring (§ 1.2).1® Alternatively it 
seemed that the adenine group in the analogues adopted a conformation quite 
different to that of AdoCbl, clearly due to the increased flexibility of the longer alkyl 
chain. The authors concluded that the large relief of conformational strain observed 
for the analogues should be involved in the cleavage of the Co-C bond.®2
1.7.1 Conformational Changes Induce the Cleavage of the Co-C bond
A number of working hypotheses have been formulated in order to explain 
these results and highlight the particular first event between the coenzyme and the 
apoenzyme that leads to Co-C labilisation, and eventual cleavage.
i) The suggestion that the protein induces changes in the conformation of the 
corrin ring is probably the earliest of them all. An upward or downward (butterfly- 
type) distortion that increases the steric interaction between the corrin nucleus and 
the adenosyl moiety, thus labilising the Co-C bond, has been very popular and is 
supported by model studies (see §1.3)."'®>''®
ii) Alternatively the enzyme can further distort the Co-CHg-C-S' angle and 
elongate the Co-C bond by means of tight binding of the adenosyl group. In view of 
studies on model systems the probability of contribution of this type is low (see § 
1.3).28
ill) Finally, alterations of the position of 5,6-dimethyibenzimidazolyl base, 
induced by the appropriate binding of the groups on the loop between ring D and 
the Co(lll), should also be considered.^® Pratt®® used U.V. data to argue that in the 
case of ribonucleotide reductase, the Co(lll)-N benzimidazolyi bond is broken 
during catalysis affording the so-called base-off form of the coenzyme. This report, 
however, has not been confirmed by any other researchers.
In 1985 Pratt®4 summarised the above views. "The metallo-enzymes emphasise 
the ability of the protein to 'activate' the metal by changing an equilibrium 
constant....instead of increasing a rate constant by lowering the energy of the TS."
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1.7.2 Stabilisation of the Transition State (TS)
The suggestion that the activation of the Co-C bond is achieved by altering the 
conformation of the coenzyme in the active site was challenged by Krautler etal.^^ 
and Nie et a/.^s Both groups argued that the TS hypothesis should be used to 
interpret older and more recent literature. The protein could stabilise the TS 
between the coenzyme and the product radicals - a "trick" widely utilised in 
biochemical systems, Krautler's argument was based on the crystal structure of 
cob(ll)alamin. Since the structure of the intact coenzyme and the cob(ll)alamin are 
so similar (§ 1.5) it did not seem likely that the protein would choose the distortion 
of the corrin ring as the initial event of the activation process. Less dramatic and 
probably more effective could be a differential binding between the two radical 
homolysis products and the intact AdoCbl. In other words the enzyme stabilises the 
TS.
Nie and Marzilli also supported the TS hypothesis but their argument was 
based on a larger collection of data concerning the cleavage of the Co-C bond. 
Elegant studies on the BDEs of coenzyme m o d e l s ^ ^ . s e  showed that many 
discrepancies could be explained on the assumption that the outcome of the 
cleavage of the Co-C bond was dependent on differences in the free energies of 
the products (and hence in the TS) rather than in differences of the ground states 
(intact coenzyme).
Finally, all the available data on the behaviour of coenzyme models are 
consistent with the stabilisation of the TS hypothesis.
I
I
TS
AG*
E + AdoCbl EAdoCbl
Structure (Reaction Coordinate)
Figure 1.8 Free energy diagram fo r Co~C bond cleavage
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Accordingly, the "relief of strain" mentioned above (§ 1.7) was the binding energy, 
transformed into AG’ ,^ the Gibbs energy of activation, and used by the enzyme to 
break the Co-C bond (Fig. 1.8). No conformational distortions of the coenzyme 
have to be evoked. The protein does not force the coenzyme to adopt a new 
conformation, it just binds the cob(ll)alamin and the 5-adenosyl radical more 
efficiently than the intact coenzyme.
1.8 Coenzyme B i2-Dependent Reactions and EPR Spectra
The ten AdoCbl-dependent enzymes mentioned above (§1.2, p. 3) catalyse 
twelve rearrangements that fall into three categories. The first one includes the 
dehydration of ethanediol, propanediol, glycerol and the deamination of ethanol­
amine. (R)-ornithine-, (S)-p-lysine-, (R)-a-lysine- and (S)-leucine-2,3-aminomutase 
fail into a second class, in which the migrating group in each case is an -NH2. The 
third group includes glutamate, methylmalonyl-CoA, isobutyryl-CoA, and a- 
methyleneglutarate mutase.
From the preceding discussion it is clear that homolytic cleavage of the Co-C 
bond is by far the most favourable and controllable mild reaction that the coenzyme 
can undergo under enzymatic control. Additionally the presence of highly reactive 
radical intermediates offers a framework which explains more satisfactorily, though 
not completely, the rearrangement step. The "hard" evidence for the existence of 
kinetically competent radical intermediates is that i) the appearance of 
paramagnetic species took place only after the addition of the appropriate 
substrate, and that ii) the species observed, were not due to any kind of interaction 
between substrates and AdoCbl, or related with any possible degradation 
products. 12
EPR  signals have been observed so far for diol dehydrase,s7 ethanolamine 
ammonia lyase, methylmalonyl CoA mutase,ribonucleotide reductase^s and 
more recently for glutamate mutase^o (Fig. 1.9, p. 19). These spectra, after the 
appropriate mathematical treatment,®"' can provide information not only about the 
radical cob(ll)alamin but also about the exchange coupling and the geometry of the 
magnetic dipole-dipole and spin-spin coupling with other species (presumambly 
carbon centered radicals) present in the active site.
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Initial attempts to obtain a interpretable EPR spectra using slow freezing 
techniques were unsuccessful. When this problem was overcome®^ a number of 
efforts were made to interpret the results. Coffman ef a/.®®-®'^  and Boas ef a/.65,66,67 
developed methods that explained thoroughly and convincingly the spectra 
obtained. The two teams performed computer simulations of the low spin Co(ll) 3cP 
system with an unpaired electron. The solutions had to fit the simpler spectrum 
obtained at 9 MGHz (Fig. 1.9.a) as well as the more complicated one obtained at 
35 MGHz (Fig. 1.9.b). The large Co(ll) separation is due to the presence of another 
radical at a distance of 9.9 A from Co(ll) at a position approximately 34° off the 
principal axis, which is the axis of the C-N-3 bond. The implication is that the 
catalytic activity in AdoCbl-dependent enzymes does not take place in the Co(ll) 
coordination sphere and that following the homolytic cleavage of the Co-C bond, 
the 5’-adenosyl radical is positioned (towards the substrate binding pocket) at a 
distance of about 10 A, where the rearrangement and hydrogen transfers occur.
The similarity of the EPR spectrum of glutamate mutase and ribonucleotide 
reductase is striking (Fig. 1,9.a, and 1.9.e.A) for systems that catalyse such different 
reactions. This fact, however, only strengthens the hypothesis outlined above to 
account for the observations concerning the initial catalytic steps.
Kinetically competent radical Intermediates were observed only after the 
addition of substrate. There was, however, evidence that in some cases binding of 
the coenzyme was sufficient to "activate" but not cleave the Co-C bond. This would 
explain the slow deactivation of the apoenzyme-coenzyme complex observed for 
diol dehydrase,44 and ribonucleotide reductase.46
1.9 Mechanistically Plausible Pathways
After the homolytic cleavage of the Co-C bond the 5’-adenosyl radical is likely to 
react directly with the substrate. The product of this step had been the subject of 
much controversy.®® A number of experiments with isotopically labelled 
substrates, 12 revealed two important mechanistical features. First, the coenzyme 
serves as an intermediate hydrogen carrier at CH2-5 ', and second, 5'- 
deoxyadenosine is an intermediate in the catalytic p r o c e s s . ^ 2,69
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9 GHz EPR spectrum of r. reductase
g=2.0036
9 GHz EPR spectrum of diol dehydrase
2.4 2.2 2.0 1.8
3000
9 GHz EPR spectrum of ethanolamine 
ammonia lyase
300 350 400
9 GHz spectrum for glutamate mutase (A) 9 GHz spectrum of methylmalonyl-CoAmutase
Figure 1.9 EPR spectrums o f B12 - dependent enzymes
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In accordance with these results the reaction of the 5'-adenosyl radical with the 
substrate gives rise to the substrate radical S’. The fate of this species is still a 
matter of debate. S’ can Interact with the protein or cob(ll)alamin, to give (Scheme 
1.1) the charged (b,c) or other (d, organocobalt) species that actually rearrange.
Pathway (a) has become popular for the carbon skeleton rearrangements since 
all data seem to support non charged intermediates.^^ With the exception of 
methylmalonyl-CoA mutase, for which pathway (c) has also been postulated 
(Scheme 1.3, p. 28), all the other carbon skeleton rearrangments can be envisaged 
to proceed through radical intermediates.
Pathway (b) may be of some importance for the reactions involving the 
rearrangement of hydroxyl- and amino- group. Golding and Radom^i used ab initio 
molecular orbital calculations to demonstrate that [1,2]-shifts in hydroxy- or amino- 
containing radicals might be facilitated by protonation of the migrating group (Fig.
1.10). An amino acid in the active site could provide the necessary proton.
r — —
Figure 1.10 Postulated charged intermediates
Pathway (c) would involve the transformation of the radical species present in 
the active site, to a negative charged substrate intermediate. S’ . Speculations 
about the formation of S’ in the active site e x i s t , 7 3  they are not supported by 
any experimental evidence.
Despite substantial early c o n s i d e r a t i o n , 7 4 ,7 5  route (d) is now regarded with 
scepticism. Many experimental efforts to prove that the cobalt actually can form 
complexes with radical intermediates and induce [1,2]-migrations have been 
inconclusive, although there were studies providing evidence for putative Co-alkyl 
complex f o r m a t i o n . 7 5 , 7 6  Unfortunately, even if these data are reproduced, no link
Chapter 1 : Coenzyme B12 Dependent Reactions 21
exists between studies of cobalt complexes in solution and the enzyme catalysed 
reactions. Pratt's suggestions^ that a long range (in order to explain the EPR 
signals, § 1.6.3) orbital coupling produces "a cobalt-promoted carbonium ion" was 
interesting but lacked experimental support. The large distance between the 
radicals present In the active site (cob(ll)alamin and the organic radical) and the 
discovery of certain chemical models for the rearrangement (§ 1.14) steps argue 
strongly against the participation of Co(ll) in the crucial step.
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Scheme 1.1 Possible Pathways fo r  the Organical Radical S*
Another aspect emerging from the inspection of pathways (a,b,c,d) is the 
importance of two hydrogen transfers. A hydrogen atom, initially abstracted from 
the substrate, equilibrates with the other two protons on C-5' of the ribose (R-CH2*, 
Scheme 1.1) and is returned after the rearrangement to the product radical P \  The
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isotope effect for these two steps has been measured and reported for most of the 
enzymes studied so far (diol d e h y d r a s e / ^  ethanolamine ammonia lyase/®  
methylmalonyl-CoA mutase/® glutamate mutase®®). The values for the primary 
isotope effect were in the expected range (between 3.5-10) and indicated that the 
initial hydrogen abstraction (A in Scheme 1.1) was actually the rate limiting step. In 
the case of ethanolamine ammonia lyase a large tritium effect {kn/kr^QO) was 
observed.77 One explanation offered by Cleland®"* to fit the experimental data was 
the presence of another hydrogen carrier in the active site closely located to the 
adenosyl group. Additional proof has been delivered®  ^but is yet to be confirmed by 
other researchers.
1.10 Oxo-Forming Reactions
The overall stoichiometry of these irreversible reactions (Fig. 11, eqs. 2-3) 
points to a deceptively simple dehydration or deamination picture. Early studies 
proved that they all proceed via an 1,2-interchange of a hydrogen and a -OH or an 
-NH2 group.®®
OH
DiolOH
Dehydrase
OHHO Diol
Dehydrase
GlycerolHO OH OHDehydraseOH
EthanolamineOH
ammonia lyase +  NH
Figure 1.11 B 22 -Dependent dehydrations
1.10.1 Diol Dehydrase
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1.10.1 D id  Dehydrase
Diol dehydrase (E.C. 4,2.1.28) is probably the most extensively studied enzyme 
of the group®  ^and catalyses the conversion of 1,2-ethanediol, and 1,2-propanediol 
to acetaldehyde and propionaldéhyde respectively (Fig. 11, eqs. 2,3). The enzyme 
was isolated and purified from extracts of Klebsiella pneumoniae and needs a 
monovalent cation for activity (K+ or N H 4 +).
The actual composition of the active apoenzyme, finally elucidated®®»®® in the 
early 1980's, revealed a complicated structure in which four subunits (Mr 60,000,
51,000, 29,000, and 15,000) combine to create a large protein of Mr 259,000. The 
large subunit, (Mr 60,000), is acidic, and contains sensitive sulphydryi groups. No 
functional assignment has been reported for any of the subunits.
The lack of substrate stereospecificity is rather impressive. 1,2-Ethanediol, (R)- 
and (S)-1,2-propanediol, 1,2-butanediol, 2,3-butanediol, (R)- and (S)-glycerol, 2- 
methyl-1,2-propanediol, 2-fluoro-1,2-propanediol are all substrates for the enzyme. 
All the rearrangement steps are stereospecific. The enzyme essentially catalyses 
the migration of the hydroxyl group from C-2 to C-1. The shift of a hydrogen atom 
from C-1 to C-2 proceeds with inversion of configuration on C-2. Which of the two 
prochiral hydrogens on C-1 migrates surprisingly depends on which isomer of 
propanediol is processed by the enzyme. The final dehydration of the diol to the 
aldehyde is not enzyme catalysed.
Diol dehydrase is the only system for which the Co participation question has 
been tackled with success.®  ^ Finke and coworkers synthesised the acetal protected 
HOCH2CH(OH)-cob(lll)alamin (Fig. 1.12), which has been postulated to be an 
intermediate of the catalytic process.®® Upon deprotection and generation of the 
corresponding radicals no rearrangement products were detected under a variety 
of conditions. Moreover, the formation of highly reactive cob(i)alamin species 
proved the incompatibility of this kind of intermediate with a protein environment.
1.10.2 Glycerol Dehydrase
Glycerol dehydrase (E.C. 4.2.1.30) is not very well studied.®  ^ Nothing is known 
about the stereochemistry of the reaction (Fig. 1.11, eq. 4)
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[R-Co{(DO)(DOH)B}l
R-Cbl
Figure 1.12 Postulated intermediate fo r Co-participation mechanism
1.10.3 Ethanolamine Ammonia Lyase
Ethanolamine ammonia lyase (E.C. 4.3.1,7) is a widely distributed enzyme.®® It 
has been Identified in many bacteria including E. colL, but was originally isolated in 
large amounts from Clostridium. The enzyme catalyses the formation of 
acetaldehyde and propionaldéhyde from ethanolamine and 2-aminopropanol 
respectively (Fig. 1.11, eq. 5) and, unlike diol dehydrase (§ 1.10.1), no other 
substrates are known.
Only the clostridial enzyme needs a monovalent cation for activity (K+ or N H 4 +). 
Both the clostridial and E. coii enzymes are very big proteins with a molecular 
weight of 520,000 and 560,000 respectively. The huge protein complex can 
actually be "seen" using electron microscopy. It is composed of at least two types of 
subunits and contains catalytically important sulphydryi groups. Early kinetic 
studies reported two active sites®® but the value was revised later to six using more 
advanced methods.®"' These findings supported an lelle subunit structure. The 
coenzyme is not dissociated by the apoenzyme during the purification procedure 
due to very strong binding.
The only important stereochemical information was reported by Gani et a/.®® 
The pro-S hydrogen on C-1 migrates to 0-2. Any stereochemical information on 0- 
2 is finally lost due to racémisation occuring during the last two reversible steps of 
the overall mechanism (Scheme 1.2).®® The behaviour of ethanolamine ammonia 
lyase with compounds of the type Ado(CH2)nCb has been discussed previously 
(see § 1.7).
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I
CH3CH0
Scheme 1.2 Ethanolamine ammonia lyase - reversible steps
1.11 Interconversion between Amines - Aminomutases
The AdoCbl-dependent aminomutases catalyse the migration of an amino 
group from and to various positions on amino acid skeletons (Fig. 1.13, eqs. 6-9).
H2N
HOoC-'ii
HO2C
H NH2
NH2 (R )-0 ">»lMne ^
Mutase HO2C
H2N
(R)-g-Lysine
NH2 mutase
(S)-P-Lysine
H2N NH2
(6 )
NH2
mutase
(S)-Leucine-^2,3-
  —ammo mutase
CO2H (8)
NH2 NH2
HO2C
Figure 1.13 Coenzyme B^-dependent amino mutases
1.11.1 (R)-Ornithine- and (R)-a-Lysine-aminomutase
(R)-Ornithine- (E.C. 5.4.3.5) and (R)-a-lysine-((S)-|3-lysine)-aminomutase (E.C.
5.3. 3.3) (Fig. 1.13, eq. 6 and 7,8 respectively) were isolated by bacteria of the 
genus Clostridia, and their biological role is to provide intermediates that can be 
easily metabolised by the bacteria. No studies are available on their mode of action
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and the most recent review was published in 1981.®  ^ The enzymes have similar 
molecular weights (200,000 and 170,000 respectively) but different subunit 
structures. Ornithine mutase: 90,000 and 12,800, (Ei £ 2)2 and lysine mutase:
61,000, 30,000, 12,800, (E-jE2E3)2. The small subunit seems to be identical in both 
apoenzyme complexes and protects the system from fast deactivation. A 
monovalent and a divalent cation are necessary for activity. Pyridoxal phosphate 
and ATP are not essential but enhance activity.
1.11.2 L-Leucine-2,3-aminomutase
L-Leucine-2,3-aminomutase (E.C. 5.4.3.7) is probably the most widely 
distributed amino-mutase. Its physiological role in humans is probably the 
conversion of p-to  a-leucine (Fig. 1.13, eq. 9).®  ^ Despite the possible medical 
interest, the enzyme has been studied only in crude extracts, since it is extremely 
unstable.
1.12 Carbon Skeleton Rearrangements
The carbon skeleton rearrangements.(Fig. 1.14, eqs. 10-13) are [1,2] 
intramolecular shifts in which the bond between the most heavily substituted C-2 
and C-3 is cleaved and a new bond between C-2 and C-4 is formed. The four 
enzymes of the group require nothing but the cofactor to promote the 
transformation.
1.12.1 Glutamate Mutase
Glutamate mutase (E.C. 5.4.99.1) catalyses the interconversion of (S)-glutamate 
to (2S,3S)-3-methylaspartate (Fig. 1.14, eq. 10) and will be discussed separately 
later (§1.16).
1.12.2 Methylmalonyl-CoA Mutase
Methylmalonyl-CoA mutase (E.C. 5.4.99.2) catalyses the rearrangement of 3- 
carboxy-propionyl-CoA to (2R)-methylmalonyl-CoA (Fig. 1.14, eq. 11) as part of the 
propionic acid metabolism. The enzyme can be found in most mammals and is 
important for the metabolism of branched-chain fatty acids and isoleucine. Some
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bacteria, such as P. shermanii use the system in the opposite direction i.e. to 
produce propionate from succinate.®®
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n  (,CH3
Glutamate h - hid ^
'‘mutase HO2C CO2H
Oo
Methylmalonyl-CoA
CoA-S 2 4 'CO2HO
CoA-S" 'CH3
CH2
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Isobutyryl-CoA
^  Mutase CoA-S
CO2H
CoA-S" ^  ( 11)
O CH3
CH3
OII CHs
H 0 2 C ''^ ^ ^ " ^ " ^ C 0 2 H  M ethylene^utarate
"'mutase CoA-S H
CHs
CH3
( 12)
( 13)
Figure. 1.14 Coenzyme B 12-Dependent carbon skeleton rearrangements
Two components (Mr 79,000, and 67,000) were identified by Leadlay and 
coworkers®® amending earlier results by Zagaiak et a/.®7 The characterisation of 
the genes containing the enzyme from P. shermanii X^ xee years later®® provided 
the first sequence for a protein of this group (Mr 80,147, and 69,465).
Methylmalonyl-CoA mutase is the only AdoCbl-dependent carbon skeleton 
rearrangement for which an anionic mechanism has been postulated to be 
operational (Scheme 1.3).®® However, the recent discovery of an EPR signal®  ^ (Fig. 
1.9.f) confirmed the involvement of radicals known to occur in other B12 dependent 
systems. The stereochemical course of the migration step was established using 
suitably labelled compounds.''®®»''®  ^ The reaction at C-2 proceeds with retention of 
configuration. Elucidating the stereochemical course of the reaction at C-3 was 
rather more complicated but retention of configuration was found to prevail. Most of 
the stereochemical problems in the reaction catalysed by methylmalonyl-CoA were 
resolved in a recent publication by Retey and coworkers. 1®® Finally a coenzyme A 
analogue in which the sulphur atom had been replaced by a methylene group was
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also reported to be turned over by the enzyme in similar efficiency to the natural 
substrate.
CO2H
< 0COSCoA
SCoA SCoA
CoA-S CoA-S
Scheme 1.3 Rearrangement involving charged intermediates
1.12.3 Isobutyryl-CoA Mutase
Isobutyryi-CoA mutase (E.C. 5.4.99.3) is the most recently discovered 
coenzyme B i2-dependent e n z y m e . 0 4  nq information is available for the 
transformation catalysed (Fig, 1.14, eq. 12).
1.12.4 a-Methyleneglutarate Mutase
The transformation of 2-methylenegiutarate to (R)-3-methylitaconate (Fig. 1.14, 
eq. 13) catalysed by methyieneglutarate mutase (E.C. 5.4.99.4) is a step in the 
fermentation of nicotinate by Clostridium barken.
The protein has been only partially purified recentiy‘>°6 and no information is 
available about the structure of the apoenzyme. Experiments performed using 
crude preparations of the enzyme established that the reaction is proceeding with 
inversion of configuration at the a-carbon.io^ 1-Methyl-c/s-and 1-methyl-frans- 
cyciopropane-dicarboxyiate have been shown not to be substrates for the enzyme.
1.13 Sulphydryi groups
Ail the coenzyme B12 dependent enzymes studied so far have been found to be 
sensitive to reagents that react specifically with -SH groups.i°'i2,io8 Usually the 
enzyme is completely inactive when the sensitive sulphydryi groups are in the
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oxidized form, in some cases the presence of the cofactor or the substrate protects 
the system against this kind of inactivation. The role of the -SH groups in the 
catalytic process is yet to be reconciled with the present knowledge on the B12- 
dependent rearrangements,
1.14 Model Systems
An integral part of the effort to elucidate the mechanistic details of the 
isomérisations presented above has been the development of appropriate 
chemical models. Carefully designed molecules can test the feasibility of various 
mechanistic pathways under a variety of experimental conditions. The oxo-forming 
reactions were the easiest to model. For example generation of a radical on 
ethyienediol yielded acetaldehyde in a straightforward manner (Scheme 1.4).io9
CH3CH0
Scheme 1.4 Chemical model fo r  eqs. 2-4 
Other more elaborate models that incorporate a hydrogen abstraction step were 
developed by Golding and others. (Scheme 1.5).^  ^In this case the model mimicked 
both the radical generation (homolytic cleavage of the Co-C bond), and the 
abstraction of a hydrogen by a methylene radical.
0 "
Ri
hv
pH 3
CH2 H P )
Rl=OH, I^=Rg=H, 10%
Ri=H, I^=-CH20H, Rg=-CH3, 20%
Scheme 1.5 Advanced model reaction fo r diol dehydrase
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For methylmalonyl mutase, Scott and Kang^io developed a successful model in 
1977. After irradiation induced homolytic cleavage of the Co-C bond, the thioester 
migrated in 70% yield (Scheme 1.6).
H3C COOEt
COSEt
CH2 EtSOC.
COOEtCo
Scheme 1.6 Model reaction or methylmalonyl-CoA mutase
An elegant model for methylmalonyl-CoA mutase was recently reported by 
Dowd and coworkers.111 The initial Co-C bond homolytic cleavage was followed by 
an intramolecular hydrogen abstraction. The radical thus formed rearranged to the 
products (Scheme 1.7). Rearrangement products could also be detected after 
treatment of the corresponding bromide with tributyltin hydride. Both models, 
however, have to be extended in order to incorporate Retey's d isco very2, 
however, that the succinyl-CHaCoA is also a good substrate for the enzyme (§ 
1.9.2).
EtOOC.
HgC COSEt
COOEt
COOEt
Co i)
or ii)
COSEt
Conditions (a) (b) (c)
i) H2O, 55°C, 14hr 50% 41 9
ii) MeOD 25% 62
EtO O C .^^Jx,^^^% ^s^. COOEt 
H(P) COOEt
EtOOC. COOEt
COSEt COOEt
H(D)
E tO O C ^^^X.,,,^^^ COOEt
COSEt 1 COOEt
(a )
(b)
(c)
H(D)
Scheme 1.7 Advanced model fo r  methylmalonyl-CoA mutase
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Models for the methyleneglutarate mutase catalysed rearrangement were 
developed by Dowd during unsuccessful efforts to model the action of glutamate 
mutaseJ ■'3 The migration of an sp^-hybridised carbon was found to be easily 
reproduced by chemical systems, although the yields were usually low (Scheme 
1.8.a).
H2C^ 5j . C 02R H2C
Co(I)alamin
15%
CO2R
PhPh
n-BusSnH (b)80%
Scheme 1.8 Model reaction fo r methyleneglutarate mutase
One could characterise the rearrangement of the bromoester (Scheme 1.8.a) as 
"metal catalysed" if it was not known that a similar bromoaspartate analogue 
(Scheme 1.8.b) rearranged when treated with tributyltin hydride without the 
presence of Co(III) species. The radical species generated clearly isomerised 
without difficulty.
1.15 Main Characteristics of The Systems Reviewed
The data presented so far suggest that the protein is completely in charge of the 
rearrangement step. This does not imply that substrate radicals initially generated 
do not have the intrinsic tendency to isomerize but that the enzyme is controlling 
the reaction in a way that it will be fast, stereochemically reliable, and of course 
with no by-products that can be very harmful to the environment of the active site. 
Finke and Golding in two recent reviews arrive at the same conclusion.39.99 
Especially Finke, who claims that the term "bound radical mechanism" describes
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accurately what is happening at the active site. Under this term the authors 
suggested a mechanistic scheme in which the enzyme is the conductor of the 
rearrangement by employing strategically positioned groups around the substrate. 
These groups interact (protonate, hydrogen bond, etc.) with the substrate and 
promote the reaction. The discovery of chemical models just points out once more 
the fruitful interplay taking place in bioorganic chemistry, without offering any proof 
against the "bound radical mechanism".
Three main points are clear from the previous discussion.
1) Coenzyme Biais a stable organometallic molecule evolved in biological 
systems in order to serve as a radical "lender". AdoCbl-dependent enzymes, in the 
presence of the appropriate substrate, activate the cofactor and generate 
cob(ll)alamin and 5'-deoxyadenosyl radicals.
2) All the Bi2-dependent enzymes are large proteins ( Mr > 130,000) with a 
complicated subunit structure, obviously necessary to perform the tasks described 
previously (see § 1.6.).
3) The uncertainty about the rearrangement step persists. Chemical models 
developed so far do not fill the gaps of our understanding. Moreover, as long as 
there are no kinetic studies and X-ray structures for any of these proteins, nobody 
will be able to claim firm understanding of the coenzyme B i2-dependent 
rearrangements.
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1.16 Biological Roie and Discovery of Glutamate Mutase
A significant number of bacteria ferment (2S)-glutamic acid through two distinct 
energy yielding pathways (Scheme 1.9). The final products in both cases are 
acetate, butyrate, CO2, and ammonia. The methylaspartic acid pathway is used 
only by species of the genus Clostridium , whereas the (R)-2-hydroxyglutarate 
pathway is used by several other genera.""
H2N
(1) NAD
H2N ^  H
(2 )
HO2C
(2S ,3S)-3-Methylaspartate
HO2C
NADH
NAD
(3)
CO2H
(2R)-Hydroxyglutarate
,.0H
COSCoA
CH3CH2CH2CO2H
Scheme 1.9 Fermentation of glutamate in bacteria
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The elucidation of the methylaspartate pathway was reported in 1958 by Barker 
et as a result of fermentation studies on the bacterium Clostridium
fefano/77orp/iu/77, strain H I. Glutamate mutase catalyses the first step of the 
pathway, converting (2S)-glutamic acid to (2S,3S)-3-methylaspartic acid. Growing 
the bacterium with glutamate as the sole carbon source results in the 
overproduction of all the enzymes involved in the pathway, including the mutase.
Charcoal treatment of the crude cell extracts inhibited the consumption of 
glutamate while ammonia could still be added to mesaconate in order to form a 
rather rare amino acid, soon identified as (2S,3S)-3-methylaspartic acid.'""'  ^ The 
existence of an enzyme that actually catalyses the interconversion of glutamate to 
methylaspartate was established in 1961.1'"6 Complete loss of activity on addition 
of alkaline cyanide and the pink colour of active protein fractions were clues 
implying the presence of corrinoids. When protein of satisfactory purity was 
available the dependence on coenzyme B12 was demonstrated.i'"7 in 1967 full 
purification protocols and some preliminary kinetic results were published.ii^.HG 
Since then only one paper^o appeared in the literature until 1992. Despite the 
involvement of many groups with other AdoCbl catalysed rearrangements, 
glutamate mutase remained out of the main stream of interest. Clostridial cultures 
are expensive, require large fermentation facilities, and the yield of glutamate 
mutase for the overall isolation is not high.
In contrast, p-methylaspartase, the second enzyme of the pathway, is stable and 
easier to purify. Its availability in large quantities (overexpressed in E. coli ) in our 
laboratory, has allowed its use as a synthetic tool in the study of glutamate mutase.
1.17 Reaction Catalysed and Assays
The formal [1,2]-migration of C-2 of glutamic acid from C-3 to C-4 (Scheme
1.10), promoted by the enzyme, is the only rearrangement known in which all the 
three carbon atoms involved, are saturated. Glutamate and methylaspartate are the 
only substrates known for the enzyme, with apparent Km values of 1.35 (see § 3.5) 
and 0.5 mM respectively.^^® Some of the compounds tested for the mutase as 
substrates with negative results were (R)-glutamate, (RS)-2-methylglutamate, 
(2S,3R)-3-methylaspartate, and 2-methyleneglutarate (see Tables 1.6, p 44, and
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3.4, p. 103).''■*5-118 The reaction is reversible. The equilibrium established, in the 
presence of the enzyme between the two substrates, at pH 8.2, favours glutamic 
acid. The K^ q is approximately 10.7. This corresponds to a AF° between glutamate 
and methylaspartate of 6 kJ mohT Molecules such as methacrylic, propionic, 
pyruvic, 2-ketoglutaric acid, glycine or ammonia have been excluded as free 
intermediates using the appropriately labelled compounds.n^ Accordingly the 
reaction proceeds in 2H2O without the incorporation of deuterium.
% CO2H Keq H2N 1 H-ffl»**- CH3HO2C 1 CO2H
Coenzym e  
G lu ta m a te  M utase
JSi V  ^  Inversion
CO2H
. CO2H
H2N" ? ^C02H 
H
Scheme IJO  The Glutamate mutase reaction
Two assays have been developed to measure the activity of the mutase. 120 The 
first is based on the conversion of glutamate to mesaconate by the coupled action 
of glutamate mutase and p-methylaspartase (Scheme 1.9). The double bond on 
mesaconate (3) allows a convenient measurement of the absorbance at 240nm. 
The method, however, has a disadvantage. Some methylaspartate analogues 
which could give valuable information for glutamate mutase are also substrates for 
p-methylasparlase, therefore interfering with the assay. The anaerobic assay relies 
on the conversion of methylaspartic acid to glutamic acid under strict anaerobic 
conditions. The amount of 3-methylaspartic acid left is calculated by enzymatic or 
chemical means. Unfortunately this modification does not cancel the restriction 
mentioned above.
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1.18 Structure of the Holoenzyme
The active form of glutamate mutase, is a complex of two subunits, both 
necessary for activity. Barker et al. reported their size as 128 kDa and 17 KDa for E 
and S respectively,ii5,ii9 recent studies by us and others'*21,122,123 dismissed 
part of these results. The correct molecular weights for the two components are 53 
and 14 KDa.
The number of AdoCbl molecules per molecule of active apoenzyme and the 
effect of the coenzyme concentration on the affinity of the two components for each 
other and for the substrate have been studied using typical saturation experiments. 
When the amount of component E was kept constant, an increase in the 
concentration of component S decreased the Km of the coenzyme (Table 1.3), and 
vice versa. In a similar manner high concentrations of coenzyme increased the 
affinity of the two components for each other.n®
Table 1.3 Effect o f the EIS 
molar ratio on the Km 
o f the coenzyme
S/E  molar 
ratio
Km 
for AdoCbl
0 .35 1.29
3.6 0.12
17.8 0.31
When the S/E molar ratio was increased further the activity of the system 
remained unaffected but the Km still decreased. An explanation for this unusual 
behaviour "would appear to require a mechanism in which the catalytic function of 
component 8 is distinct irom its function in enhancing coenzyme binding".H8
It is well established that the coenzyme binds on component E II8 but the 
number of molecules per molecule of component E is still uncertain. Analysis of 
kinetic data indicated a value of 1 mole coenzyme per mole of component E (after 
correcting for the molecular w eig h t).H 5  When tritium labelled coenzyme was 
incubated with the enzyme the label was transferred to the product amino acids. 
From the percentage of the radioactivity transferred the ratio of coenzyme 
molecules per molecule of component E was calculated as 3.124 This discrepancy 
cannot be easily explained on the basis of the present knowledge on the system.
Chapter 1 : Glutamate Mutase 37
1.19 Purification and Physicai Properties of the Enzyme
The two purification procedures reported so far for component E are 
summarised and compared in Table 1.4. In the original method, reported by 
Barker,118,119 the overall yield was 18%. The partially purified protein was 
estimated to be 75% homogeneous and displayed a specific activity of 3.6 units 
mg-f. The procedure recently reported by Buckei and coworkers afforded the pure 
protein with higher specific activity (6.57 units mg-i) despite the low overall yield 
(6%).i2i A small amount of component S (5-10%) was still present.
The presence of sodium glutamate or p-methylaspartate had been shown to 
protect component E against deactivation in cationic buffers (e.g. Tris).n8 These 
findings suggest that the "pocket" for the substrate is located on component E. This 
protective effect could arise either from exclusion of solvent molecules from the 
active site or adoption by the protein of a more stable conformation.
Table 1.4 Purifications o f component E of glutamate mutase
Barker's purification 
(C. tetanomorphum)*
Activity
Units(%)
Units/
mq-1
Buckel's Purification 
{C. cochlearium)*
Activity
Units(%)
Units/
mg-1
Sonic vibration 2 6 1 (1 0 0 ) 0 .02 Sonic vibration 4 34 (1 0 0 ) 0 .09
Charcoal/protamine 2 54  (97) 0 .06 Ammonium Sulphate 414  (95) . 0 .12
Ammonium Sulphate 240 (92) 0 .12 DEAE-Sephacel 168 (39) 0.41
DEAE cellulose and G-100 144 (55) 1.10 Superdex 200 131 (30) 1 .28
Carboxymethyl cellulose ._51 (20) 3 .20 Mono Q 78 (18) 3 .10
Brushite 46 (18) 3 .60 Phenyl-Superose 25 (6) 6.57**
* Data adjusted for lOOgr of cell paste
** More recently Buckei reported briefly that he improved his purification by 
achieving a specific activity of 12.4 units mg-i.^o
The primary structure of component E contains seven cysteines. None of the 
sulphydryl groups seems to be catalytically important, since treatment with 
iodoacetate or 2-mercaptoethanol had no effect on the activity of the 
h o lo e n zy m e .118 Nevertheless, the presence of mercaptoethanol in the storage 
buffers quickly deactivated the protein.
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AdoCbl was shown to have no effect on the stability of component E, but the 
experiments were performed in the absence of component S. Subsequently, no 
comparison can be made with other systems, like for examble diol dehydrase, 
known to lose their activity faster in the presence of the coenzyme 89
Component S is more stable than component E and has been purified 350-fold 
over the crude extract in 25-30% yield to give preparations of much higher specific 
activities (28-35 units mg-"*). An effective early step in Barker's original purification 
was an isoelectric precipitation at pH 4.6. Stability under these denaturing 
conditions implies a rather simple tertiary structure.
Exposure to oxygen results in the formation of intra- and inter-molecular S-S 
bridges. Activity was lost but the affinity of component S for component E remained 
unaffected. 118 Incubation with reducing agents like 2-mercaptoethanol or 
dithiothreitol restored activity. The protein is marginally more stable during storage, 
in its oxidized state than the reduced one. Under optimum conditions (T<-20 °C, 0.1 
M K2 H PO 4 , pH 7.4) no activity losses were observed for months.n®
The complicated behaviour of the sulphydryl groups prompted a more careful 
study by Switzer and Barker.HQ Underestimating the accuracy of their results, they 
suggested the presence of five or six cysteines in the polypeptide chain instead the 
four actually present (their experimental value was 4.4). Reaction with 5,5'-dithio- 
b/s-(2-nitrobenzoic acid) under denaturing conditions showed that only three of 
them could be exposed to the solvent. One reacted with labelled iodoacetate 
resulting in a 65-70% loss of activity.n® At the same time complete inhibition by 
arsenite implied the presence of two vicinal -SH groups that could form a S-S 
bridge and both were necessary for full activity. An interesting picture emerged. 
One of the -SH groups is deeply buried in the protein and very un reactive, a 
second one is on the surface and can be readily oxidized or reduced but it is not 
involved in the catalytic activity. The last two are closely located (maybe cysteines 
71 & 78, Fig. 1.16) and both have to be reduced for the protein to attain full activity. 
Whether the thiol groups are somehow involved in the catalytic activity, or, more 
likely, are important for binding, is still not clear.
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1.20 Amino Acid Sequences
The sequence of component E and 8 were reported recently by Marsh and 
Hollaway‘*22,i23 and Brecht et The two genes are located just before the gene 
of p-methylaspartase (Fig. 1.15).126
Component E consists of 485 amino acids, (Mr 53,708). Comparison of its 
deduced amino acid sequence (Fig. 1.16) with other proteins revealed no 
homologies with AdoCbl-dependent e n z y m e s .1 2 2  a  possible explanation is that the 
size of the coenzyme causes a "dilution" of the amino acids necessary for its 
binding and activation. Similarities must be conserved in the structural level and 
will be established when three-dimensional structures are available.
Component 8 is located further upstream and consists of 137 amino acids (Mr 
14,748) (Fig. 1.16). An unusual finding by Hollaway and Marsh was that the two 
sequences are not adjacent to each other on the chromosome (Fig. 1.15). Between 
E and 8  lies a 1500 bp piece of DNA designated as L .122  its expression (Mr 50,171) 
together with 8 , E, and p-methylaspartase as one operon seems to be almost 
certain. The deduced amino acid sequence for L suggested no involvement in the 
glutamate fermentation pathway or any other biological function.
PHP H H S3N H H S3 S3
E X ~>l E ) l MeAsp >
pGM1
pSG4
pGM2
0 360 770 1 I i _ 2227 (bp) 3810 I_________________I___ 4565 600J
Figure 1.15 The gene containing S, L, E, and p-3-methylaspartase. Restriction
sites by different nucleases are indicated. pGMI an pGM2 are plasmids 
sequenced in ref 122, and pSG4 is the plasmid sequenced in ref. 126. 
Restriction enzymes are H, Hind\\\; N, Nco\\ P, Ps/I; S3, SauSAI.
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K V P T E K N F A K L V R A K E A G IT L A Q P R A G V A L L D E H IN L L R Y 8 0 G S D C H A V G N K I 2 2
L Q D E G G A D L L P S T ID A Y T R Q N R Y E E C E IG IK E S E K A G R S L 1 2 0 L D H S F T N A G F N 3 3
L N G F P G V N H G V K G C R K V L E S V N L P L Q A R H G T P D S R L L A E I 1 6 0 W N IG V L S S Q E 4 4
-IH A G G W T S N E G G G IS Y N IP Y A K S V P ID K C L K D W Q Y C D R L V 2 0 0 D F IN A A IE T K A 5 5
G F Y E E Q G V H IN R E P F G P L T G T L V P P S M S N A V G IT E A L L A A 2 4 0 D L IC V S S L Y G Q 6 6
E Q G V K N IT V G Y G E C G N M L Q D IA A L R C L E E Q T N E Y L K A Y G Y 2 8 0 G E ID C K G L R E K 7 7
N D V F V T T V F H Q W M G G F P Q D E S K A F G V IV T A T T IA S L A G A T 3 2 0 C D E A G L K G IK L 8 8
K V IV K T P H E A IG IP T K E A N A S G IK A T K M A L N M L E G Q R M P M 3 6 0 F V G G N IW G K Q 9 9
S K E L E T E M A IIK A E T K C IL D K M F E L G K G D L A V G T V K A F E T 4 0 0 N W P D V E Q R F K A 1 1 0
G V M D IP F G P S K Y N A G K M M P V R D N L G C V R Y L E F G N V P F T E E 4 4 0 M G F D R V Y P P G T 1 2 1
L K N Y N R E R L A E R A K F E G R E V S F Q M V ID D IF A V G K G R L IG R 4 8 0 S P E T T IA D M K E 1 3 2
P E N K 4 8 5 V L G V E 1 3 7
Component £ Component S
Figure 1.16 Amino acid sequences o f component E  and S
While further research is needed (site-specific mutagenesis or X-ray structures) 
to establish the role of specific amino acid residues, the possibility of post 
translational modifications as the means for studying the reaction is now not far in 
the future.
1.21 Catalytic Properties
The activation of the coenzyme and the breaking of the Co-C bond by the 
protein have been discussed (see § 1.7). Modified or incomplete corrinoids are 
inactive with glutamate mutase.48 Additionally some of these modified, inactive 
derivatives at the Co-5’-deoxyadenosyl moiety acted as very strong competitive 
inhibitors with respect to AdoCbl.
The only type of change that seemed to be tolerated was on the sixth a-axiai 
position, where the enzyme could accept ligands such as 5-hydroxymethyl- 
benzimidazole, adenine (the main natural form occurring in C. tetanomorphum), 
benzimidazole etc. (Table 1.5). It was interesting that the coenzyme with the bulkier 
base at the (3-axial position, 5,6-dimethylbenzimidazole (entry 1, Table 1.5) had a 
similar Vmax but higher Km than the benzimidazolyl coenzyme (entry 6). The 
benzimidazolyl coenzyme could fulfil its coenzyme duties in much lower 
concentrations. The size of the base affected the binding but not the catalytic 
activity. The activation of the Co-C bond did not appear to be directly related with
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the tight binding of the intact coenzyme in the active site. This observation is in 
accordance with previous discussion concerning the cieavage of the Co-C bond by 
the protein (see § 1.7.2).
Table 1,5 Kinetic properties o f dijferent coenzymes with 
glutamate mutase
Cobamide
Coenzyme
Km 
M X 10-7
Vmax
AA/mln
Relative 
molar act.
1) 5,6-dlmethvlbenzlmidazolvl 128.0 0.27 1.00
2) Diaminopurinvl 16.4 0.27 8.8
3) Adenilyl* 12.4 0.29 10.0
4) 5-Nltrobenzimldazoiyl 5.3 0.32 30.0
5) 5-Metiiyibenzimidazolvl 4.3 0.40 43.0
6) Benzimidazolyl 2.3 0.36 85.0
* The natural occurring coenzyme in C. tetanomorphum
Exposure of the reaction mixtures to oxygen resulted in at least partial inhibition 
of the reaction.117 Maximal activities could only be obtained when the reaction 
mixture was treated so as to remove dissolved oxygen. This sensitivity towards 
oxygen is probably related with the existence of the catalytically competent radical 
species.
Two different EPR signals have been obtained from glutamate mutase reaction 
mixtures. Partially purified preparations of component E displayed a spectrum 121 
with very similar hyperfine splitting as the one observed during deactivation of 
ribonucleotide reductase‘'27 in the presence of the coenzyme (Fig. 1.17).
Figure 1.17 A) EPR: Signal from
inactivated glutamate mutase 
B) EPR: Signal from inactivated 
ribonucleotide reductase
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A second EPR signal due to kinetlcally competent species, was reported by 
Buckei and coworkers.Go (Fig. 1 .18.A). The similarities with other AdoCbl- 
dependent enzymes have already been discussed. Surprisingly the assignment of 
the signal (Fig. 1.18.A) was wrong.
2.2 2.0 1.82.4
Figure 1.18 EPR Spectrum o f glutamate mutase
Buckei based his interpretation on an early publication by Coffman et a/.,63 and 
claimed^o that the spectra implied the presence of two Co(ll) species in a strongly 
distorted 6-fold coordination. Coffman and coworkers, however, in a followup 
study,64 which superseded their initial findings, reported (see discussion in §1.8) 
(Fig. 1.9) that the hypothesis of a 5-coordinated Co(ll) radical coupled by an 
organic radical at a distance of around 10 Â, explained all the available data and 
therefore was more reliable.65
1.22 Substrates and The Rearrangement Step
The 5’-deoxyadenosyl radical, after its generation, occupies a new position -10  
Â away from the cobalt and close to the substrate, already bound on the enzyme. 
The part of the active site where the rearrangement and the hydrogen transfers 
take place is inaccessible to water or oxygen molecules (see § 1.17). However, this 
may not be the case for the location where the cob(ll)alamin is kept, thus explaining 
why the enzyme is so easily inactivated by oxygen during the reaction.
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The adenosyl radical abstracts the pro-S hydrogen from C-4 of glutamic acid 
and the [1,2] shift of the glycine moiety takes place. The product radical retrieves its 
proton back from the C-5' of a d e n o s i n e . ^ ^ s  yve do not know if the Co-C bond is 
reformed before the start of another catalytic cycle. It is conceivable that the 
enzyme can control the flux of substrate molecules without allowing solvent 
molecules to enter the active site. In this way we could have the adenosyl radical 
working in a catalytic cycle before it recombines with cob(il)alamin. For 
ribonucleotide reductase it has been shown that 1000 catalytic events take place 
before the two radicals recombine.li
Incubation of [4-i4C]-glutamic acid with the mutase and p-methylaspartase 1 ^ 9 
afforded mesaconate (3) labelled on C-2 (Scheme 1.11). This observation was 
sufficient to establish the identity and the destination of the migrating carbon. 
Sprecher e fa /.i2® synthesised (2S,3S)-[3-2H]-3-methylaspartic acid (4). Incubation 
with the enzyme afforded (2S,4R)-[4-2H]-glutamic acid (5). A careful inspection of 
the result revealed that the new bond is formed in a Sn2 fashion. In this aspect the 
enzyme is similar with a-methyleneglutarate mutase.
HO2C CH3
H CO2 H
(3 )
H2N %
 CH3
HO2C CO2H
(4 )
H2N
(5 )  H
HO2 C>  H
Product of Inversion at 
C-4 of glutamate
H2N
(6) H" 
H02C
Product of Retention at 
C-4 of glutamate
Scheme 1,11 Stereochemical course o f the rearrangement
If the relative position between the substrate and the adenosyl radical does not 
change drastically after the migration, it is most likely that inversion occurs also on
0-3 of glutamic acid. Evidence, however, is difficult to obtain due to the reversibility
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of the reaction and the torslosymmetry of the product methyl group. Hence, when 
Hartrampf and B u c k e M ^ o  incubated (2S,3S)-[3-2H]-glutamlc acid with the enzyme, 
the equilibration of the hydrogens on the methyl group could not be prevented.
Tritium labelled coenzyme at C-5', in the presence of appropriate amount of 
protein, exchanged more than 90% of the label with glutamate and 
methylaspartate. 121 Eagar et al. in 1972 published data concerning the isotope 
effect of the hydrogen transfers.®® Their elegant but complicated analysis showed 
that the hydrogens on 5'-deoxyadenosyl radical become equivalent. The kinetic 
isotope effect for hydrogen abstraction was 7.5±1.0. Although this value kn/ko was 
not the actual microscopic isotope effect, it strongly suggested that the abstraction 
of the hydrogen was the rate-determining step. Another point which emerged from 
their research was the existence of an intermediate between 3-methylaspartic acid 
and glutamic acid. The value of the intermediate's partitioning ratio was calculated 
1.7 in favour of glutamate. It seems that the TS from intermediate, to reactant or 
product, reflects in some degree the relative ground-state energies of reactant and 
product (see § 1.17).
A variety of derivatives of glutamic acid and (2S,3S)-methylaspartic acid did not 
rearrange. Some of the compounds cited in older literature and their interaction 
with the enzyme is presented in Table 1.6.
Table 1.6 Some substrate analogues and their effect
Compound* Substrate Inhibitor Km or K|
(2S)-Glutamlc acid (1) + 1.35
(R)-Glutamate (7) .
(2S.3S>-3-methvlasDartic acid (2) + t 0.5
(RS)-2-Methvlglutamate (8) t •
2-Ketoglutarate (9) _ t
{2R,3R)-3-methylaspartlc acid (10) - t -
All compounds tested by Barker, refs 118,119. See also Table 3.4, p. 103. 
t  No data available
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1.23 Model Systems
The discovery of a good model for glutamate mutase proved to be rather 
elusive,G9 reflecting the absence of similar known organic r e a c t i o n s / jh e  groups 
of Dowd and MurarakamI have performed most of the work In this field.
3'-MethylaspartyIcobalamlns (11) were prepared by Dowd and coworkers, by 
reacting cob(l)alamin with the appropriate b r o m i d e . 1  irradiation of 
alkylcobalamin (11) generated the radicals, thought to be the intermediates In the 
glutamate mutase reaction. Unfortunately under a variety of conditions no 
rearrangement product was formed (Scheme 1.12). Inconclusive results were 
obtained when the corresponding 3-methylaspartate esters were tested as 
alternative substrates with c o b ( l ) a l a m l n . i i 3 a
HsN. .CO2
Co (11) (12) No Rearrangement Product Detected
Scheme 1.12 Dowd's unsuccessful model
Similar models were more successful and high yielding when C-2 was activated as 
the keto- or imine-analogues, (12) and (13) respectively (Scheme 1.13).i^3b
X<:5^ C 02Et
COzEt
X^^^COzEt
i) or ii)
CH3
Be _ ...Conditions
X=0 (12) i) Cob(n)alamin + , E^ O, 70%
X=N-CH2-Ph (13) ii) n-BugSnH, QHg, 80%
Scheme 1.13 Rearrangement o f (12) and (13)
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The first successful model for glutamate mutase was reported six years ago by 
Murakami ef a//32 a  highly modified corrin ring, [Cob(l)7C3ester]CI04 (Fig. 1.16), 
was reacted with diethyl 3'-bromomethyl-[3-2H]-(RS)-aspartate to prepare the 
lipophilic fully esterlfled alkylcobalamin (14). The molecule was then Incorporated 
Into an Intra-membrane domain formed by synthetic lipid molecules of the type 
Me3N+(CH2)5CHONCH(CH3)HCON- (C i6H33)2-
+ ClOT
(14)
Rj=Me
R2-(CH2)2C02Pr 
R3=-CH2C02Pr
X= CH2C%(C02Et)CH(NH2)C02Et 
Y=H20
Figure 1.19 Murakami's model compound (14)
After irradiation, glutamate (16) was indeed detected In low yields (8-15%) 
(Scheme 1.14). Diethyl glutamate (18) can be formed by the shift either of C-2 or 
C-4. Labelling experiments established that most of the product (70-83%) is formed 
via the desired biomlmetic rearrangement of C -2 .133 The discovery was important 
because It established the feasibility of the rearrangement in an environment that 
suppresses molecular motion and where hydrophobic interactions were 
d o m i n a n t . 134 a  variant of the system was able to serve as a model for 
methylmalonyl-CoA mutase but the yield of the product succinate was even lower
The differences between Murakami’s experiments and Dowd's unsuccessful 
attempts have to be emphasised. The corrin ring and Its substituents were not 
important. The modifications performed on the corrin by Murakami were necessary 
just to make the species soluble in the lipid layer. Estérification of the carboxyl 
groups of the 3-methylaspartatyicobalamin (14), in comparison with the
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unprotected alkylcobalamin (11), probably did not effect the electronic properties 
of 0-3 (no interference with the rearrangement step).
8-15%
Scheme 1,14 Product after generation o f radicals by irradiation
The most important difference, however, was the environment in which the radical 
was generated. The lipid side chains were obviously more inert to radical attack 
and offered more time to the structure to rearrange. Another subtle point emerging 
from this comparison was the certain non involvement of the cobalt in the migration 
step. If cobalt participation was the key mechanistic feature of the rearrangement 
(see §1.9), Dowd's model should have provided some glutamate. Subsequently 
the success of Murakami's model focused our attention onto the environment 
created by the amino acids in the active site and demonstrated that the enzyme 
catalyses an unusual but not "impossible" reaction.
Summary
It is clear that studying a system like glutamate mutase can further our 
understanding in a number of areas. Both mechanistical enzymology and radical 
chemistry have something to learn from Nature's approach to a problem of this 
kind. Some of the questions that have to be addressed concern the structure of the 
TS of the uncatalysed (Murakami's model) reaction and its relationship with the 
enzymatic catalysed reaction. Finally, the means by which the protein protects the 
high energy intermediates present in the active site, and manipulates the substrate 
radical to form the product, have to be elucidated.
Chapter 2
Synthesis of Substrates
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2.0 Introduction
The transformation catalysed by glutamate mutase is a uni-uni reaction. (2S)- 
Glutamic acid (1) and (2S,3S)-3-methylaspartic acid (2) are the only known 
substrates. The high selectivity of the enzyme for these two compounds,ii7 
severely restricts the physico-chemical methods that can be used in order to 
delineate details for the rearrangement. The discovery of appropriate molecular 
probes, substrates or inhibitors, which might interact with the enzyme and provide 
information about the mechanism and the radical chemistry involved, was therefore 
of highest priority.
The structures initially identified as possible mechanistical probes were
(2S,3S)-3-methylaspartic acid (2), (2S,3R)- (17) and (2S,3S)-3-methylglutamic 
acid (18), and 1-amino-1,2-cyclopropanedicarboxylic acid (2,3-methanoaspartic 
acid) (19). Our efforts towards these synthetic targets are discussed in this chapter.
H2N H 
H'«im  .
HO2C CO2H
(2a) (2 S,3S)-[3 '-% 3]-3 -Methylaspartic acid 
H2N
H2N H
H 
HO2C CO2H
HO2C
CO2H
(17) (2S,3R)-3-Methylglutamic acid (19) 2,3-Methanoaspaitic acid
(18) (2S,3S)-3-Methylglutamic acid 4 Isomers
Figure 2,1 Mechanistic probes fo r  the enzyme glutamate mutase
2.1 (2S,3S)-[3',3’,3’-2H3]-3-Methylaspartic Acid (2a)
(2S,3S)-[3',3',3'-2H3]-3-Methylaspartic acid (2a) can be synthesised via the 
stereoselective addition of ammonia to deutehated mesaconic acid (3a) catalysed 
by p-methylaspartase (see § 1.16). Two routes were considered for the preparation 
of the diacid (3a). Treatment of ethyl acetoacetate with sodium ethoxide followed 
by alkylation with pHaJ-iodomethane, affords ethyl 2-methylacetoacetate (20a). 
Reaction of the ester (20a) with bromine and subsequent treatment with base
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(sodium ethoxide) would give mesaconic acid (3a). Previous work in our 
laboratory showed that the overall yield over the three steps was acceptable (-30- 
35%) when R=Et or Pr, (21) and (22) r e s p e c t i v e l y . in the case of R=CH3 (20), 
however, we found that the corresponding overall yield was -15%  (Scheme 2.1 
a,b,c). The main problem encountered was the high level of dimethylation 
occurring during the first step (Scheme 2.1 a).
OEt
H  R
R=CH3 (20)R=C%3 (20a) o O 
R=C2H5 (21) a
t  R = C 3 H 7  ( 22 )
^ __
50% CHs' OEt
HO2C 
(2h)H
b,c 
>=<
35%
C%3 H 2 N  H
(3a)
CO2H 85%
C% 3  15%
Overall
60%
>93% Deuterium Incorporation 
C O 2 H
(23)
CO2H
HO2C CO2H
(2a)
55%
Overall
H 0 l
H ^-----
Conditions, a) EtONa, CD3I, rf. 3h; b) Brz ; c)Ethanolic KOH; 
d) Methyl aspartase, K ,^ NI%, pH 9, Id.; e) NaOD (lOeq.),
D 2O, rf. 24h.
Scheme 2.1. Synthesis o f (2S,3S)-[3'-^H3]-3-methylaspartate (2a)
A method used by Barker et 8/.J24 to prepare (2S ,3 S)-[3 '-3H 3] - 3 - 
methy(aspartate, was adapted in order to obtain the deute hated analogue. Itaconic 
acid (23) was refluxed in NaO^H/ 2H2O for 12-24 hr. The base promoted 
isomérisation of itaconate to mesaconate (3a) in 50% yield, was accompanied by 
high levels of deuterium incorporation. When care was taken to exclude all the 
protium present in the original reaction mixture, the deuterium incorporation, as 
judged by ‘•H-NMR, and accurate mass spectrometry, was higher than 95%.
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2.2 (2S,3R)- and (2S,3S)-Methyiglutamic Acids (17) and (18)
Despite the importance of (2S)-glutamic acid and its analogues in many 
physiological pathways, the 0-3 alkyl derivatives have received very little attention. 
Ring opening of a p-lactone,‘*36 Evan's chiral auxiliary methodology,^^? or other 
methodsi38 can be used to obtain 3-alkylglutamates. However, no stereocontrolled 
syntheses of the enantiomerically pure (2S,3S)- and (2S,3R)- diastereomers have 
been reported so far. Only very recently Paz and Sardina^^  ^managed to obtain the 
versatile dimethyl 3,4-di-dehydroglutamate derivative (24) which can be attacked 
by Me2CuLi to afford the fully protected versions of 3-methylglutamates (17) and 
(18). Despite the absence of any stereoselectivity during the 0 -0  bond formation it 
was claimed that the two diastereomers were separated after selective pyrrolidone 
formation.
PfHN  
H-•11^  -
H3CO2C CÜ2CH3
(2S,3R)-3-Methylglutamic acid (17) could also be synthesised via an Arndt- 
Eistert homologation of (2S,3S)-3-methylaspartic acid (2) which was available in 
gram quantities in our laboratory.
2.2.1 Homologation of (2S,3S)-3-Methylaspart!c Acid j
The N-protected anhydride (25) was synthesised in quantitative yield by |
treatment of 3-methylaspartic acid (2) with trifluoroacetic anhydride in THF. |
Alcoholysis of the anhydride ring with cold methanol gave a mixture 3:1 of the C- |
1 :C-4 esters. 1"^ ° The higher electrophilicity of the a-carbonyl was more pronounced I
when isopropanol was used, and the 1-isopropyl ester (26) was exclussively I
formed (Scheme 2.2). In the ‘’H-NMR spectrum of the product (26) only one ester 
group could be detected.
Refluxing the 4-carboxylic acid (26) in thionyl chloride afforded a mixture of {
compounds including the desired acid chloride (27) in 40% yield.141 j
Recrystallization removed most of the impurities but the sensitivity of the product to
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moisture routinely resulted in the contamination of the chloride (27) by the free 
acid (26). The optimum conditions for the formation of 1-isopropyl 3-methylaspartic 
acid chloride (27) were established as Ihr. reflux of (26) in dry dichloromethane 
in the presence of 4eq. of SOCI2. The acid chloride (27) was furnished in 
quantitative yield, and after thorough removal of the volatile material under 
reduced pressure, it was treated with an excess of dry diazomethane. The 
diazoketone (28) was obtained in 96% yield from the free acid (26) as a clear 
yellow oil which upon freezing to 0 °C solidified as large bright yellow crystals (m.p. 
22-24 °C).
NH2 H
H- 
HO2C
(2S,3S)-methylaspartic acid (2)
i>ti  xi 
■im......^
J# Tr
CH3
CO2H
a
CF3CONH H
(25)
CF3CONH H  
H-.iA------
'P1O2C CO2H
(26)
CF3CONH H 
H 
‘Pr02C
(27)
Jj Jbl M
. J ------ CH3
C O C l
CF3CONH H
‘Pr02C COCHN2
(28) (5 steps -85%)
50%
CF3CONH H CH3 
‘P1O2C
(29)
M .
CO2CH3
H2N H
H 
HO2C/  CO2H
30%
Overall
(2S,3R)-3-methylglutamic acid (17)
Conditions, a) (Cp3C0 ) 2 0 , THF; b) 'PrOH, 24h, 40PC;
c)4eq SOCI2 , CH2CI2, reflux Ih,; d) CH2N 2, ether; e)MeOH, Ag2 0 ;
f)H ^  ; g) propylene oxide in EtOH.
Scheme 2.2 Homologation o f (2S,3S)-3-methylaspartic acid
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The Wolff rearrangement, promoted either by irradiation under a medium pressure 
mercury lamp or by heating in methanol in the presence of Ag2 0 , afforded the 1- 
isopropyl 5-methyl 3-methylglutamate (29). The yields after irradiation or treatment 
with silver oxide in methanol were similar (-50%), although In the latter case a 
small amount of 1-isopropyl 4-methyl methylaspartate (26) was formed (5-10%), 
probably due to decomposition of the diazoketone prior to rearrangement. The 
protected 3-methylglutamate (29) was purified by flash chromatography on silica 
gel (10% ethyl acetate in hexane). (2S,3R)-3-Methylglutamic acid (17) was 
obtained after hydrolysis of the protecting groups in 6 M hydrochloric acid. In low 
pH all the three protons of 3-methylglutamate (2 x 4-H, 3-H) have similar shifts in 
their iR-NMR spectrum (2.4 -2.6 ppm) (Fig. 2.3, B). Hydrochloric acid (6 M) or 
water:ethanol mixtures were not very effective in obtaining the pure, salt-free amino 
acid. Treatment of the hydrochloride salt with propylene oxide in ethanol, 
centrifugation and prolonged drying under vacuum at 50 °G afforded the pure 
amino acid. 3-Methylglutamic acid (17) cyclised readily under basic conditions to 
form the (4R,5S)-2-oxo-4-methyl-tetrahydropyrrole-5-carboxylate (30). The 
characteristic ABX quartet of the two C-4 methylene protons could be more reliably 
identified in the '•H-NMR spectrum of the cyclic derivative (30) (Fig. 2.2). The 
homologation was concluded in 30% overall yield without encountering any major 
difficulties (Scheme 2.2).
H
(30)O
2.3 Synthesis of (2S,3S)-3-Methylgiutamic acid (18)
2.3.1 1,2,3-Oxathiazolidine S,S-Dioxide Methodology
The absence of any stereospecific route leading to the desired (28,38)- 
diastereomer (see § 2.2) prompted us to investigate the 1,2,3-oxathiazolidine 8 ,8 - 
dioxide methodology.
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(17)
t  ?PH.
(30)
s . !  5 . 0  ‘^ • - a . j „ ' ^ ' 6  !  1 3 . 6  J .S  2.C l . O O.j
Figure 2,2 Spectrum o f (2S,3R)-3-methylglutamate (17) and its cyclised derivative (30)
This approach was originally developed by Gao and Sharpless, who showed in 
1988 that cyclic sulphates (31) were synthetic equivalents to epoxides. Opening of 
the five membered ring was facile, regioselective and did not require the presence 
of a Lewis acid.i42,i43 Baldwin e t a P ^  replaced the diols used by Sharpless with 
serine, to form the 1,2,3-oxathiazolidine S,S-dioxide (sulphamidate) (32). In 
preliminary experiments it was found that the attack of diethyl malonate anion at 0 - 
5 of the sulphamidate (32) proceeded in 70% yield. In a similar fashion, the attack
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of diethyl malonate anion at the corresponding threonine derivative (33) would 
furnish the carbon skeleton of 3-methylglutamate. The 1,2,3-oxathiazolidine S,S- 
dioxide (33), originating either from threonine or a//o-threonine would provide the 
desired glutamate (17) or (18) respectively.
P  BnN'" O BnN^2 o snNH H
R H ' H H —5^. CH3 —3^«‘0H
R H RO2C H RO2C H HO2C CH3
(31) (32) (33) (34)
An extended study of the opening of these ring systems could also be performed in 
an effort to evaluate other possible synthetic applications.
(2S,3R)-Threonine was treated with benzaldehyde in the presence of 
potassium hydroxide. The imine formed, was further reduced with NaBH4 to afford 
N-benzyl protected threonine (34) in 8 5 % . The reaction was reliable and high 
yielding in contrast to a more recent protocol which employs sodium 
cyanoborohydride as the reducing agent and gave compound (34) in only 30%
y i e l d . 146,147
A bulky group protecting the ester can often prevent the removal of the acidic a- 
H  in the presence of a strong base, so Baldwin and c o w o rk e rs i4 4  chose to protect 
the acid functionality by forming the fe/t-butyl ester. Armstrong ef a/-i4s developed a 
method for synthesising this hindered ester which employed the 
trichloroacetamidate (36)149 |n the presence of BFa EtaO as the catalyst.
BnNH H (3g )  BnNH H
H -.J  ^-O TB D MS NH  ^ ___L.OTBDMS
( 3 5 ) 'BuOzC (3 7 ) CH3
Scheme 2,3 Formation o f ^butyl N-benzyl-O-TBDMS-threoninate
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Accordingly, after we protected the alcohol functionality of A/-benzyl-threonine 
(34), by forming the O-TBDMS derivative (35), we tried to esterify the carboxyl 
group (Scheme 2.3). The yields, however, of the fully protected threonine (37) 
were remarkably low (15-20%), probably due to the insolubility of the free acid 
(36) in the dichloromethane:hexane mixtures used.
Treatment of A/-benzyl-threonine (34) with isobutene in a pressure cell in the 
presence of H2SO4, afforded no ester either. A/-Benzyl-threonine was again 
completely insoluble in dicloromethane, which was used as the solvent for the 
estérification. Searching for a convenient way to form the less hindered isopropyl 
ester we refluxed N-benzyl-threonine (34) in isopropanol in the presence of 
thionyl chloride. The clean product formed for periods of reflux less than 10 hr. had 
a very characteristic ''H-NMR spectrum. The downfield shift of the a-H and the 
absence of any hydrogen atom on the amine were in agreement with the structure 
of the sulphamidite anhydride (38). Alcoholysis of the five-membered ring of 
sulphamidite (38) to furnish the desired ester was achieved only after prolonged 
periods of reflux. Typically, isopropyl Af-benzyl-threoninate (39) was formed in 
good yield (-75%), by refluxing protected threonine in dry isopropanol for three 
days in the presence of 4 eq of SOCI2. The ester (39) was purified by flash 
chromatography on silica gel (Rf 0.25 in 10% ethyi acetate in petrol ether) and its 
identity was secured by all the spectroscopic data collected.
OH CH,
B n N ^
X / H  
— o
.................................. (38)
O
The methyl ester analogue (39a) was formed in MeOH in the presence of 
H2SO4. Treatment of the protected threonine (39) with SOCI2 and EtaN resulted in 
the formation of the two diastereomeric 1,2,3-oxathiazolidone S-oxides (epimeric 
sulphamidites) (40) and (41) as a 1:3 mixture, which was separated by flash 
chromatography on silica gel (Rf 0.25 and 0.30 respectively in 10% ethyl acetate in 
hexane) (Scheme 2.4). The two sulfamidites (28) and (2R), (40) and (41)
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respectively, were isolated in similar amounts after the chromatography on silica 
gel. Clearly half of the (2R) isomer (41), present in the crude mixture, partially 
decomposed on the silica gel.
BnNH OHCH3
HO2C H
(34 )y
BnN p  .^4—5^. CH3H
RO2C H
R =T r (33) 
R=Me (33a)
a orb H . T 1 %  (39)/  V. R= CH3 (39a)RO2C H
Q
H
RO2C
BnN (2S) 0
CH3 +
VBnN (2R )p
 ^ ‘ CH3
(40)
RO2C H
(41 )
Conditions, a) SOCl2 (5eq), ^PrOH, rf. 3 days 75-80% ; b) MeOH, 
H2SO4, rf. 2h,70% ; c) EtgN (2.2eq), S0 Cl2 (l.leq ), toluene, O^C,90% ; 
d) NaI0 4  (1.5eq), RUCI3.H2O (cat.), MeCNiB^O (1:1), 20°C, 93%.
Scheme 2.4 Synthesis o f 1,2,3-Oxathiazolidine S,S-dioxide (33)
The differences between the ^H-NMR spectra (Fig. 2,3) of the two sulphamidites 
alio wed assignment of their absolute stereochemistry according to the analysis of 
Lowe and R e e d .  14 4 c  The proximity between the oxygen and the methyl group in the 
(2R)-epimer (41) caused a characteristic shift downfield (0.2 ppm) in the ^H-NMR 
of the methyl group. A similar effect was observed for the 5-H (0.5 ppm difference 
between the two corresponding hydrogens) (Fig. 2.3).
The mixture of the pure 1,2,3-oxathiazolidine S-oxides (40 and 41) was 
smoothly oxidized under carefully controlled Sharpless c o n d i t i o n s , ^ 4 2  (sodium 
metaperiodate in the presence RUCI3 .H 2 O), to afford the 1,2,3-oxathiazolidine S,S- 
dioxide (33) in high yield (90%). Satisfactory microanalysis and accurate mass 
confirmed the synthesis of the sulphamidate (33) in four steps, and in 50% overall
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yield from threonine, improving by far the previously reported sequence for
serlneJ44
s®
(40)
83.48 HjC
81.47
64.77
\  " f
if
83.94
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Figure 2,3 ^H-NMR o f the epimeric sulphamidites (40) and (41)
The reaction between the diethyl malonate (42) and ferf-butyl acetate (43) 
anions with the oxathiazolidine (33) could now be studied. Both anions were 
generated at -78°C by LDA in THF, and sulphamidate (33) was added to the 
reaction mixture last. Careful isolation of the products was necessary because 
during standard work-up, either with saturated ammonium chloride or acetic acid in 
THF, the sulphonate group was not always removed. If the desired attack had taken 
place (Fig. 2.4) the two hydrogens on the newly introduced 4-methylene group on
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glutamate (44) would show a characteristic ABX signal (Fig. 2.3, B), not present in 
the starting materials. Unfortunately the alkene (45) emerged as the main product 
when either of the anions (42 or 43) was reacted with the oxathiazolidone (33). 
No Sn2 attack product (44) could be detected under a variety of conditions. For 
temperatures lower than -70°C the recovery of starting material was usually higher 
than 50% and no elimination product (45) was obtained. Formation of the alkene 
was always observed at elevated at temperatures, higher than -50°C. Prolonged 
reaction times at -70°C had no effect on the outcome of the reaction. At room 
temperature the isopropyl 2-amino-but-2-enoate (45) was the exclusive product 
with a yield of 75%. The alkene (45) can be also synthesised by stirring 
oxathiazolidine (33) in a mixture of LiOH, MeOH, and H2O for 24 hr.
\ / / SO3H
(33)
H
'Pr02C
niy CH3
Nu :-CH(C0 Et>2, (42) 
■CH2C02^Bu,(43)
(45)
'PrOzC
Figure 2,4 Attack on the oxathiazolidine (33)
The use of THF:HMPA mixtures, apart from introducing complications in the 
work-up, had no effect on the mode of the attack. Finally no improvement was 
detected when the nucleophile (43) was reacted with the dioxide (33) in the 
presence of Lewis acids, namely titanium(IV)isopropoxide and BF3 EtzO. In the 
latter case, in an HMPA:THF (50% mixture) with 0.5 eq. of the Lewis acid present, 
the characteristic ABX multiplet of the two 4-methylene protons was observed in the 
 ^H-NMR spectrum of the crude product. Unfortunately the yields of the glutamate
(44) were very low (<5%). It was clear that in the case of the sulphamidate (33)
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the elimination was competing successfully with the more hindered attack on the 
secondary carbon centre.
At this point we decided to evaluate the vulnerability at 0-5 of the sulphamidate 
(33) using the well documented^^^ mild nucleophiles azide or thiocyanate, which 
react in an Sn2 fashion with a variety of simiiar electrophiles. The reaction with the 
azide was followed by TLG and the 3-azido-2-amino-butanoate (46) was indeed 
formed after two days of stirring in aqueous acetone. For comparison the reaction 
times necessary for completion of the azide attack were reported to be 12 hr. for 
serine (32),"'44 and just 1 hr. for the cyclic sulphates (31) . " ' jh@ azide (46) was 
thoroughly dried under reduced pressure and then recrystallized from ethyi 
acetate/petrol ether to afford (46) as highly hygroscopic white crystals in 80% 
yield. All the spectroscopic data collected were in accordance with structure (46).
SO3H
BnN CH3
( « )
H3CO2C N3
The above result prompted us to extend the range of the attacking species. The 
obvious choice was a large variety of organometallic complexes known for their 
mildness and s e l e c t i v i t y . iso ,is i,152 copper G r i g n a r d s , various types of 
o r g a n o c u p r a t e s , ^ s 4 and titanium c o m p l e x e s ^ are by far the most widely used and 
have been employed to achieve a variety of t r a n s f o r m a t i o n s .  1^ 6,157
The mild and very selective RTiCIa reagent (formed by the addition of TiCU to a 
solution of allyltrimethylsilane^®®) did not react with oxathiazolidine (33). Mori et 
a/. reported in 1984 the displacement of a primary O-tosyl group by a methyl 
group using the complex (CH3)2Cu(CN)Li2. The same methodology was not as 
successful in promoting the sulphamidate ring opening. The mono- and di- 
alkylcyanocuprates (entries 2,3, Table 2.1) were prepared and reacted with the 
sulphamidate (33) but the desired mode of attack was still elusive. One of the 
problems encountered in the case of the copper complexes was the short half-lives
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of these reagents. For reaction times less than 4 hr. (the useful reaction time for 
cuprate c o m p l e x e s ) i 54 starting material was often recovered.
Two alternative organocopper complexes were employed. The more reactive 
organocopper-Lewis acid species (entry 4, Table 2.1) afforded a mixture of 
unidentifiable by-products. The Grignard-Cu complex RMgBr/Gu(l) (1.2eq.), 
prepared by adding the appropriate volume (0.1 molar equivalents) of a U2CUCI2 
solution in THF to a cooled solution of the Grignard reagent, reacted cleanly and 
efficiently with the oxathiazolidine (33) over a variety of temperatures to give a 
mixture of starting material (33) and the tertiary alcohol (47). Interestingly when 
one molar equivalent of Li2CuCl2 was used^Go the desired 1-isopropyl 2-amino-3- 
methyi-hex-5-ene (48) was found by mass spectroscopy to represent -10%  of the 
crude product (Fig. 2.5). The structure of the alcohol (47) was also verified by 2D- 
NMR and accurate mass spectrometry. Varying the equivalents of the cuprate 
complex did not improve the yield of the ester (48).
BnN O
HO
W ) ,
H
(47) M.W. 337
.SO3H 
BnN CH
H**»ii
3H
0 ‘Pr 
(48) M.W. 355
\
o '' O
(31)
STR[3GBNiieZ* xlB Bgd=88 lB-mY-92 10:344:82:42 12-2S3J Cl*Bpl»=B I=98Bw TIC=5478708 Bcnt-HfflTZfllMB Sys=flCE■3.2.BS. B.C.E.NH3 ««433 PT= 9" Cal'lCHllea, 91
SB
147
128
ilu lU
168
258
226T  248
... i ll,288 258
338
298 2 .
355
HM«: B482BB«HSS= 338
158 388 358 488 458 588
Figure 2.5 Mass spectrum o f the crude mixture o f (47) and (48).
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Unfortunately the ability of the Grignard-Cu reagent to open the ring was 
accompanied by a non-selectivity, towards the ester. Transformation of the 
carboxylate to an oxazolidone or an ortho-ester can protect it from Grignard 
attackiGi but this line of investigation was not pursued further.
In Table 2.1 are listed the reagents used in increasing order of "hardness". The 
allyl group was usually employed as R since the double bond could be later 
efficiently transformed to a methyl ester via an ozone c l e a v a g e . ^ ^ 2
Table 2.1 Organometallic reagents used fo r attacking C-5 of the sulphamidate (33)
Ent. Organometallic
Complex
Result* R
1 RSiMe3+TiCl4 No Reaction Allyl
2 R2Cu(CN)Li2 No reaction Allyl or "Bu
3 RCu(CN)Ü2 No reaction Allyl or "Bu
4 RCU'BFs Mixture Allyl
5 RMgBr/Cu(l) (47) + (4 8 )t Allyl
* Under the conditions specified in the text, 
t  Yield for (48) -10% .
Finally the fe/t-butylhydroperoxide anion (fe/t-BuOO") generated by BuLi"i63 at 
-70 ‘^ C was reacted with the oxathiazolidone (33a). The 1 H-NMR spectrum of the 
products suggested ring opening but no peroxy ether could be detected. Obviously 
the nucleophile attacked the sulphur. This behaviour had been also observed by 
Berridge ef a/./G4 when the phenoxide anion was used to open various sulphury! 
pyranosides (31). Whether the displacement took place on the sulphur or on the 
carbon, depended on the 3-dimensional structure of the sulphate (31).
The experiments described so far underline the importance of steric factors in 
the opening of similar ring systems. In the case of sulphamidate (33) the 
secondary centre reduced the rate of the nucleophilic displacement at C - 5 ,165 and 
subsequently, when "hard" carbon anions were used, the formation of the alkene
(45) became dominant. The Grignard copper reagent seemed to be sufficiently
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reactive to open the ring. Unfortunateiy its seiectivity towards the ester was very 
iow. The rest of the organometailic compiexes were too mild to interact with the 
eiectrophiie.
Only if a short and good yielding protocol is developed to incorporate a 
Grignard resistant protection on the carboxylate, will the above methodology 
become of practical importance for forming C-C bonds. Nevertheless the 1,2,3- 
oxathiazoiidone S,S-dioxides (32 and 33) can be conveniently employed to 
functionaiise 0-3 of serine and threonine with a variety of mild nucleophiles.
2.3.2 BIs-Lactim Ether Methodology
Preliminary experiments showed that (2S,3R)-3-methyiglutamic acid (17) was 
not a substrate for the glutamate mutase catalysed rearrangement. We were, 
therefore, keen to obtain the (2S,3S)-diastereomer (18) in order to compare the 
behaviour of the two (2S)-3-methylgiutamic acids. Schoiikopf's bis-lactim ether 
methodology had been used successfully in our laboratory to prepare a wide 
variety of a-amino acid anaiogues.iG6,i67
RQ
(49) H (50)
OR
The anion (50), generated from the b/s-iactim ether of cyclo-(D-Vai-Gly) (49) 
and BuLi, can attack various nucleophiles including bromides (51) and alkenoates 
(52) in order to give the alkylated dihydropyrazines (53) and (54) respectively 
(Fig. 2.6).
The utility of the methodology originates from the facile establishment of the 
stereochemistry at C-2', since the attack takes place almost exclusively from the 
face opposite to the bulky isopropyi group of valine. When (2R)-vaiine has been 
incorporated in the bis-lactim ether ring (50), the a-amino acid centre formed after 
the attack has the (S) stereochemistry.”*®® The enantiomeric excess is typically 
higher than 97%.
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(52)
E orZR02C-'iiiJ— CH3 ( 5 1 ) OR
H  (50)
RO,RQ
»==N.* = N ,
2'ST  S
OROR
(53) (54)
Figure 2.6 Alkylating reagents and alkylation products in bis-lactim 
ether methodology
The attack on the bromide (51) was the key step in an effort to construct 
analogues of 3-methylaspartic acid. (S)-alanine was treated with a mixture of acetic 
anhydride / acetic acid-^H to produce racemised N-acetyl-alanine (55a) (Scheme 
2.5). Acylase I  de-acetylated only the (8 ) isomer. Free (S)-aianine was easily 
separated from the A/-acetyl-{R)-alanine, which was subsequently hydrolysed in 6 
M hydrochloric acid to afford {R)-[2-2H]-alanine (56a). Treatment of compound 
(56) with NaN02/HBr/KBr furnished, with retention of configuration, the 2- 
bromopropanoic acid (51) which was further reacted with the anion (50) to 
generate the 2-alkyl-dihydropyrazine (53) (Fig. 2.6). Hydrolysis liberated (28,38)- 
[3-2H]-3-methylaspartlc a c id .  1^7
H2N
C H 3
H O 2 C
AcNH
CH3
H O 2 C
(55a)
b,c
H O 2 C
H2N
. A CH3
2h
(56a)
Conditions a) (CH3C0 2 )0 , CP^COg^H; b) Acylase I;
c) 6MHC1; d) NaNOj, HBr, KBr
HO2C
BrAC H 3
%
(51)
Scheme 2.5 Synthesis o f (2R)-[2-^H]-bromopropanoic acid
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Alkylated dihydropyrazines (54) can be prepared via a Michael type addition of 
the anion (50) to the double bond of various crotonate derivatives (52). Hydrolysis 
of the product pyrazine (54) would secure (2S)-3-aikylglutamate and (2 R)-valine 
(Scheme 2.6, p. 66).
Schollkopf and coworkers performed the above reaction with various 
alkenoates (52) to obtain a number of C-3' substituted dihydropyrazines-2- 
propanoic acid methyl esters (54). 1^ 9 Only compound (54), with R=Ph, had its 
stereochemistry at C-3' assigned by comparison to known structures. The rest of 
the pyrazines that were synthesised, were characterised using H-NMR or 
chromatographic methods. For dihydropyrazine-2-[3'-methyl]-propanoic acid 
methyl ester (60) (R=CH3 on (54)), only a moderate diastereomeric excess was 
reported (3:1). More importantly the means used to calculate the ratio of the two 
diastereomeric pyrazines ((60) and (61), see p. 66) was not specified.
(57) E Ri=H,
(58) Z Ri=CH3,
OR'
The stereoselectivity observed was rationalised by postulating a transition state 
in which the two 2 Ti-systems (the %-system from the diazapentadienyt anion (50) 
and the 7i-system of the 2-alkenoate, (57) or (58)) form a jc-complex (59) which is 
stabilised by HOMO-LUMO interactions (Fig. 2.7). Because of the nature of the 
reactants there is only one orientation that minimises the electrostatic interactions 
and allows the attack to occur smoothly. Only when the carboxyl group of the but-2- 
e no ate ester (57) is positioned over N-4 of the ring, the electrostatic repulsions 
between the oxygens are minimised. Atop view of the transition state suggests that 
the trans alkenes (57) will accommodate themselves slightly better over the ring.
When the complex (59) is formed between the anion (50) and the cis isomer 
(58) an additional steric interaction between Ri and the methoxy group on C-3, 
might affect the yield but it cannot cancel the strong repulsion which is present 
between the carboxyl group of the alkenoate and the methoxy group on 0-6. In this 
manner the outcome of the reaction as far as it concerns the stereochemistry on 0 -
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3' is defined by the nature of the alkenoate (E or Z ). According to this rationale, 
reaction of the anion (60 ) with the trans crotonate (57 ) would provide the (2S,3S)- 
3-methyiglutamate (1 8 )  carbon skeleton. The reported 3:1 excess''®® was 
satisfactory for some preliminary experiments with the enzyme; so we carried out 
the alkylation of pyrazine (49 ) using trans crotonate (52) as the Michael acceptor.
H
(59)
c -
OR
Figure 2,7 Transition state o f the attack
(5R,2S)-5"isopropyi-3,6-dimethoxy-2,5-dihydropyrazine-2-propanoate (6 0 ), 
(Scheme 2.6 A), as judged by "'H-NMR spectroscopy, was the main product but it 
could not be easily purified. Despite Schoiikopf's reports"'®® distillation did not 
remove any of the impurities. Finally dihydropyrazine (60 ) was carefully flash 
chromatographed twice on silica gel (1:20 ethyi acetate:hexane) and obtained pure 
in moderate yields (60%); the only way to actually visualise the compound (60 ) on 
a TLG plate was by phosphomoiybdic acid (10% in ethanol), but even this 
procedure was successful only when concentrated solutions of the product were 
used. The characteristic yellow spot obtained was very different from the deep 
green colour of the impurities (probably N-alkyiated compounds). The 1H- and 1®C- 
NMR spectra of the pure aikyipyrazines, at 300 MHz and 75 MHz respectively, 
offered no indication for the existence of two diastereomers. Either the selectivity of 
the reaction was higher than reported"'®® or the pyrazines (60 ) and (61 ) could not 
be differentiated by NMR spectroscopy.
Hydrolysis of the dihydropyrazine (6 0 ) in 6 M hydrochloric acid gave a mixture 
of 3-methylgiutamic acid (1 8 ) and valine (6 4 ). Whereas (2S)-glutamic acid and 
valine can be easily separated using an anion exchange column (e.g. amberlite),
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(2S,3S)-3-methyiglutamic acid (18) cyciised readily under basic conditions to give 
the (4S,5S)-4-methyl-pyrroglutamate (62), which couid not be separated from 
vaiine. Selective crystallization of 3-methylgiutamic acid (18) at iow pH was one 
alternative, but the method was not Ideal for two reasons.
A-TRANS
,.CH3
( 5 2 )  O
( 6 0 )
H2 N  CH3  
H-'iif
« ^ S l/_ C O ,R
HO2C
(18) (2S,3S)
R=CH3
CO2H
B-CIS
RO. OR
H . OH3 CO2R'
 .
H O ./  ^ C O .H
(17a) (2S.3R)
Identical with the one 
prepared v/fl homologation
R’=QHn
Conditions, a) BuLi, methyl crotonate, -78 °C;
b) 0.25 M  HCl, 2 days; c) Flash chromatography, silica gel
d) 6 M  HCl ; e) Propylene oxide in ethanol; 
f) Crystallization from water/ ethanol, pH 1.5
Scheme 2.6 Synthesis o f 3 -methylglutamic acids
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First, salts co-crystallized and second, the amount of the amino acid that couid be 
obtained was only about 50% of the total product. The residual 3-methyiglutamate 
couid not be separated from valine. Alternatively stirring the pyrazine (60) in 0.20 
M hydrochloric acid for two days afforded the methyl pyrrogiutamate (63) and 
vaiine methyl ester. The two compounds were easily separated on silica gel. 
Hydrolysis of the methyl (4S,5S)-4-methyl-tetrahydropyrroie-5-carboxylate (63) in 
6 M hydrochloric acid and crystallization in ethanol using propylene oxide 
furnished 3-methylglutamic acid (18) in reasonable overall yield; 42% from the 
pyrazine (49 ). Satisfactory microanalysis was obtained for (2S,3S)-3- 
methyigiutamic acid and the melting point (166-167°C) was identical to that of 3- 
methyigiutamate (17) prepared via homologation.
H2N ÇH3 
HHqCOnC O HOnC
(62) (63) (64)
The optical rotation values of (28,38)- (18) and (28,3R)-3-methylgiutamic acid 
(17) (prepared via homologation) (Table 2.2 , p. 69) were substantially different. 
This encouraging result, however, was not sufficient to establish the diastereomeric 
excess of the reaction. Only when the (28,3R) diastereomer (17a) was obtained 
via the same route and compared with our standard (28,3R)-3-methylgiutamic acid 
(17) (prepared by homologation (Scheme 2.2)), were we be able to clearly 
comment on the stereoselectivity of the attack (see p. 64). To this end, c/s-crotonate 
(58) had to be used as the alkylating agent.
The first reliable method for the synthesis of c/s-crotonic acid (67) was reported 
in 1956. A mixture of trans- (57) and c/s-but-2-enoic acid (67) (1:5) was obtained 
after hydrogenation of but-2-ynoic acid (65) over Lindiar c a t a l y s t .  Separation of 
the two isomers was easily achieved since the two acids have very different 
physical properties. Accordingly the expensive but-2-ynoic acid (65) was
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synthesised in muitigram quantities by saturating a solution of BuLi in THF with 
methyiacetylene and then purging the reaction mixture with carbon dioxide at -50 
°C. The crude acid (65) was distilled and recrystallized twice. Hydrogenation of 
but-1 “ÿnoic acid (65) over Lindiar catalyst in MeOH for 1 hr. afforded c/s-crotonic 
acid (67) including 10% of the trans isomer. The regioselectivity of the 
hydrogenation improved markedly when a mixture of ethyl acetate:pyridine (9:1)171 
was used as the solvent mixture. No trans isomer couid be detected but ironically 
the reaction times for the completion of the reaction Increased to 2-3 days. Finally 
the cis isomer (67) was quantitatively formed in less than 3 hr. when freshly 
prepared 172 pq on BaS04 was employed as the catalyst. The two acids can be 
easily identified by their very characteristic 1 H-NMR spectra. The chemical shift for 
the 2-H methylene proton is 6.9 ppm and 6.3 ppm, for the trans and the cis isomer 
respectively.
CH3*
CH3-
•H
CO2R
75% CH3' CO2H
b ore
(65) 63%
94%
H H> -<
(66a)
(66b) R=QH7
C H 3
(67) R=H 
(58a) R=C5H ii
Conditions, a) BuLi, COj, THF, -50°C; b) (CHg)2CHOH, SOClj 
(4eq.), rf. 30 min.; c) (CI%)2CHCH2CH20H, SOCI2 (4eq.),rf. 30 min;.
d) Pd on BaS0 4 , K^ , EtOAc:Pyr. 10:1,2-4 hr.
Scheme 2,7 Synthesis o f cis-crotonate esters
c/s-But-2-enoic acid (67) isomerised or even decomposed under the usual 
estérification conditions (acid or SOCia in the presence of the alcohol). c/s-Crotonic 
acid methyl ester (58c) was obtained after treatment with diazomethane but its low 
b.p. (~35 °C) prevented easy isolation. Therefore, the but-2-ynoate esters (66 a,b) 
were prepared first, and further reduced to the corresponding but-2-enoates (58a 
and 58b). (Scheme 2.7, d). Both esters were easily purified on silica gel (Rf 0.6 in
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5% ethyl acetate in petrol ether) but only isoamyl c/s-crotonate (58a) (b.p. 135°) 
was isolated in sufficient quantities.
With the cis aikene (58a) in hand, we turned to the preparation of the pyrazine 
(61) (Scheme 2.6). Treatment with the diazapentadienyi anion (50) furnished the 
pure dihypropyrazine (61) which was isolated in the anticipated (see p. 64) slightly 
lower yield (45%), compared to the diastereomeric pyrazine (60) (55-60%). The 
1 H-NMR spectra of the two diastereomeric molecules (60 and 61) revealed no 
substantial differences. The i^C-NMR at 75 MHz, however, showed small but 
detectable differences in the shifts of C-3' and C-4'. The (2S,3R)-3-methy!giutamic 
acid (17a) could not be isolated in the same manner as the (2S,3S)-isomer (18), 
because during the mild hydrolysis of the pyrazine (61) the corresponding 
(4R,5S)-3-methyipyrogiutamate was not readily formed (see p. 65). So the pure 3- 
methylglutamic acid (17a) was simply crystallized out from water;ethanoi at pH 
1.5. One additional re-crystaiiisation was necessary for the product to give 
satisfactory microanaiysis and melting point. The optical rotation values (Table 2.2) 
verified the high stereospecificily of the attack (> 90%) hinted by our previous NMR 
spectroscopy experiments. Therefore the method was considered to be suitable for 
obtaining 3-aikylgiutamates of high optical purity.
Table 2.2 Optical rotation values fo r (2S)-3~methyl^lutamic acids
3-Methyiglutamates
(c 1 in 6M HCl)
m.p.°C
(2S,3R)-Methylglutamate 
(17) (homologation)
+22.0 169-171
(2S,3R)-Methyiglutamate 
(17a) (attack on c/s-crotonate)
+23.7 167-169
(2S,3S)-Methyiglutamate 
(18) (attack on frans-crotonate)
+36.8 166-167
We cannot speculate about the reason Schollkopf and coworkers reported such 
a iow stereoselectivity for this particular attack. According to our findings no mixture 
of diastereomers could be detected by NMR spectroscopy at 300 MHz (1H) or 75 
MHz (13C) for the pyrazines (60) and (61) and the diastereomeric excess seems
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to be at least 90%. One additional advantage of the method described above is that 
labels can be incorporated in literally every desirable position by using the 
appropriate starting materials.
2.4 Synthesis of 1,2-Cyclopropanedicarboxylic Acids
1-Amino-1,2-cyclopropanedicarboxylic acid (19) was a molecule of 
considerable importance, due to its possible structural resemblance to the 
transition state for the rearrangement catalysed by glutamate mutase. A number 
methods exist for the preparation of cyclopropane ring bearing carboxyl 
substituents. The Simmons-Smithi^s cyclopropanation of olefins (Scheme 2.8, A), 
and the use of haio-acetates and acrylate analogues, as developed by McCoy et 
a/. 174 and McDonald and Reitz (Scheme 2.8, B),i7s are the best known 
approaches. More recently the dipolar addition of diazo compounds (e.g. 
NaCHCOaEt) to dehydro alanine derivatives was developed as an alternative
route. 176
Ri 
R2
R] 
R2
R3
R4
R3
C uC l, CI%l2 )
+ ^CHC02R -  — —
Ri
R2
Ri
(A)
R4
R4
CO2R R4
X=Br,C l
(B)
CO2R
Scheme 2.8 General methods fo r the preparation offunctionalized 
cyclopropane rings
One synthesis of the amino acid (19) was published by Kraus ef a/.i77 in 1990. 
The bromo diester (68) was treated with potassium bis-(trimethyIsiiyl)amide to give 
the cyciopropenedicarboxylate intermediate (70) (Scheme 2.9), Regioseiective 
addition of ammonia to the double bond furnished dimethyl 2,3-methanoaspartate
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(71) in yields between 30-50%. The cis and the trans isomers (71) w ere  
separated and hydrolysed to afford the corresponding free amino acids (19). 
Despite the low yield the method seemed to be short and reliable.
In the same year, however. Stammer reportedi^s that only the amino protected 
version of 2,3-methanoaspartic acid (19) could be synthesised in his laboratory. 
Upon deprotection, the free amine formed the imine with concomitant destruction of 
the three-membered ring. Finally only the corresponding keto compound was 
isolated.
Our efforts to reproduce Kraus synthesis afforded only mixtures of starting 
material (68 and 69) often partially deprotected. A large number of protocols was 
evaluated including different bases (NaH, LDA, EtO") and a spectrum of 
temperatures. Lastly the reaction was performed in a pressure cell which allowed 
the reaction to be warmed up to room temperature without lowering the 
concentration of ammonia. No amino acid (71) couid be unequivocally detected by 
NMR spectroscopy under any of the above conditions. There was no doubt that the 
cyclopropene intermediate (70) was formed since addition of the base caused a 
characteristic change to the colour of the reaction mixture to brown, due to the 
release of bromine. The addition of ammonia to the double bond seemed to be the 
problematic step. Our failure to obtain any reasonable amounts of product seems to 
confirm Stammers report on the instability of the free amine.i^s
Br. H2N
\ H B' RO2C- %  \  „
RO2C
CO2R
7RO2C X ^RO2C ^
CO2R(68) and (69) (70) (71)
Scheme 2.9 Unsuccessful synthesis o f 1-amino 1,2-cyclopropanedicarboxylate
The bromide (68 or 69) was also heated in concentrated ammonia in the 
presence of silver nitrate in an effort to promote an Sn1 type of nucleophilic 
substitution. Only starting material was isolated from the reaction mixture.
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Obtaining methanoaspartic acid (19) Wa an amino protected precursor would 
allow us to evaluate the claims concerning its stability. Ali the possible synthetic 
routes to the amino acid (19), briefly mentioned above (see p. 69) couid provide 
the desired compound (19) in its fuiiy protected form. Two molecules were 
required as starting materials. According to the Simmons-Smith approach, dimethyl 
(2,3)-methanoaspartate (71) could be constructed by the reaction of amino 
fumarate (72) with diiodomethane. Aiternativeiy, 2-aminoacryiate (73) could be 
employed; its reaction with bromo acetic acid methyl ester or a diazo compound 
(Scheme 2.8, B) wouid furnish the protected cyclopropane amino acid (71).
RCO2C H HO2C
(72) (73) (74)
Domschkei79 synthesised dimethyl aminofumarate (72) by refluxing dimethyl 
oxaioacetate (74) in toluene under an ammonia atmosphere in 40% yield. The 
reaction was repeated twice but no fumarate (72) was isolated. NMR spectroscopy 
showed that ammonolosysis of the esters took place. At the same time the 
commercially available version of ami noacrylate (73) proved to be sensitive under 
usual estérification procedures {e.g. acid , thionyl chloride), it usually decomposed 
rather quickly, even before the ester was formed. Alternatively to prepare the fully 
protected ami no-acrylate derivative (76), serine was fully benzylated in one step 
under the conditions described by Velluz and A m i a r d . i ^ o  The dehydration reaction 
using CuCia and dicyciohexylcarbodiimide in dry CH2Cl2i^i proceeded smoothly to 
afford the benzyl A/,A/-dibenzyl-2-aminoacrylate (76) in good yield. The identity of 
the product was verified by its characteristic 1 H-NMR spectrum (Fig. 2.8). 
Unfortunateiy all our efforts to remove residual cooper and carbodiimide were 
unsuccessful. The acrylate (76) decomposed on silica gel, or during Kugeirohr 
distillation (60-70 °C) to afford a red polymer. The crude material was treated with 
sodium hydride and bromoacetate (Scheme 2.8B) but no cyclopropane ring 
formation was detected by NMR spectroscopy.
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sodium hydride and bromoacetate (Scheme 2.8B) but no cyclopropane ring 
formation was detected by NMR spectroscopy.
H2N OH 
H 
HO2C
B112N OH B112N
H '  ^  ^
BIÎ02C
— y
Bn02C(75) (76)
Conditions. a)BnBr, NaOH; b) CuCl, dicyclohexylcarbodiimde
Scheme 2,10 Synthesis o f benzyl N J>î-dibenzyl-2-aminoacrylate
IT S !54.r 54.4H
/ ~V- CHj — 55.1 35.3
(76)
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Figure 2.8 ^H-NMR spectrum o f benzyl N,N-dibenzy 1-2-aminoacrylate (76)
Since the amino dicarboxylate (19) seemed to be more difficult to obtain than 
originaiiy thought, a sample of dimethyl 1 -bromo-cyclopropane-1,2-dicarboxylate 
(mixture of 9:1 cis and trans (68) and (69) respectively) was hydrolysed in 6 M 
hydrochloric acid to give the free acid (80) (Scheme 2.11). The bromo diacid was 
recrystailized from ethyi acetate/hexane and incubated with the enzyme, its 
inhibitory action prompted us to synthesise the trans isomer (81) and compare 
their behaviour.
McCoy studied the synthesis of substituted cyclopropane rings bearing two 
carboxyl groups (Scheme 2.8, B) and reported that the stereochemistry of the 
cyciised products depended on the co-operative or opposing nature of two
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"steric effect" simply means that the TS conformation is estabiished by the equai 
distribution of the bulk of the substituents, to each side of the ring under formation, 
thus favouring structure (78) (Fig. 2.9). When the two effects co-operate the result 
Is clear cut, otherwise mixtures of the isomers are obtained. Accordingly the use of 
toluene (Scheme 2.11) resulted in an internal solvation effect, thus favouring 
structure (77) and finally the cis product (68) was almost exclusively formed 
(10:1). When DMF was used together with elevated temperatures, TS (78) was 
stabilised by the solvent. Subsequently the weak steric effect became operational 
and the trans- isomer (69) emerged as the main product (3:2).
o H
H,CO
Figure 2,9 Transition sates leading to dimethyl cis and trans-1-bromo- 
1 pL -cyclopropane-dicarboxylates
isolation of the pure dimethyl 1-bromo c/s-cyclopropanedicarboxylate (68) 
(reaction in toluene) was achieved by flash chromatography on silica gel (5% ethyi 
acetate in hexane). The small amount of the trans isomer initially present was 
easily removed under these conditions. Unfortunately this was not the case for the 
frans-dicarboxylate (69) (reaction in DMF). When the 2:3 mixture of the isomers 
was subjected to flash chromatography only a small amount of compound (69) 
was obtained completely pure. Therefore, we decided to take advantage of the 
proximity of the two carboxyl groups on the c/s-isomer.
The mixture of the esters (68) and (69) was hydrolysed and re-esterified using 
isopropanol and H2SO4 for 8 hr. without reflux. Under these condition the cis 
isomer was only partially esterified. indeed, normal work up, afforded the trans 
dicarboxylate more than 90% pure. Further purification was effected on silica gel.
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Hydrolysis of the diester (69) afforded the pure 1-bromo-frans-1,2-oyclopropane 
dicarboxylate (81) (Fig. 2.10) in 20% overall yield from the dibromoacetate (79) 
(Scheme 2.11). Forming the anhydride of the cis isomer is an alternative method 
for separating the two dicarboxylates (81 and 81). Each of the pure cis and trans 
isomers is a 50% mixture of two enantiomers. Specifically bromo-c/s-dicarboxylate
(80) Is a mixture of the (1S,2R)- and (1R,2S)- enantiomers; bromo-frans- 
dicarboxylate (81) is a mixture of the (1R,2R)- and (1 R,2R)- enantiomers.
.CO2R
NaH
cis (6 8 ) : trans (69)
Toluene
DMF
R=H (80) (81)
Scheme 2,11 Synthesis o f cis and trans l-brom o-l,2- 
cyclopropane-dicarboxylic acids
51.94Br Hp
fl.73 (SI)
52.62
I ITT I t I I ■I' I I'l lT TT I I j  I i I I I r i - iT
Figure  2,10  ^H -N M R spectrum o f pure 1-bromo trans-1^ -
cyciopropanedicarboxylate (81) and the mixture
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The synthesis of the substituted cyclopropane dicarboxylates proved to be quite 
problematic. Many methods exist in the literature for their preparation but are 
neither very selective nor good yielding; if they work at all. Our failure to obtain 1- 
amino-1,2-cyclopropanedicarboxylate (19), by addition of ammonia on the 
cyclopropene intermediate (70) was puzzling, but in accordance with recent 
reports on its instability. Synthesising these compound in a stereoselective manner 
not only will be of great importance for the study of glutamate mutase but seems to 
be a demanding synthetic challenge in its own right.
Chapter 3
Purification
and
Mechanistic Studies
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3.0 Protein Purification
Early studies on glutamate mutase in our la b o r a to r y ^ s a  indicated that 
experiments with crude preparations can be ambiguous or even misleading. In 
order to circumvent this problem and take advantage of the large number of 
potential molecular probes that had been synthesised by the group, the enzyme 
had to be purified in reasonable amounts, following reproducible protocols. 
Possible substrates or inhibitors could then be evaluated and various kinetic 
experiments performed. Finally, homogeneous samples of the two components E 
and S of glutamate mutase would allow N-terminal sequencing of the two proteins 
and subsequent elucidation of their primary structure.
Glutamate mutase was purified by Barker and coworkers in the sixties.ii8,ii9 
The source of the enzyme was frozen cell paste of Clostridium tetanomorphum, 
fermented on glutamic acid as the only source of carbon. An overview of Barker's 
purification made clear that the two components of the enzyme (see § 1.18,1.19) 
had to be isolated separately. It was also evident that the old-fashioned techniques 
would have to be replaced by modern high performance chromatography steps in 
order to purify each component to homogeneity. The purification protocols 
developed for component E and S are reported below.
3.1 Purification of Component E
The cell paste was thawed, sonicated and treated with protamine sulphate to 
precipitate the nucleic acids.ii8,119 After centrifugation, the protein content of the 
supernatant liquid, was fractionated to 45% saturation with ammonium sulphate. 
The precipitate was discarded and the supernatant saturated to 85%. The solution 
was centrifuged and the pellet formed was dissolved in the appropriate phosphate 
buffer. The resulting solution contained more than 95% of the mutase activity and 
was used for the following steps.
The activity measurements were initially performed according to Barker etal.^^^ 
A sample of the crude enzyme solution was added to the assay buffer (50 mM 
TrisCI, pH 8.4) which contained (2S)-glutamic acid (1), 2-mercaptoethanol, and p- 
methylaspartase. Upon addition of coenzyme B12, mesaconic acid (3) is produced
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(see Scheme 1.9 and § 1.17). The rate of mesaconic acid formation can be 
monitored at 240 nm.
The crude protein mixture obtained after the ammonium sulphate fractionation, 
displayed only minimal amounts of mutase activity. This worrying finding verified 
similar observations reported by Buckel and Barker,''■>7 but it was in contrast with 
Barker's original purification information (see Table 1.4)."'18 The reasons for this 
discrepancy were not obvious, but impurities with inhibitory action or the presence 
of other enzymes that react with mesaconic acid (see § 1.16) were the most 
probable explanations. Initial concern about the quality of the cell paste of C. 
tetanomorphum provided by the UEA fermentation facilities were dismissed, when 
during the course of the purification it was realised that mutase of higher purity was 
substantially more active.
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) was 
routinely employed to evaluate the protein content of the various fractions isolated 
during the purification. The chromatogram of the crude protein mixture (Fig. 3.1.A.4) 
showed that only one of the 6 different major protein components qualified for the 
high molecular weight component E. Using gels of lower density (7.5% acrylamide) 
the molecular weight for this particular protein was calculated (Mr 110,000±2000) 
(Fig. 3.1.B.1-2). This value was considerably lower than the one reported by Barker 
(Mr 126,000).118 The strong band at the low region was attributed to the presence 
of component S (Fig. 3.1.A. 1 and 4). The amount of component E was estimated at 
5-8% of the total protein content.
Typically the crude protein mixture after sonication, and ammonium sulphate 
fractionation had to be dialysed and the ionic impurities removed. The use of ion- 
exchange chromatography on DEAE-52 cellulose equilibrated at pH 7.5 was 
reported not only to achieve partial purification but also to remove most of the (3- 
methylaspartase activity.ns Our efforts to reproduce the separation between the 
mutase and p-methylaspartase activity were not successful. A shallow linear salt 
gradient was applied but no improvement on the separation was observed.
Chapter 3 : Results & Discussion / Purification 79
Component E ->  j
Component S ->
97,000 3 -#  j
iff ‘ ^
66,000
49,000 w
i3^  ,000
»21,000 
14,000
B
Component E ->
' 97,000 
!a4 66,000
m  rs
66,000
49,000
31,000
21,000 
14,000
7^ __ 8^__ 9 l
Figure 3.1 Gels from early purification steps o f glutamate mutase
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The inadequacy of the DEAE-52 cellulose for this particular separation was further 
highlighted by the SDS-PAGE chromatogram of the major peaks (Fig. 3.1.C.2-7). 
Nevertheless, the DEAE-52 was routinely used to fractionate the useful enzymes 
from the Ionic Impurities present In the mixture.
The crude material was applied on the DEAE-cellulose and the total protein 
content was eluted with 60 mM of potassium phosphate at pH 6.8. Altering the 
conditions (pH, eluting salt etc.) usually resulted In lower yields. The fractions 
containing the mutase (recovery of activity was usually higher than 80%) could be 
concentrated either by ultrafiltration or by saturation with (NH4)2S0 4 . The latter 
method was usually followed In large scale preparations when some of the 
material had to be stored in the pellet form at -80 °C for future use. This partially 
purified material was still too crude to be applied directly to an FPLC system.
Partial separation of the mutase component E and p-methyiaspartase (Mr
110,000 and 92,000 respectively) activities was achieved on an exclusion 
chromatography column packed with G-150-Sephadex or Superfine G-100 gel. p- 
Methylaspartase eluted as the dimer and subsequently the difference between the 
molecular weights was not sufficient enough to effect complete separation. The 
absorbance of the eluent at 254 nm was recorded over the period of 30 hr. 
necessary to fractionate all the proteins contained In the sample (Fig. 3.2). 
Interestingly, the protein eluting between 200-250 ml from the G-150 column 
showed mutase activity (without addition of component S) and therefore both 
components must have been present. If Barker's Information was accurate 
components E and S should have been separated on the column. Clearly the 
interaction between the two subunits are stronger than originally thought.^^^
The activity containing fractions (Fig. 3.2, 200-270 ml) from the previous step 
were concentrated and applied on an Ion exchange 5-PW DEAE FPLC system, 
eluting with 0.5 M KCI (Fig. 3.3). Electrophoretic analysis of the proteins eluting in 
the main peaks revealed two features. First, the Intensity of the band assigned to 
the high molecular weight component E had diminished substantially, and second, 
no separation could be detected between component E and residual p- 
methylaspartase (Fig. 3.4.A.1-9).
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Figure 3.2 Protein elution trace from the G-150 exclusion chromatography 
column
A, B : Activity profiles for component E 
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Figure 3.3 FPLC  trace o f component E on the TSK DEAE-PW. For details see text
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Figure 3.4 Gels from later steps during the purification of glutamate mutase
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Re-application of the enriched in component E fractions (Fig. 3.4.A.3-4) on the ion 
exchange FPLC column resulted in complete loss of component E (Fig. 3.4.B.1,3- 
5). It was evident that the protein was dissociating as the purification proceeded.
A more rigorous approach, involving the use of the assay, was obviously 
necessary to solve the problem of the "unstable" component E. Essentially, an 
extension of the assay protocol discussed above, would allow component E to be 
located by its activity rather than its molecular weight.
Component S activity, free from component E, was obtained when the late 
fractions of the G-150 exclusion chromatography column (Fig. 3.2, 350-400 ml) 
were concentrated and assayed in combination with the mutase active fractions 
that had eluted earlier. The mutase activity previously measured in the early 
fractions (Fig. 3.2, 200-250 ml, p. 79) increased many fold when reduced 
component S was added.
With the activity of component S in hand we could assay all the fractions 
collected from the ion exchange FPLC system. It was discovered that a fraction of 
the total component E activity was eluting at 18 ml and a second at 25 ml (Fig. 3.3). 
Moreover the SDS-PAGE revealed that each of the above fractions contained the 
active component E as a protein of different molecular weight. The fraction that 
eluted sharply first (Fig. 3.3, 15-18 ml, 8%, 40 mM KCI) (Fig. 3.4.C.4), contained a 
protein with a molecular weight of -53 KDa, whereas the later fractions (Fig 3.3, B, 
12%, 60 mM KCI) (Fig. 3.4 C.5-6) contained a small amount of the initially observed 
dimer (Mr 110 KDa, Fig. 3.1.B). It was now clear that the dimeric form of component 
E eluted later during the gradient, together with p-methylaspartase, thus explaining 
the failure of the low performance DEAE-cellulose step to separate them.
The TSK DEAE-PW ion-exchange column provided us consistently with 
reasonable and sufficiently pure amounts of component E. The yield, however, 
over the step was not satisfactory. The protein typically lost 50-60% of its activity on 
the column after every FPLC run. No conditions could be developed to prevent or 
reduce the amount of deactivation. Component E was also applied to a 
hydrophobic interactions column (TSK Phenyl-PW) but no activity could be 
detected in the fractions collected.
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Component E after one high performance step (80% homogeneous) (Fig.
3.4.B.5) was used for kinetic studies and incubations. A pure sample of the protein 
was obtained after a second run on the FPLC system (Fig. 3.5). Finally, the total 
activity of component E isolated from 50 g of cell paste, after one FPLC run, was 
-10 units (1.27 units mg-i) in 2 ml of 50 mM phosphate buffer, pH 7.0. The half-life 
of the activity at -30 °C is one month, but for temperatures between 0-5 °C is only 
-1 2  hr. When the concentration exceeded 2 mg/ml the solution was slightly pink, 
due to small amounts of corrinoid coenzymes bound to the protein.
—  Salt gradient
—  Absorbance
Component F
43
Elution volume (ml)
Figure 3.5 Purified Component E - Final FPLC
3.2 Purification of Component S
Barker's p ro toco l^ fo r component S was reproduced but the activities we 
obtained were much lower, compared to the values in the original r e p o r t . in  our 
protocol the late fractions from the G-150 column (Fig. 3.2, 380-500 mi), contained 
more than 70% of the total component S activity, so they were combined, 
concentrated and applied on an FPLC system. The protein was deactivated on the
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ion exchange 5-PW DEAE column eluting with 0.5 M KCI. On the other hand the 
TSK Phenyl-PW hydrophobic interactions coiumn proved to be ideal (Fig. 3.6, A). 
The small protein was eluting at 35% ammonium sulphate ( 0.35 M, 43-46 mi).
A : Activity profile for component S
 Salt gradient
 Absorbance
— 40
— 30
— 20
—  10
Elution volume (ml)
Figure 3.6 FPLC trace fo r component S on Phenyl-PW
A -30%  loss of activity was observed after every run. Unlike component E, 
component 8 can be purified directly from the material after the DEAE-cellulose 
step (see p. 80). The Phenyl-PW column seems to be able to fractionate the protein 
mixture eluting from the DEAE-ceiiuiose very successfully. From 50 g of cell paste 
15-20 units of pure component 8 (3.6 units mg-i) were isolated. While the protein is 
less sensitive than component E on the high performance columns, its half-iife 
during storage at -30 °C, is shorter (-15 days). Two FPLC runs were again required 
to obtain homogenous protein (Fig. 3.7.1). The molecular weight of component 8 
could not be calculated accurately because of its position very low on the gel, but a 
fair estimation was 13,000±1000 KDa.
Chapter 3 : Results & Discussion / Purification 86
Component E ->
-A  ■‘l V,:
Component S ->  K
i _  - 1 2 3
97.000
66.000
# ^ p q g
31,000 t
? 21,000
14,000
' 4 52?. tùT*. '.VT^%*<Sk.
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3.3 Discussion of the Purification - Function of Components E and S
The purification of glutamate mutase from C tetanomorphum was undoubtedly a 
tedious and time consuming task. The half-life of the activity in the phosphate 
buffers used, at 4 °C, was ~1 day. Therefore, aii manipulations of the protein took 
place fast, without unnecessary delays, until each component had been subjected 
to one FPLC purification step. One week was typically required to isolate 10-15 
units of each component per 50 g of cell paste. While developing our protocol it 
was necessary to compromise the yield for the purity. Later, the optimised 
purification procedures had to be followed methodically to minimise any losses of 
activity. Undoubtedly there was room for improvement, but at this stage the purity 
and quantity of enzyme was sufficient for the immediate purposes.
One of the advantages of the purification described above is that both 
components were isolated from the same cell paste. In Barker's p u h f i c a t i o n . n s  
component E was essentially treated as an impurity and removed during the drastic 
isoelectric precipitation step (§ 1.17 Table 1.4, p. 37). In comparison with Barker's 
our protocols were simpler and more reproducible. The availability of the FPLC 
systems offered the opportunity to isolate the homogeneous components.
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Despite the failure of the DEAE-cellulose to separate component E from (3- 
methyiaspartase, Barker’s experimental details were very useful during the initial 
stages (Table 3.1). For example all the buffers described in the original purification 
publications were found to be optimised. No improvement could be devised, 
despite our systematic efforts.
Table 3.1 Purification o f glutamate mutase - initial steps
STEP
(ml)
Protein
(mo/ml)
Activity
(units)
Specific
Activity
Yield
%
1. Sonicatlon (50a cell paste) 149 15.3 94±1* 0.041 100
2. Protamine Sulphate 189 5.0 41.5 0.044 44
3. Ammonium sulphate tract. (50-80%) 43 12 ** ** **
4. Dialysis 53 10.1 18.2 0.035 28
5. Fractionation on DEAE-Cellulose 9 31.4 17.0 0.59 31
Value not reproducibie-Mean of three measurements 
* Value could not be obtained reliably
The low mutase activities measured during the initial steps was another 
puzzling finding, especially in relation with Barker's early results. Buckei and 
Barker in 1972 made similar observations''''2 but unfortunately they did not 
comment on this discrepancy. The most probable explanation, as suggested by an 
overview of the data available, is that various impurities acted in an inhibitory 
manner towards glutamate mutase. In many instances the total amount of activity 
increased two or even three fold after the protamine sulphate cut or the DEAE- 
ceiiuiose fractionation. Finally, a -70%  loss of activity, over the five initial steps, 
was typical. It has to be emphasised, however, that yields mentioned in Table 3.1, 
most probably underestimate the amount of mutase activity actually present.
This became apparent after every gel exclusion chromatography coiumn (p. 
82), when the activities, detected for both components, increased at least 2-foid 
(Table 3.2). After application on the ion exchange (5-PW DEAE) FPLC system, 
component E was isolated in similar specific activities as in Barker's purification.''‘'®
Chapter 3 : Results & Discussion /  Purification 88
The protein was homogenous and had a specific activity of 3.8 units mg-^  (Tabie 
3.2).
Table 3,2 Purification o f Component E  - Final Steps
STEP Volume
(ml)
Protein
(mg)
Activity
(units)
Specific
activity
Yield*
%
1. G-150 3 62.5 45.0 0.72 50
2.1st FPLC on PW-DEAE 1.9 12.4 15.8 1.27 17.5
3. 2nd FPLC on PW-DEAE 1.8 1.1 4.2 3.8 5
* Values use 90 units as the total component E activity - See table 3.1
Similar amounts of both components of glutamate mutase were obtained. The 
totai amount of component S activity typicaiiy isolated, was slightly higher than that 
of component E (15-20 units per 50 g of ceil paste). Unfortunately the small protein 
has a shorter half-life under the specific storage conditions. Barker's 
accomplishment in isolating ten times more units of component S than component 
E, could not be duplicated. Component S was purified to homogeneity (Fig. 3.7); 
the overall yields seemed to be consistent, and reproducible but much lower than 
these of Barker's (Tabie 3.3).
Table 3,3 Purification o f component S -final steps
STEP Volume
(ml)
Protein
(mg)
Activity
(units)
Specific
activity
Yield
%
1. G-150 3.0 120 39.6 0.33 44
2.1st FPLC on PW-DEAE 1.9 20.0 17.5 0.87 19
3. 2nd FPLC on PW-DEAE 1.2 2.7 9.7 3.6 10
While the final details of our purification were being established, and the pure 
components were to be subjected to N-terminai sequencing, Buckei ef a/.^2i 
published the purification of glutamate mutase from Clostridium cochiearium, a 
bacterium of the same species as 0. tetanomorphum. The German group 
encountered a number of difficulties similar to ours {e.g. gradual deactivation, loss 
of activity on FPLC systems etc.). Component E was purified on a hydrophobic
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interactions column and in accordance with our results lost at least -50%  of its 
activity during this kind of manipulation (Table 2.2, p. 37).
The high specific activities reported (6 units m g-\ Tabie 1.4, p. 37) could be 
attributed either to the source of the protein (C. cochlearium), or the different FPLC 
columns employed. A comparison between the purification tables (Tabie 4.1 and
2.2, p. 38), however, revealed that preparations from C tetanomorphum or C. 
cochlearium do not actually contain different amounts of mutase activity. For 
example, after the common exclusion chromatography step (see Tables 3.2 and
2.2, p. 37), we obtained 90 units of component E (from 100 g of ceil paste), 
whereas Buckei using a much faster gel (the separation lasted only of few hours 
instead of days), obtained 130 units. Although the claim that component E isolated 
from C. cochlearium was more stable than that from G. tetanomorphum was not 
rigorously supported by the available data, a more thorough comparison has to be 
performed, especially if component E is to be cloned and overexpressed.
Our estimations concerning the molecular weights of components E and S, 
were also confirmed by Buckei.^i^ Advances in the molecular biology area support 
the notion that the large component is produced by the ceil as a monomer with a 
molecular weight of 53 K D a . 2^2,123 j^ e  value of 128 KDa reported by Barker, was 
an artefact caused by the use of native gels. The above value for component E 
almost certainly represented an inactive complex with a composition of E2S.
It is not clear at aii if the discovery of the monomer solved aii the problems 
concerning the composition of the apoenzyme. If E2 was a simple dimer, due to the 
presence of weak interactions between two monomers, it should not have been 
observed in the first place under the denaturing conditions of the SDS-PAGE 
electrophoresis. A similar example Is p-methylaspartase, which is known to be 
active as a dimer, but only the monomer can be detected on the gels (Fig. 3.4.C.3). 
An overview of our experiments suggested that the integrity of the E2 complex 
depended on both the presence of component S and the overall progress of the 
purification. One satisfactory explanation can be that the two monomers are 
connected with an S-S bridge which is somehow protected when E and S are 
complexed but finally breaks down after prolonged exposure to 2-mercaptoethanol. 
Interestingly Buckei and coworkers who used the more powerful reducing agent.
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1,2-dithiothreitol, throughout their purification do not mention observing any of the 
dimer. There was some difficulty in establishing a consistent relation between the 
dissociation of the dimer and loss of activity for component E. The reason for that is 
that the dimer is always complexed with various amounts of component S, so it is 
not possible to attribute the apparent increased stability of the dimer to either the 
presence of component S or to the existence of the dimer itself.
A few months after Buckel's report, the amino acid sequence of glutamate 
mutase was published by Marsh etal. (Fig. 1.16, p. 40).^22,123 This knowledge can 
be useful if significant homologies between the protein under inspection and other 
better studied enzymes were found, in the case of glutamate mutase a region with 
significant local similarities (Fig. 3.8) between component E and p-methylaspartase 
was discovered and reported by Marsh and H o i i a w a y .122 This observation can 
quite possibly reveal the substrate (3-methylaspartic acid) binding site. Ser-173 
from p - m e t h y l a s p a r t a s e , i 2 6  thought to be involved in the deamination mechanism, 
is indeed included in this region. This local homology is also in agreement with the 
early experimental evidence that suggested the location of the glutamate binding 
site on component E.it^
170 190 210
p-Me Asp *  *  *  #  0 0 0  # 0 0 0 0 0 0 *  *  *  0  #  0 0 'k 0 *k ic "k ^ “k  "k *  ^
GAEINAVPVFAQSGDDRYDNVDKMIIKEADVLPHALINWEE KLGLKG EKLLEYVK
Comp.E GADLLPSTIDAYTRQNRYEECE IGIKESEKAGRSLLNGFPGVNHGVKGCRKVLESVN 
90 120 140
Figure 3.8 Homologies between comp.E and Me Asp. Identical residues are 
denoted by conserved by
The small subunit (14 KDa) on the other hand shows an appreciable amount 
(40%) of conserved positions with methionine synthase and methyimalonyl-CoA 
mutase from a number of sources (Fig. 3.9). Based on these data a possible role for 
component S during catalysis was s u g g e s t e d . 123 The small protein may be 
important for the crucial binding of the coenzyme from the a-side (chapter 1). The 
fact that oxidation of the -SH bond did not affect the affinity for component E but
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reduced activ ity ,im p lied  an important binding role specifically for the cysteines 
of component S in connection with the coenzyme.
Methionine Synth.
ttt
QGKTNGKMVI
t * 
ATVKGDVHDI GKNIVGWLQ
tt t * 
CNNYEIVDLG
Hum. Methvlmal.CoA REGRRPRLLV AKMGQDGHDR GAKVIATGFA DLGFDVDIGP
Mous.Methylmal.CoA REGRRLGLLV AKMGKDGHDR GAKVIATGFA DLGFDVDIGP
P. S'il .Methylmal. CoA AEGRRPRILL AKMGQDGHDR GQKVIATAYA DLGFDVDVGP
Component S MEKKTIVL GVIGSDCHAV GNKILDHSFT NAGFNWNIG
* t t t tt** t*t* t t ttt t t* t t** t
VMVPAEKILR TAKEVNADLI GLSGLITPSL DEMVNVAKEM ERQGF.TIPL LIGGATTSKA
LFQTPREVAQ QAVDADVHAV GVSTLAAGHK TLVPELIKEL NSLGRPDILV MCGGVIPPQD
LFQTPREVAH DAVDADVHAV GVSTHAAGHK TLVPELIKEL TALGRPDILV MCGGVIPPQD
LFQTPEETAR QAVEADVHW GVSSLAGGHL TLVPALRKEL DKLGRPDILI TVGGVIPEQD
VLSSQEDFIN AAIETKADLI CVSSLYGQGE IDCKGLREKC DEAGLKGIKL FVGGNIWGK
t tt *tt* t
HTAVKIEQNY SGPT...VYV QNAS.R..TV GWAALLSDT QRDDFVARTR
YEF.... .L FEVGVSNVFG PGTRIPKAAV QVLDDIEKCL EKKQQSV
YEF..... L YEVGVSNVFG PGTRIPRAAV QVLDDIEKCL AEKQQSV
FDE..... L RKDGAVEIYT PGTVIPESAI SLVKKLRASL DA
QNWPDVEQRF KAMGFDRVYP PGTSPETTIA DMKEVLGVE
Figure 3.9 Homologies between o f component S and other coenzyme dependent 
enzymes; identical amino acids denoted by conserved by ”t"
Although more data have been available recently, the question of the 
composition of the active form of the apoenzyme is still a matter of speculation. 
Typicaiiy, purified component E contains substantial amounts of inactive protein 
which makes the calculation of the molecular ratio between E:S rather difficult. 
Barker’s kinetic studies in combination with the correct values for the molecular 
weights allowed an estimation of 0.85 for the molar ratio between E and 
According to this calculation the most likely structure of the active holoenzyme 
complex is E2S2.
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Finaiiy the stability of the apoenzyme was studied in the presence and absence 
of coenzyme. For other enzymes of the group the effect varied, and in some cases 
the presence of AdoCbl induced an irreversible fast deactivation of the system (see 
§ 1.10.1), This observation implied the presence of activated species in the active 
site even before the addition of substrate. This was not the case for glutamate 
mutase. Two identical mixtures of component E and S were incubated in the dark 
at 35 °C in a 50 mM potassium phosphate buffer, pH 7.0. One of the mixture 
contained 20 mM AdoCbl. Aliquots were taken and their activity measured every 
hour for around 10 hr. The percentage of inactivation detected during that period 
was very similar in both cases. This result dismissed the presence of any activated 
form of the coenzyme in the active site prior to the addition of the substrate.
3.4 Assay Conditions - Limitations and Improvements
The standard method developed by Barker"'was used for routine assays. The 
principal and its applications were discussed above (see 1.17, and 3.1 p. 75). The 
activities measured are usually slightly lower (10-20%) than those obtained under 
strict anaerobic conditions. Nevertheless, the values can be accurate and 
reproducible, even suitable for kinetic analysis provided that the buffers are 
degassed prior to use. Additionally the solutions of AdoCbi and (2S)-glutamic acid 
were prepared fresh every 3-4 days.
Modifications in several instances were necessary to Increase efficiency and I
reproducibility or to fulfil certain requirements. Component S was found to be 
reduced rapidly and attain full activity by incubation with 3 mM of 2-
imercaptoethanoi for 6-10 min in 37 °C. Component E and the coenzyme were j
added last. Longer incubation times of component S with 20 mM 2- i
Imercaptoethanoi, as suggested by Barker,"'^® usually resulted in much lower 
activities. j
Some effort was spent to develop an assay that will measure the activity from |
the direction of 3-methylaspartic acid (2) to glutamate (1 ). Glutamate i
dehydrogenase could be used to remove glutamic acid from the equilibrium. The 
reaction would be monitored by the changes in the absorbance of NADH at 340
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nm. Unfortunately the activities obtained using glutamate dehydrogenase were 
much lower than these obtained under the classic method, which utilizes p- 
methylaspartase. Further elaboration on the conditions was probably necessary.
3.5. Catalytic Constant
The availability of pure enzyme and the knowledge of the exact molecular 
weight allowed us to calculate with accuracy the Km for glutamic acid as 1.35+0.05 
mM, and the Kcat catalytic constant (turnover number) of the enzyme as 300±100 
s-^M'T This value was calculated from the Micheaiis-Menten equation 3.1 (Mr 53 
KDa for component E).
v = -^[£]o[S] (3.1)Km
The catalytic constant represents the number of catalytic events that take pace at 
every active site per second. For the active holoenzyme, assuming a structure of 
E2S2,the turnover will be -10^ s-tM-L Glutamate mutase is indeed a slow enzyme.
3.6 Mechanistic Studies
With the protein available in sufficient amounts the mechanistic studies could be 
initiated. The a long list of structures that might interact with the enzyme (Fig. 3.10) 
included (2S,3S)-3-ethyiaspartic acid (82), (2S)-homocysteic acid (83), (3S)- 
methylsuccinic acid (84), (28,38)- (17) and (28,3R)-3-methylglutamic acid (18), 
(28,3R)-3-methyiaspartic acid (85), A/-methyi-(28,38)-3-methylaspartic acid (86), 
1-brom o-c/s-cyciopropane-1,2-dicarboxylic acid (80), 1-bromo-frans- 
cyciopropane-1,2-dicarboxytic acid (81). Unfortunately the synthesis of 2,3- 
methanoaspartic acid (19) was not concluded (see chapter 2). The interactions 
discovered between some of these molecules and the protein are reported below. 
The mechanistic implications suggested by our findings are discussed later in this 
chapter.
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H2N Ri 
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HO2C R3
' L i ' "  R3
HO2C CO2H
Rl=H, R2=CH3, R3=C02H (17) Ri =NH2,
R i =CH3,R2=H, R3=C02H (18) Ri=NH2,
Ri=H, R2=H, R3=S03H (83) Ri=NH2,
Ri=H, R2=H, R3=0P03H (87) Ri=NH2,
Ri =NH2,
H2N
H 2C -^
HO2C
(8)
CO2H
R2=H, R3=CH3 (2)
R 2 =CH3 , R 3 =H (85)
R2=H, R3=H (88)
R2=H, R3=CH2CH3 (82)
R2=H, R3=CH(CH3)2 (89)Ri=NHCH3, R 2-H, R3=CH3 (86)
Ri=Br, R2 =H, R 3 -C H 3  (90)
Rl=H, R2 =H, R 3 =CH3  (84)
CO2H
R i =CH2NH2 (91)
Ri =CH2C02H (92)
R i =CH2CH2C02H (93)
Br Br
HO2C ^  HO2C ^
CO2H H
(80) (81)
Figure 3,10 Molecules studied with glutamate mutase
3.6.1 (2S ,3S)-3-M ethyiaspartate Analogues as inh ib itors or 
Substrates
(2S,3R)-Methyiaspartic acid (85), N-methyi-(2S,3S)-methyiaspartic acid (86), 
(3S)-methyisuccinic acid (84), and aspartic acid (88) were tested with glutamate 
mutase as inhibitors. No interaction seemed to take place between them and the 
active holoenzyme. The first three methyiaspartic acid analogues were also 
incubated with the enzyme but no rearrangement products detected. (2S,3S)-2- 
Bromo-3-methylsuccinic acid (90) was another promising structure but it was 
found to react quickly with 2-mercaptoethanol present in the incubation and assay 
mixtures.
Defining the stereochemical course of the reaction at C-3 of glutamic acid was a 
long pursued target of our research. As discussed earlier (§ 2.7) the 
stereochemical course of the rearrangement at C-3 cannot be easily defined due to 
the torsiosymmetry of the -C H 3  group formed on 3-methylaspartic acid. So we had 
to design a molecule that on rearrangement would preserve the stereochemical
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information introduced by the enzyme. This can be done by replacing one of the 
three protons with a methyl group and a second with a deuterium, thus forming the 
specifically labelled 3-ethylaspartic acid (82a) (Scheme 3.1). During the initial 
stages of the project, we were fairly confident that the presence of an additional 
methyl group on the substrate apart from reducing the rate of the reaction, it would 
not interfere with the fundamental aspects of the rearrangement. Additionally the 
methyl group could also "lock" the methylene group of 3-ethyiaspartic acid (82a) in 
such an orientation that only one of the two prochirai protons present would be 
removed. The identity of the proton abstracted and the stereochemistry at the C-3 of 
the 3-methylglutamic acid product (Scheme 3.1, (17 or 18)) would be sufficient to 
establish if the rearrangement proceeds via an inversion or retention of 
configuration.
Although (2S,3S)-ethylaspartic acid (82) was available in our laboratory crude 
preparations of the mutase could not be incubated with the compound for two 
reasons. First, the impure enzyme loses its activity quickly, usually after 2-3 hr. This 
means that a slow substrate, would require large amounts of enzyme to give any 
detectable quantities of product.
HzN
H-«j
HO2C
CO2H
H2N.
H C02H
HO2C
(17) or (18)
H2N H HO2C CH3
H -  A— ^
HO2C
H2N H ,CH3
C^ HH
HO2C
(82a)
H CO2H
HO2C (2H).CHCH3
CO2H
Scheme 3.1 Plan fo r defining the stereochemical course of the reaction 
at C-3 o f glutamic acid.
Additionally the equilibrium is shifted to the direction of ethyl fumarate (Scheme 
3.1) because the substrate (82) is processed by p-methyiaspartase present in the
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crude mixture. It is possible to inhibit p-methylaspartase using Ca2+ ions but the 
inhibition was bound to be inefficient for slow substrates for the rearrangement.
The incubation of ethylaspartic acid (82) with the mutase was repeated a few 
months later, when protein free of p-methyiaspartase activity was available. Using 
substantial amounts of enzyme (1-2 units) no 3-methyiglutamic acid could be 
detected by ^H-NMR spectroscopy in the incubation mixtures.
Although it was clear that 3-ethyiaspartic acid was not a substrate for glutamate 
mutase, no satisfactory explanation was available at this stage. The key information 
missing was whether or not the holoenzyme in the presence of 3-ethyiaspartic add, 
activates the coenzyme and subsequently generates the 5'-deoxyadenosyi radical. 
If the 5’-adenosyl radical was formed then a proton would be most certainly 
abstracted from the molecule of 3-ethylaspartic acid occupying the active site, in 
other words the lack of rearrangement products was not conclusive as far as it 
concerned any hydrogen exchange between ethylaspartic acid and the coenzyme.
To investigate this possibility a number of deuteriated ethyiaspartates (82  
b,c,d) were synthesised in our laboratory by S. Gulzar and K. Badiani, and 
incubated with unlabeiied 3-ethyiaspartic acid or (2S)-giutamic acid in several 
different molar ratios. (2S,3S)-[3'-H3]-3-methylaspartic acid (2a) (§ 3.1) was also 
incubated with the enzyme in the presence of unlabeiied 3-ethyiaspartatic acid. A 
combination of ^H- and ^H-NMR spectroscopy was then employed to detect any 
exchange of deuterium.
HzN H
H'ifJ-----
H02C C02H(2a)
H2N
HO2C C02H 
(82b)
H
Lc%2C%3
H2N H
 L C H 2C%3
HO2C CO2H 
(82c)
H2N H
 ^ .C % 2CH3
HO2C CO2H
(82d)
Figure 3.11 Deuteriated ethylaspartic acids employed
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For example, a mixture of [3’-2H3]-3-methyiaspartic acid (2a) and unlabeiied 
ethylaspartic acid (17) was incubated with the pure mutase. After a few hours p- 
methyiaspartase was added, the aikyi aspartic acids present were transformed into 
aikyl fumarates (3a), (3b), and extracted into ether, if any deuterium label had 
been transferred from [3'-2H3]-methylaspartic acid to ethylaspartic acid (82) 
(Scheme 3.2) it would have been easily detected by means of ^h -N M R  
spectroscopy, since now all three sets of protons present in the product mixture 
were different. Complete lack of deuterium exchange confirmed that the 
holoenzyme could not abstract hydrogens from either the 3'- or the 4'-position of 3- 
ethyiaspartic acid (82).
H2N
HO2C
CO2H
H2N
H-“|j
HO2C
MUTASE
H2N H
JJ .rtlW ■
h o /  CO2H
(2a)
Possible 
Label
H2N H
CO2H
Exchange
H ^  CH2CH3 ( 8 2 )
HO2C \ CO2HWork-upH
Easily 
identifiable 
sets of protons 
by ^H-NMR or % -NMR
HO.C
> = =<  (3b)
>  H3(^H)CH2(^ H)C CO2H
H02Ç
C02H
(3a)
Scheme 3.2 Label Exchange experiments with glutamate mutase
The 1R-NMR spectra of the experiment described above is shown in Fig. 3.12. After 
the incubation (Fig. 3.12, C), the aspartic acids were deaminated and the ^h -NMR 
indicated no label exchange. The 4-H of [3'-^H2]-(2S)-giutamic acid produced by 
the enzyme can be seen at 2.2 ppm (Fig. 3.12, B).
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F ig  3.12 N M R spectra o f incubations containing 3-methylaspartic acid (2a) and 3- 
ethylaspartic acid (82). For details see text, p. 97
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3.6.2 3-Methylglutamic Acids
The inability of the enzyme to tolerate any additional groups on the C-3' of 3- 
methyiaspartlc add, did not exclude the possibility of 3-methylglutamic acids being 
substrates for the rearrangement. The compact structure of 3-ethylaspartic acid
(82) could be more difficult to be accommodated In the active site than the 
relatively more flexible 3-methylglutamate structure. If any of the two diastereomers 
on C-3 (17 and 18) (see § 2.3) was a substrate, Interesting stereochemical 
Information could still be deduced. An additional practical advantage of 
Investigating the reaction from the direction of 3-methylglutamic acid to 
ethylaspartic acid (Scheme 3.11), is that p-methylaspartase can be used to 
deaminate any product 3-ethylaspartic acid. Even if the rearrangement of 3- 
methylglutamlc acid to ethylaspartic acid was an favourable equilibrium, some 
product ethyl fumarate would have been easily detected (Scheme 3.11), In the 
presence of (B-methylaspartase. Unfortunately neither of the two diastereomers, 
(17) or (18), rearranged at any detectable rate under the conditions of the 
Incubations (0.5-1 unit of enzyme present).
While 3-ethylaspartlc acid cannot be reliably evaluated as an Inhibitor because 
It Is a substrate for p-methylaspartase, the two methylglutamic acids (17) and (18) 
were Inhibitors for glutamate mutase (Figs. 3.13, 3.14, and Fig. 3.15 respectively).
01
E
o
>
4
3
♦ [l]1.5mM
n [I] S.SmM
2
1
0 ^  -0.5 0,5 1.5 2.5
1/[S] 10 (1/M)
Figure 3.13 Lineweaver-Burk plot fo r  (2S,3R)-3-methylglutamate, characteristic
o f competitive inhibition. The lines coincide on the Y-axis
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Typically the plot (1/v) vs. (1/s), for (17) verifies the competitive nature of the 
inhibition (Fig. 3.13). The Kj values indicate that both diastereomers bind in a 
similar unproductive manner the holoenzyme complex, competing with the 
substrate for the active site. The difference in the Kj values for the two 
diastereomeric 3-methylglutamic acids probably reflected the preference of the 
enzyme to accommodate the (2S,3S)-isomer (18) better in the active site.
B [S] o.SmMoE 2 -I
"e
n [S] 2mM
>
-0.001 -0.000 0.001 0.002 0.003 0.004 0.005
[I] (M)
Figure 3,14 Inhibition by (2S,3R)-3-methylglutamic acid [K i =  U  m M ]
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♦ [S] I.SmM
B [S] 2mM
8
4
2
0 -0.001 -0.000 0.001 0.002 0.003 0.004 0.005 0.006
[I] (M)
Figure 3,15 Inhibition by (2S,3S)-3-methylglutamic acid [K i = 1 m M]
3.6.3 Homocysteic acid (83) and Phosphohomoserine (87)
Replacing the carboxyl group of glutamic acid with -SO 3 or -OPO 3 leads to the 
structure of (2S)-homocysteic acid (83) and phosphohomoserine (87)
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respectively. The former is commercially available and the latter had been 
synthesised in our grou p .H o m o cyste ic  acid was a competitive inhibitor for 
glutamate mutase (Kj 5 ± O.SmM) (Fig. 3.17).
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■ 8 mM [I]
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Figure 3,16 Lineweaver-Burk plot ,fo r  (2S)-homocysteic acid
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Figure 3.17 Inhibition by (2 S)-homocysteic acid, Ki = 5 ± 0 .5 m M
The high Kj value for (2S)-homocysteic acid (83) was somewhat a surprise, 
since the only essential difference between (83) and (2S)-glutamic acid is the 
slightly larger volume of the sulphonate in comparison with the carboxylate. It was 
expected that the the molecule would bind better in the active site. At the same time 
the inability of the enzyme to process homocysteic acid suggested that changes in 
the electronic properties of 0-4 (the carbon atom is attached to a sulphur instead of 
a carbon) cannot be tolerated.
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Phosphohomoserine (87) has a longer side chain (1 additional oxygen atom ) 
and the expected lack of interaction with the enzyme was verified. No inhibitory 
action could be observed.
3.6.4 Straight Chain Analogues
4-Aminobutyric (GABA) (91), 1,5-pentadicarboxylic (92), and adipic acid (93) 
were not substrates and no inhibitory action could be detected at concentrations up 
to 20 mM, with the substrate at 0.5 mM.
3.6.5 1-Bromo-fra/fs-and c/s-cyclopropanedicarboxylic acid, (80) and 
(81)
The precursors of 2,3-methanoaspartic acid (19), pure 1-bromo-frans- and cis- 
cyclopropanedicarboxylic acids, (80) and (81) (see discussion § 2.4) were the 
only molecules available containing the cyclopropane skeleton. The two acids, 
each one a mixture of two enantiomers, were tested with glutamate mutase as 
inhibitors and substrates. It was immediately clear that the cyclopropane diacids 
absorbed at the region of 240 nm. After the necessary alterations in the assay 
conditions to accommodate this feature, it was found that both cis and trans (80) 
and (82), interacted with the enzyme. The mode of their interaction, however, was 
completely different. The cis isomer (80) was a typical example of competitive 
inhibitor with a Kj of 2.2+0.2 mM. No other effects on the kinetic behaviour of the 
enzymatic system were detected when the diacid (80) was present in the assay 
solution.
On the other hand the behaviour of the bromo-frans-1,2-cyclopropane- 
dicarboxylate (81) was far more complicated. Under the specific assay conditions, 
discussed previously in detail (p. 77), the enzyme reaches its maximum activity 15- 
20 seconds after the addition of AdoCbl. When the diacid (81) is present in the 
solution no activity was observed for several minutes. After this period, formation of 
mesaconic acid (3) was observed. The performance of the enzyme kept increasing 
for several minutes. The time-delay for the appearance of activity, and the final rate 
attained depended on the concentration of the trans isomer. At higher 
concentrations of the diacid (81) the system stayed inactive for longer and the final
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rates achieved by the enzyme were lower. Unfortunately, because initial rates 
could not be measured, accurate K\ determination was not possible. However, a fair 
estimate of K; would be ~3 mM.
A first evaluation of the data accumulated hinted that the trans diacid (81) might 
be a substrate for glutamate mutase. Unfortunately no rearrangement products 
were detected by ^H-NMR spectroscopy when either the frans (81), or the cis (80) 
cyclopropanediacids were incubated with the mutase.
3.7 Discussion
All the important compounds that have been used as probes for the glutamate 
mutase system in our laboratory or by others are listed in Table 4. The variety of 
structural characteristics incorporated in these structures allows a thorough 
evaluation of the substrate requirements for glutamate mutase. Unfortunately, none 
of these molecules is chemically modified in the presence of the holoenzyme.
Since no information is available on the three dimensional structure of 
glutamate mutase, our knowledge about the overall shape of the active site is 
bound to be sketchy. Nevertheless the data collected can be used to address three 
important issues. First, is the design of novel structures to probe the mechanism of 
the rearrangement in relation with the shape of the active site. A second Issue is 
highlighting the role of the different functional groups on (2S)-glutamate (and
(2S,3S)-3-methylaspartic acid). Finally, the various mechanistical aspects of the 
actual rearrangement step can be evaluated and a satisfactory working hypothesis 
will be proposed.
3.7.1 Mapping of the Active Site
The remarkable selectivity of glutamate mutase is probably due to the unique 
characteristics and requirements of the rearrangement step. The pocket reserved 
for (2S)-glutamic acid is clearly very tight. (R,S)-2-Methylglutamic acid (91) and N- 
methyl-(2S,3S)-3-methylaspartic acid (86) did not interact with the enzyme in any 
detectable manner, implying that there is no free space neither towards the re-face 
of the a-amino acid centre nor in the pocket that binds the amino group (Fig. 3.18, 
region A). Phosphohomoserine (87), with an additional oxygen atom on its
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skeleton, but acceptable electronic properties was not an inhibitor. The size of each 
group and the length of the molecule (5 atom units) is important.
Table 3,4 Compounds studied with glutamate mutase
Compound Substrate inhibitor* Km or K| Ref.
(2S)-Glutamlc acid (1) + 1.35 119
(2S.3S)-3-MethvlasDartic acid (2) + 0.5 119
(2S,3R)-3-Methvlaspartic acid (85) m - - "V
(2S,3S)-3-Ethvlaspartic acid (82) m - - V
N-Methvl-(2S,3S)-3-methvlaspartic acid (86) m _ - V
(2S)-Aspartic acid (88) m - V
(2S,3R)-3-Methylaiutamic acid (17) m + 1.5±0.1 V
(2S,3S)-3-Methviautamic acid (18) m + 1±0.1 V
(2S)-Homocysteic acid (83) m + 5+0.5 V
1 -Bromo-cyciopropane-c/s-1,2-diacid (80) m + 2.2+0.2 V
1 -Bromo-cyclopropane-frans-1,2-diacid (81 ) . + ~3mM V
(RS)-2-Methylqiutamic acid (8) . - _ V
(2S,4S)-4-Fluorofliutamic acid _ + 0.07 121
2-Methyleneaiutaric acid - + 0.4 121
(S)-3-Methylitaconic acid - + 0.1 121
Itaconic acid - + 1.2 121
* All the inhibitors discovered in our laboratory were competitive. The behaviour of 
(81) has not been accurately evaluated (see § 3.6.5). For the inhibitors discovered 
by Buckel no information was reported on the mode of inhibition.
V Our work.
The situation with the 3-aikylglutamic acids, (17), (18), is slightly different. 
Although they are good inhibitors, implying a firm occupation of the active site, they 
do not rearrange. These results are related with the inability of the enzyme to 
process 3-ethylaspartic acid (82) or to exchange any labels with the deuteriated 
analogues (82 a,b,c,d). It seems logical to suggest that when (2S)-glutamic acid
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(1) is present in the active site the pocket accommodating the methyl group (Fig. 
3.18, region D) is almost empty. On formation of 3-methylaspartic acid, however, 
this pocket gets neatly occupied by the newly formed methyl group. The good 
competitive but non productive binding of 3-methylglutamic acids, and especiaily of 
the (2S,3S)-isomer (18) was probably due to the fact that region D was occupied 
by the additional methyl group (Fig. 3.18). Subsequently there is no space for an 
additional methylene group to develop.
This hypothesis by itself cannot account for the lack of any label exchange in 
our detailed experiments with 3-ethylaspartic acid (82) and its deuteriated 
analogues (82 a,b,c,d) (see p. 94). It could be envisioned, however, that the 
addition of the extra methyl group on 3-methylaspartic acid disturbed the geometry 
of the active site so much that even if the 5’-adenosyl radical was generated, the 
substrate (82) might not have been appropriately positioned to have its protons 
abstracted. Of course the other alternative would be that the conformational 
changes induced by the extra methyl group resulted in complete obstruction of the 
radical generation process.
As far as it concerns the role of the two carboxyl- and the amino- group two 
results were of particular interest. Both c/s- (80) and trans- (81) brom o- 
cyclopropanedicarboxylic acids, were inhibitors of glutamate mutase. The ability of 
the bromo diacids (80) and (81) to interact with the enzyme suggests an amount 
of flexibility for the binding of the C-5 carboxyl group. Additionally Buckel and 
coworkers observed, using ERR, the presence of radicals during incubation of 
methyleneglutaric and 3-methylitaconic acids with the enzyme (Table 3.4), 
although no rearrangement products were observed. Compounds lacking either of 
the carboxyl groups, for example 4-aminobutyrate (GABA) (91) were completely 
inactive. (2S)-Homocysteic acid (83) bears all the necessary for binding groups 
and it was a competitive inhibitor. Whereas the carboxyl groups are important for 
"anchoring" the substrate in the active site, the amine can clearly be replaced by 
another group of similar size. This substitution can be tolerated by the enzyme and 
does not affect the binding properties of a substrate or even the ability to induce the 
generation of radicals species.
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In the circles are enclosed the 
hydrogens abstracted by 
the 5 - adenosyl radical
3-Methylglutamate occupying the active 
site in a non-productive manner
A) Binding Pocket for the Amine
B) " for the a-carboxyl group
C) " for the (3-carboxyl group
D) " for the methyl group
Figure 3.18 Main characteristic o f the active site and non-productive 
binding of 3-methylglutamic acids
The binding of the two substrates (glutamic acid or methylaspartic acid) takes 
place in a highly selective binding site. The enzyme recognises every part of the 
molecule and does not tolerate any additions on the basic carbon skeleton. The 
two carboxyl groups and the five atom long chain are responsible for "anchoring" 
the substrate in the active site. The amine, or a group of similar size (bromo, or 
methylene), is necessary to "steer" the molecule in the correct orientation. The 
methyl group is probably involved in the radical generation process. The enzyme 
seems to rely, for the success of the whole process, on the adoption of a very strict 
conformation during the actual rearrangement step.
3.7.2 Cyclopropane Containing Inhibitors
The usefulness of rigid inhibitors for probing active conformations of enzyme 
substrates is well d o c u m e n t e d .^ ^ s  Their binding in the active site is entropically 
favoured, and they can offer reliable information about the arrangement of the
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protein residues. Cyclopropane containing structures possess a number of 
advantages over unstrained inhibitors. For a start they do not contain any 
additional atom(s) that will prevent their entrance into the active site. Additionally, it 
was conceivable that the enzyme might be "fooled" and abstract a proton from the 
substrate inducing destruction of the cyclopropane ring. Finally these compounds 
have a rigid structure that should mimic, at least structurally, the TS of the 
rearrangement.
If the enantiomerically pure bromo-cyclopropane diacids were availabie, we 
would be able to comment on the exact conformation of the substrate in the active 
site prior to, and after the rearrangement. Nevertheless, compounds (80) and (81) 
proved to be quite useful. Most certainly the Br occupied the space reserved for the 
amino group (radius of -Br and -N H 3+, 1.14 A and 1.00 A respectively) so the 
molecules can fit in the active site without any problems. In their racemic form, the 
cyclopropane diacids (80) and (81) were both inhibitors of the enzyme, but their 
mode of action followed a completely different pattern. On the one hand is the cis 
isomer (80) represented a simple case of competitive inhibition, and on the other 
the trans isomer (80) prevented the enzyme from turning over any substrate for 
several minutes (see § 3.6.5). The two molecules were neither substrates nor 
inactivators.
Since bromo-frans-1 -cyclopropane-1,2-dicarboxylic acid (81) was not a 
substrate, but the nature of its interaction with the enzyme, from t=0 (enzyme not 
active) to t=10min (activity present) changed, it was clear that the enzyme existed in 
two significantly different conformations. The first (ground state) binds the trans 
isomer (81) very tightly, resulting in the inability of (2S)-glutamic acid to access the 
active site. Subsequently the holoenzyme complex remained inactivated. Because 
the binding of acid (81) in the active site was reversible, glutamic acid (1) slowly 
activated the system which adopted a new conformation (excited conformation). 
The new shape of the active site did not favour the binding of compound (81), 
which from then on acted only as weak inhibitor (3 mM). In other words our 
suggestion is that the trans bromo diacid "locks" the enzyme in an inactive 
conformation, until the substrate manages to slowly replace the inhibitor and 
activate the system.
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The ability of the holoenzyme complex to adopt two distinct conformations is 
more or less expected according to the discussion in chapter 1, concerning the 
activation of the Co-C bond. In the excited conformation, the 5'-adenosyl radical is 
located close to the substrate, 10 A away from the cob(ll)alamin radical. This 
assumption can also explain the facile deactivation of the system by oxygen, only 
after substrate is added in the enzyme solution (§ 1.21). Only in the excited 
conformation, triggered by (2S)-glutamic acid, the oxygen is harmful since it can 
react with the radicals in the active site and destroy the important Co-C bond.
3.7.3 Energetics of the Rearrangement
The rearrangement catalysed by glutamate mutase is energetically a highly 
unfavourable reaction. The activation energy for such a transformation is very high. 
In solution the enzyme has to perform two energy consuming tasks. One is to 
assembie the reactive complex (desolvation, entropy etc.) and the second to form 
the enzymatic transition state. In the case of glutamate mutase and other Big 
dependent enzymes this energy undoubtedly originates from the binding of the 
intricate cofactor and the substrate. Energetics of this kind have been analysed in 
detail by Schowen"'®® and shown to fit perfectly the fundamentalist view of
"transition state stabilisation."^
3.8 The Mechanism of the Rearrangement
Glutamate mutase is stabilising transition state intermediates whose exact 
nature are yet to be established. Although the literature on the subject is limited, 
three different routes can be envisaged, on the basis of chemically plausible 
alternatives, existing rearrangement models (§ 1.10.2) and theoretical studies.^®®
The involvement of a Schiff's base (94) (Scheme 3.3) was one of the first 
suggestions'*®® concerning glutamate mutase. It was dismissed in the sixties when 
it was established that the enzyme does not require pyridoxal phosphate for 
activity. The presence an N-terminal pyruvoyl anhydro serine residue in the active 
site of was another possibility. This assumption, however, is not supported by the 
recent molecular biology studies performed on the system."*25
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The possibility of charged intermediates to be operational has already been 
discussed for methylmalonyl-CoA (see § 1.12.2). Merkelbach and coworkersi®^ in 
a theoretical study extended this mechanism to include the case of glutamate 
mutase. Their suggestion, that the rearrangement can proceed through an e no late 
cyclopropane anion (95), has some interesting features, as for example, control of 
stereochemistry by electronic instead of steric factors. One of the weak points, 
however, of this pathway is lack of any reasonable suggestion concerning the 
generation of the anion (95). Although the ability of enzymes to generate enolates 
is well established, 1®® it is very difficult to envision a link between the generation of 
the 5'-adenosyl radical and the abstraction of a H+ to afford anion (95).^2,73
In a more general context both these mechanism are not compatible with 
Murakami's findings concerning the dimethyl methylaspartylcobalamin (14) (see § 
2.8). His discovery that the 3-methylaspartic acid carbon skeleton has the intrinsic 
tendency to rearrange, even in low yields, in the absence of any factors that would 
promote Schiff's base formation or énolisation, poses a severe problem for the 
proponents of either of these two aiternatives.
The third suggestion, which has not been presented in this form elsewhere, 
involves the abstraction of a proton by the 5'-adenosyl radical to form the radical 
(96) on C-4 of glutamic acid (Scheme 3.3, C). This initial abstraction is supported 
through many lines of evidence discussed previously (§ 1 .6, 1.9). The radical (96) 
breaks down to two intermediates, namely the glycyl radical (97) and acrylic acid
(99). These two intermediates are very strongly bound on the enzyme and cannot 
leave the active site in this form (see § 1.17). The radicals (97) and (98) are 
probably very short lived. In the special environment created by the active site 
residues, with all the side reactions suppressed, recombination is probably the only 
alternative.
Glycyl radicals like (97) are considered to be very stable due to the combined 
action of an electron withdrawing (CO2") and electron-releasing group NHa.''®'*''*®^  
This well documented phenomenon is called captodative effect, and the pair of the 
amine and the carboxyl group is one of the best stabilising pairs known. In other 
words a radical on the a-centre of an amino acid (97), is much more stable than 
the radical originally generated on C-4 of glutamic acid (96).
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Scheme 3 3  Intermediates fo r the rearrangement step
Finally we could comment that the third pathway is very sensitive to any steric 
perturbations. Any alteration of the substrate structure will either prevent the 
intermediates (97 and 98) from being generated or will destroy the geometry and 
orientation of the radical species involved. The enzyme would not have been so 
selective for its substrates if any of the other two mechanisms was operating.
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3.9 Proposal about the overall mechanism
Essentially the enzyme performs three tasks. First it binds the coenzyme and the 
substrate in the correct conformation, second, second it triggers the homolytic 
cleavage of the C-Co bond every time a compound with the correct conformation 
occupies the active, and third, the enzyme adopts a conformation that keeps the 5 -  
adenosyl radical away from cob(ll)alamin and promotes the formation of 3- 
methylaspartic acid ("excited" state).
Components E and S form the active apoenzyme complex. The affinity of the 
two components for each other is not very high, which is reasonable if the 
coenzyme is complexed in a region between the two subunits. The increase of Km 
for the coenzyme (see § 1.18) at high concentrations of component S supports the 
notion that the enzyme must have a large flexible domain which will allow the 
sizeable cofactor to be enclosed. In glutamate mutase this domain seems to be 
component S. After the holoenzyme is formed, (2S)-glutamic acid is confined in a 
highly selective sub-region of the active site, on component E (Fig. 3.19, p. 112) 
adopting the conformation shown in Fig. 3.19, A. This kind of binding will afford the 
product 3-methylaspartic acid in a frans-like and less strained conformation, with 
the two carboxyl groups as far away from each other as possible (Fig. 3.19, D). The 
5'-adenosyt radical is located above the plane defined by the glutamic acid 
skeleton and probably does not move during the catalysis. The radical is attached 
on a highly functionalised ribose ring, whose rigidity had been shown to be of vital 
importance (§ 1.7). The enzyme is likely to exist in two different conformations, the 
ground state conformation-radical off, and the excited state conformation-radical 
on. The latter probably favours the binding of the more compact structure of 3- 
methylaspartic acid to that of (2S)-glutamic acid. Glutamate binding induces the 
necessary changes on the protein backbone for the Co-C bond to be cleaved and 
the adenosyl radical to be generated. After the abstraction of the pro-S 4-H, and 
formation of the acrylate and the glycyl radical, the enzyme must use the binding 
region C (Fig. 3.19) of the C-5 carboxyl group in order to push the acrylic acid in the 
methyl group binding pocket. The (NH2) / (CO2H) captodative pair stabilises the 
glycyl radical during the time necessary for the enzyme to adjust the acrylate in a 
conformation, that favours the formation of the new bond between C-2 and C-4.
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Figure 3.19 Possible shape o f the active site o f glutamate mutase. The 5'- 
deoxyadenosyl radical is located above the page
3.10 Conclusions
Glutamate mutase is an intriguing enzymatic system. Research on the 
mechanistic details of its action has been hampered by the low yielding purification 
procedures and the high stereospecificity of the enzyme for its substrates. Recent 
advances by BuckeP^i and Marsh'^^s contributed in obtaining the primary structure 
of the protein but no additional understanding on the mechanistic details of the 
rearrangement emerged. Our approach was more fundamental since we tried to 
elucidate the basic structure of the reaction transition state and the interactions
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between the substrate and the protein. Achieving these two targets Is essential in 
order to understand the mechanism of such a complicated process. The enzyme by 
orienting the substrate accurately in the active site and manipulating the coenzyme 
B i2, manages to conduct the very reactive intermediates and promote the 
isomérisation. The information presented above will be soon integrated with more 
stereochemical and kinetic data.
For a molecule to be chemically modified by the enzyme three requirements 
have to be fulfilled. First, the compound has to fit in the active site; second, it must 
generate the 5'-deoxyadenosyl radical; and third it should be able to adopt a 
conformation that will allow proton abstraction. Compounds that fulfil all three 
requirements like other cyclopropane intermediates, 2,3-methanoaspartate (19) 
and (2S)-3-methyleneaspartate (100) are currently under synthesis in our 
laboratory. The exact mode of interaction with 1-bromo tra ^ S '^ ,2 -  
cyclopropanedicarboxylate (81) has also to be elucidated.
H iN
^  ( 100]
HO2C CO2H
Additionally the isotope effect from the direction of (2S)-glutamic acid to
(2S,3S)-3-methyIaspartic acid will be measured by employing [4-2H2]-(2S)- 
glutamic acid. The compound was synthesized very recently and the isotope effect 
is about be measured.
When the research described above is coupled with E.S.R and stop-flow kinetic 
studies, this complex enzymatic system will reveal most of the details of its action, 
including the nature of the cobalt intermediate and its relation to the reaction 
coordinate profile. Elucidation of the three dimensional structure could finally 
provide a unique opportunity of answering the fundamental question of how a 
proteinic structure manipulates all the highly reactive intermediates known to 
participate in the process.
Chapter 4
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A) Synthesis of Substrates and inhibitors
Elemental microanalyses were performed in the departmental microanalytical 
laboratory.
NMR spectra were recorded on a Broker AM-300 (300 MHz; FT. iR-NMR, and 
74.76 MHz; i^C-NMR.), or a Varian gemini 200 (200 MHz; FT. ^H-NMR and 50.31 
MHz; ■•3C-NMR) spectrometers. ^H-NMR spectra are described in parts per million 
downfield shift from TMS and are reported consecutively as position (ÔHorSc), 
relative integral, multiplicity (s.-singlet, d.-doublet, t.-triplet, q.-quartet, d.d.-double of 
doublets, sep.-septet, m.-multiplet, and br.-broad), coupling constant (Hz) and 
assignment (numbering according to the lUPAG nomenclature for the compound). 
^H-NMR were referenced internally on ^hOH (4.68 p.p.m.), CHCI3 (7.27 p.p.m.) or 
DMSO (2.47 p.p.m.). i^C-NMR were referenced on CH3OH (49.9 p.p.m.), C2HCI3 
(77.5 p.p.m.), or DMSO (39,70 p.p.m.).
I.R. spectra were recorded on a Perkin-EImer 1710 FT IR spectrometer. The 
samples were prepared as Nujol mulls, solutions in chloroform or thin films 
between sodium chloride discs. The frequencies (D) as absorption maxima are 
given in wave numbers (cm-i) relative to a polystyrene standard. Mass spectra and 
accurate mass measurements were recorded on a VG 70-250 SE, a Kratos MS-50 
or by the SERC service at Swansea using a VG AZB-E. Fast atom bombardment 
spectra were recorded using glycerol as a matrix. Major fragments were given as 
percentages of the base peak intensity (100%). UV spectra were recorded on Pye- 
Unicam SP8-500 or SP8-100 spectro-photometers.
Flash chromatography was performed according to the method of Still ef 
using Sorbsil 0  60 (40-60 pm mesh) silica gel. Analytical thin layer 
chromatography was carried out on 0.25 mm precoated silica gel plates 
(Macherey-Nagel SIL g/UV254) and compounds were visualised using UV 
fluorescence, iodine vapour, ethanolic phosphomolybdic acid, or ninhydrin.
Melting points were taken on an Electrothermal melting point apparatus and are 
uncorrected. Optical rotations were measured at 23 °C on a Optical Activity AA-100 
polarimeter using 10 or 20 cm path length cells.
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The solvents used were either distilled or of analar quality and light petrol ether 
refers to that portion boiling between 40 and 60° C. Solvents were dried according 
to literature procedures. Ethanol and methanol were dried using magnesium 
turnings. Isopropanol, isopentanol, DMF, toluene, CH2C I2, acetonitrile, 
diisopropylamine, triethylamine, and pyridine were distilled over CaH2* THF and 
diethylether were dried over sodium / benzophenone and distilled under nitrogen. 
Thionyl chloride was distilled over sulphur, and the initials fractions were always 
discarded. Bull was titrated according to the method of U p t o n .  194
Diazomethane:
Potassium hydroxide (10 g) was dissolved in isopropanol (40 ml) with heating 
using the minimum amount of water (2-3 ml). Ether (40ml) was added to the 
solution and the temperature was raised to 50 °C. Diazald (42 g), dissolved in ether 
(250 ml), was introduced into the solution over 45min. The yellow distillate was 
collected in a flask immersed in an ice bath and the whole system was fitted with a 
drying tube. An additional amount of ether (100 ml) was added until the ether 
distilling over was colourless. The etheral solution in the receiver (-400 ml) 
contained around 8 g of diazomethane.
Acetic acid-2H:i95
Freshly distilled acetic anhydride (36.7 g, 36 mol), zinc powder (1 g), and CCI4 
(1 ml) together with a trace of P2O5 were stirred under vacuum for 3 hr. in a three 
necked flask provided with a thermometer. The solution was cooled to 0 °C and 
2H2O (7.4 g, 0.37 mol) added slowly over 30 min. under N2. The temperature was 
gradually raised to 60 °C for 2 hr. and stirring continued overnight at room 
temperature CH3CO22H was distilled in a trap cooled to -50 °C; (39 g, 88%);. b.p. 
117 °C (lit.,196 117.9 °C). The acid prepared in this manner contained ^ 98% as 
judged by iH-NMR spectroscopy, using the methyl group as internal integration 
reference.
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[2 '-2 H3]-Mesaconic acid (3a);i24
>=<
Methylenesuccinic acid (29) (2 g, 20 mmol) and NaOH (8 g, 200 mmol) were 
dissolved in deteuterim oxide (18 ml, 0.9 mol) and the solvent was removed in 
vacuo. The process was repeated twice. Deteuterim oxide (18 ml, 0.9 mol) was 
added and the resulting solution was refluxed for 24 hr. under nitrogen. After 
cooling to room temperature the pH of the solution was adjusted to 1.5 with 6 M 
HOI. Water (40 ml) was added and mesaconic acid was extracted with diethyl ether 
(3 X  100 ml), the organic phases pooled, dried (MgS04) and reduced in vacuo to 
give [2'-2H3]-mesaconic acid (3a) as white residue which was crystallized twice 
from ether/ petrol ether (1.3 g, 43%), m.p. 196-197 °C (lit.,196 204-205 °G ); (Found: 
0, 45.9; H, 4.3. Calc, for C5H6O4: C, 46.1; H, 4.6%); m/z (Found: [M + NH4]+ 
152.086. C5H22H4O4 requires 152.086); ôh (200 MHz; 2H2O) 1.9 (s, residual CH3), 
and 6.4 (s, C=CH); 5c (50 MHz; 2H2O, NaQ2H) 16.20 (m, C2H3), 123.21 
(£(C2H3)C02H), 140.08 (ÜHCO2H), 177.3 (C-1) and 177.7 (C-4); m/z (El) 135 (M+, 
4%), 115 (42), 87 (39), 70 (22) and 45 (100). Dimethyl mesaconate was prepared 
by treatment of mesaconic acid (3a) with diazomethane. The sample contained > 
95% 2h as judged by ^H-NMR spectroscopy, using the methyl ester group as 
internal integration reference.
[3'-2H3H2S,3S)-3-Methylaspartic acid (2a);i97
Mesaconic acid (3a) (1 g, 7.5 mmol) was dissolved in water (10 ml), and the pH 
of the solution was adjusted to 9 with concentrated aqueous ammonia solution. 
Magnesium chloride hexahydrate (0.1 g, 0.5 mmol), potassium chloride (20 mg,
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0.27 mmol), and p-methylaspartase (~80units) were added and the solution was 
incubated at 30 °C. The absorbance at 240 nm was monitored. Periodically the pH 
was readjusted to 9 using concentrated ammonia solution. When the absorbance 
at 240 nm stopped decreasing (usually after 2 days) the solution was boiled for 1 
min., then allowed to cool and the denatured protein was removed by filtration 
through a celite pad. The solvent was removed under reduced pressure and the 
residue was recrystallised from the minimum amount of hot water to afford [O'-^Hs]-
(2S,3S)-3-methylaspartic acid (2a) as white crystals (0,73 g, 65%), m.p. 266-267 
°C (lit.,196 276-278 °C); (Found: C, 40.3; H, 6.1; N 9.4. Calc, for C5H9NO4: C, 40.4;
H, 6.15; N, 9.50%.); m /z (Found: [M +H ]+ 152.0861. C5H52H4O 4N requires 
152.0861); [ajo -10.2° (c 0.4 in HgO), (Iit.,i97 -10±2 (c 0.42 in H2O)); 6h (200 MHz; 
2H2O) 3.24 (1H, m, p-H) and 4.35 (1H, d, a-H); 6c (50 MHz; 2H2O, NaQ2H), 12.35 
(CH3), 42.35 (C-3), 57.63 (C-2), 175.48 (C-4) and 182.69 (C-1); m/z (El) , 148 {M+,
I.3%), 147 (2.7%), 102 (68.2), 84 (62), 57 (84), 45 (89) and 28 (100). The sample 
contained > 95% 2h as judged by iH-NMR spectroscopy, using the 3-H as internal 
integration reference.
1-lsopropyI A/-trifluoroaoetyi-(2S,3S)-3>methylaspartic acid (26): 140
CF3CONH
'PrOzC
Trifluoroacetic anhydride (50 g, 0.24 mol) was added to a stirred suspension of
3-methylaspartic acid (2) (4 g, 27 mmol) in dry tetrahydrofuran (50 ml) at 0 °C over 
10 min. under nitrogen. The reaction mixture was then allowed to warm up to room 
temperature and stirred until dissolution was complete (approximately 1.5 hr.). The 
solvent was then removed in vacuo and the residue dried for 3-4 hr. under high 
vacuum. Dry 'PrOH (40 ml) was then added and the solution left at 30 °C overnight. 
'PrOH was removed in vacuo to give 1-isopropyl N-trifluoroacetyl-(2S,3S)-3- 
methylaspartic acid (26) which was recrystallized from ether / petrol ether as a
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white solid (6.6 g, 85%), m.p. 113-115 °C; (Found: C, 42.0; H, 4.8; N, 4.8. Calc for 
C10H14O 5F3N: C, 42.1; H, 4.95; N, 4.9%); [a]D+11.8° (c 0.53 in CH2CI2); Dmax 
(CHCl3)/cm-i 3410 (NH), 2987-3155 (CO2-H) and 1705, 1732 (2 x CO); ôh (200 
MHz; C2HCI3) 1.26, 1.30 (6H, 2 d, J 2 Hz, (CW zCH), 1.36 (3H, d, J3.6 Hz. CH3),
3.08 (1H, dq., J 3',3 3.6 Hz and J 2,3 2 Hz, 3-H), 4.79 (1H, dd., Js,2 ^ Hz and J nh ,2 4 
Hz, 2-H), 5,11 (1H, Sep., J 3  Hz, (CH3)2CJ1), 7.23 (1H, d, NH) and 8.3 (1H, s, 
COOH); ÔC (50 MHz; C2HCI3), 13.71 (CH3), 21.99, 22.06 ((£H3)2CH), 42.01 (C-3),
54.68 (C-2), 71.44 ((CH3)2C.H), 118.75 (CF3), 159.10 (CONH), 168.75 (C.O2CH) 
and 177.80 (ÛO2H); m/z (El) 240 (5.5%), 226 (31), 198 (74), 102 (68), 153 (76), 69 
(41) and 43 (100). No 4-isopropyl 3-methylaspartic acid could not be detected in 
the crude product by ‘•H-NMR spectroscopy at 200 MHZ.
1-Isopropyl Af’<trifluoroacetyI-(2S,3S)-3-methylaspartic acid chloride
(27):14o
CF3CONH H
COCl
1-Isopropyl A/-trifluoroacetyl-3-methylaspartate (26) (5.5g, 19 mmol) was 
dissolved in dry CH2CI2 (30 ml) and the solution was cooled in an ice bath. SOCI2 
(9.0 g, 5.65 ml, 4 eq) was added dropwise over 5 min. The solution was then 
heated to reflux for 1 hr. Removal of the volatile material under reduced pressure 
gave 1 -isopropyl 3-methylaspartic acid chloride (27) as an off white solid, which 
was recrystallized from dry ether / petrol ether (1.76 g, 83%), m.p. 67-69 °C; m/z 
(Found: M +304.0562. C10H13O4NF3CI requires 304.0563); Dmax (CHC^/cm-'' 3326 
(NH), 2987, 1780 (COCl) and 1727 (CO); Ôh (200 MHz; C2HCI3) 1.30 (6H, 2d, 
(Cjd3)2CH), 1.43 (3H, d, CH3), 3.48 (1H, dq, 3-H), 4.88 (1H, dd, 2-H), 5.14 (1H, Sep., 
(CH3)2CH) and 7.12 (1H, d, NH); ôc (50 MHz; C^HCIg) 14.33 (CH3), 22.01, 22.07 
((C.H3)2CH), 53.58 (C-3), 54.49 (C-2), 68.47 ((CH3)2£H ), 113.04 (CF3), 157.27 
(CONH), 168.05 (1QO2CH) and 175.08 (COCl); m/z (Cl) 303 (M+, 92%) and 240 ([M- 
COCI]+, 10%).
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1-Isopropyl (2S,3S)-5-diazo-4-oxo-Af-trlfluoroacetylisoleucinate (28): 1 4 0
CF3CONH H  
‘PrOaC COCHN2
The crude 3-methylaspartic acid chloride (27) (5.8 g, 18.5 mmol) was 
dissolved in dry THF (10 ml). The resulting cloudy solution was added dropwise 
over 10 min. to an etheral solution of dry diazomethane (2.66 g, 150 ml, 63 mmol) 
cooled in an ice-water bath. After 1 hr. at room temperature the solution was 
purged with nitrogen to remove the excess of diazomethane and filtered. The 
volatile material was removed under reduced pressure to afford the diazoketone 
(28) as a bright yellow solid (5.75g, 96% from (26)), m.p. 23-25 °C; (Found: C, 
42.45; H, 4.9; N, 13.4. Calc, for C11H14N3O4F3: C, 42.70; H, 4.6 N, 13.58%); D^ax 
(CHCl3)/cm-i, 3326 (N-H), and 2113 (CHN2); ôh (200 MHz; C^HCW 1.19 (6H, d, 
(Cid3)2CH), 1.26 (3H, d, CH3). 3.01 (1H, m, 3-H), 4.52 (1H, m, 2-H), 5.05 (1H, Sep., 
(CH3)2CH), 5.37 (1H, s, CHN2) and 7.24 (1H, d, NH); Ôc (50 MHz; C^HCW 14.65 
(CH3), 22.03, 22.08 (aH 3)2CH), 46.30 (C-3), 55.14 (C-2), 67.54 (CHN2), 70.92 
((CH3)2£^H0 ), 113 (CF3), 169.9 (£02*Pr), 179 (ÜOCHN2) and 183 (CF3ÜO); m/z (El) 
308 (M+,1%), 239 (13), 166 (26), 154 (36), 126 (71), 69 (100) and 43 (92).
1-Isopropyl 5-methyl A/-trlfluoroaoetyl-(2S,3R)-3-methylglutamate (29):
C F 3C O N H  H  P H 3 
H
'PrOzC/  ^C 02C H 3
The diazoketone (28) (5.5 g, 18.6 mmol) was dissolved in dry MeOH (50 ml) 
and the solution was flushed with nitrogen. Silver oxide (0.5 g) was added and the 
solution was heated in a water bath at 50 °C for 30 min. The solution was filtered 
through a celite pad and the solvents were removed in vacuo. The resulting dark oil 
was subjected to flash chromatography (10% ethyl acetate in petrol ether) to give
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the 3-methylglutamate diester (29) as a clear oil (3.1 g, 53%), b.p. 115 °C (15 
mmHg): (Found: 0 , 46.1; H, 6.2; N, 4.8. Calc, for G12H18O4NF3: 0 . 46.0; H, 5.8; N, 
4.5%); m/z (Found: M + 313.1137. C12H18O5NF3 requires 313.1137); [a]p +32.1° (c 
1.15 in CH2CI2); 5h (200 MHz; C2H0 i3), 0.96 (3H. d, J3 .4  Hz, CH3), 1.29 (6H, d, 
(Ctb)2CH), 2.11-2.52 (2H, ABX q, J 3,4 3.4 Hz, 4-H2), 2.66 (1H, m, J 3,33.4 Hz and J
2,3 1.4 Hz, 3-H), 3.69 (3H, s, OCH3), 4.7 (1H, dd, 2-H), 5.10 (1H, Sep., (GH3)2CH) 
and 7.38 (1H, d., J 4  Hz, NH); 5c (50 MHz; G2HGI3) 15.73 (GH3), 22.14 ((GH3)2), 
33.23 (G-4), 37,94 (G-3), 52.38 (OGH3), 56.42 (G-2), 70.86 ( GH3)2&H), 112.86 
(GF3), 169.91 (£02iPr) and 173.02 (GO2GH3), 179.7 (GF3C); m/z (El) 313 (M+, 2%), 
271 (5, [M - G3H7M , 226 (67, [M - G4H702]+), 194 (69, [M - G7H10O3M , 166 (85, [M - 
C3H7I+), and 43 (100); (R, 0.35, 20% ethyl acetate in petrol ether).
(2S,3R)-3-Methylglutam ic acid (17);
H9N H
The A/-protected glutamate diester (29) (0.4 g, 1.27 mmol) was refluxed In 6 M 
HGI (20 ml) for 2 hr. The solvent was removed in vacuo and the residue was 
treated twice with water to remove the excess acid. The residue was thoroughly 
dried under high vacuum, dissolved In dry ethanol (10 ml) and propylene oxide (4 
ml) was added. The mixture was refluxed for 30 min., cooled to room temperature, 
centrifuged, and the solvent decanted. (2S,3R)-3-Methylglutamlc acid (17) was 
dried for 2 days under reduced pressure (120 mg, 58%), m.p. 166-168 °G; (Found: 
G, 44.47; H, 6.7; N, 8.7. Gale, for G6H11O4N: G, 44.7; H, 6.9; N, 8.7%); m/z (Found: 
[/W+ H]+162.0766. G6H12O4N requires 162.0766); [a]o+22.6 (c 1.03 in 6 M HGI); 6h 
(200 MHz; 2H2O) 0.93 (3H, s, GH3), 2.26 (1H, m, 3-H), 2.38-2.43 (2H, m, 4-GHa), 
and 3.66 (1H, s, 2-H); 6c (50 MHz; 2H2O) 17.11 (GH3), 34.00 (G-3), 41.86 (G-4), 
61.56 (G-2) and 177.8,179.9 (2 x GOgH); m/z (FAB), 162 ([M + H]+, 23%), 144 (32, 
[M - HgO+H]*, and 98 (40, [M - GH4O2NM.
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feff-Butyl-(2,2,2)-trichloroacetimidate (3 6 ): 1^ 9
The solution prepared by the dissolution of sodium (1 g, 43 mmol) in tert- 
butanol (20 ml) was added dropwise (0.5 ml per min.) to a vigorously stirred 
solution of trichloroacetonitrile (18 g, 12,5 ml, 124 mmol) and fe/t-butanol (18.5 g, 
250 mmol). The reaction mixture became a clear yellow-orange and its 
temperature increased slightly. When the colour of the solution changed to 
brownish the addition was stopped. Stirring was continued for 30 min. and the 
product was directly distilled under vacuum. The white distillate quickly solidified 
and was identified as ferf-butyl-trichloacetamidate (36) (19 g, 70%); b.p. 64-66 °C/ 
40 mmHg; 6h (200 MHz; C^HCIs) 1.55 (9H, s, 3 x CH3) and 8.25 (1H, s, NH).149
Af-Benzy(-(2S,3S)-threonine (3 4 ):^45
L-Threonine (11.9 g, 0.1 mol) was dissolved in 2 M NaOH (50 ml). Freshly 
distilled benzaldehyde (10.1 ml, 0.11 mol) was added to the solution under 
vigorous stirring. After the solution had become homogeneous (20-30 min.), 
sodium borohydride (1.14 g, 30 mmol) was added slowly and in small portions over 
30 min. The temperature, during the addition, was maintained at 5 °C with an ice- 
water bath. After an additional 30 min. of stirring, benzaldehyde and sodium 
borohydride (identical quantities) were added in exactly the same manner at 5 °C. 
The solution was finally left for 3 hr. at room temperature, diluted with water (20 ml), 
and extracted with ether (2 x 30 ml). On acidification of the aqueous layer to pH 6-7 
the product A/-benzyl-(2S,3S)-threonine (34) crystallized out. The solution was 
kept at 2 °C for 24 hr. and filtered. The white crystalls were washed with cold water 
and dried at 100 °C under vacuum (18.45 g, 88%), m.p. 236-238 °C; [a]D-28.5° (c 1 
in 2 M NaOH); (Found: C, 62.9; H. 7.2; N, 6.55. Calc, for C11H15O3N: C, 63.1 ; H, 7.2; 
6.7%); m/z (Found: [M + H]+ 210.1130. C11H15O3N requires 210.1130); Ôh (200 
MHz; 2H2O, Na02H), 1.1 (3H, d, CH3), 2.9 (1H, d, 2-H), 3.40 -4.55 (2H, ABX,
Chapter 4: Experimental____________________________________________ 122
PhCHa), 3.5 (1H, m, 3H) and 7.2 (5H, s, CeHs); ôc (50 MHz; 2H2O), 20.10 (CH3), 
52.65 (Ph^Hg), 69.62 (C-3), 70.57 (C-2), 128.4 &129.7 (aromatic), 140.1 (ipso-C) 
and 181 (COgH); m/z (Cl) 210 ([M + H]+, 100%); m/z (El) 165 (5%), 120 (9), 91
(100), 74 (23), 65 (22), and 45 (7).
Isopropyl N-benzyl-(2S,3R)-threonlnate (39);
N-Benzyl-threonine (34) (3 g, 4.8 mmol) was suspended in dry isopropanol (90 
ml). Thionyl chloride (1.87 ml, 24 mmol, 5 eq) was added to the suspension over 10 
min. at 0 °C, The cloudy solution was allowed to warm up to room temperature and 
refluxed for 3 days. Triethylamine (4.8 g, 2.6 ml, 48 mmol) was added, the solution 
was diluted with water (40 ml) and extracted with CHgClg (2 x 50 ml). The organic 
phases were pooled, washed with brine (2 x 50 ml), dried (MgS04) and removed 
under reduced pressure to give isopropyl N-benzyl-(2S,3R)-threoninate (39) as a 
clear yellow oil, which was further purified by flash chromatography on silica gel 
(20% ethyl acetate in petrol ether) (2.7 g, 75%), b.p. 217 °C; m/z (Found: [M + H]+ 
252.1600. CuHgiOgN requires 252.1599); [a]o -56.5 (c 1.35, in CHCI3); ôh (200 
MHz; C2HCI3) 1.20 (3H, d, CH3), 1.25 (6H, d, (CÜ3)gCH), 2.85 (1H, br., OH), 2.97 
(1H, d, 2-H), 3.65 (1H, m., 3-H), 3.75 (2H, ABX, 2H, PhCHz), 5.06 (1H, sep., 
(CH3)2CJd) and 7.27-7.32 (5H, aromatic); ôc (50 MHz; C2HCI3) 19.76 (CH3), 22.25, 
22.41 ((JQ.H3)2CH), 53.20 (PhC.H2), 68.02 (C-2), 68.51 (C-3), 69.27 ((CH3)2&H), 
127.83, 128.81, 128.98 (aromatic), 139.58 (ipso-C) and 173.6 (C.Og); m/z (El) 252 
([M+ H]+, 18%), 210 (64, [M -C 4H7O2M , 120 (21) and 91 (100, PhCHg+).
Chapter 4: Experimental_____________________________________________123
Methyl Af-benzyl-(2S,3R)-threoninate (39a):
A/-Benzyl-threonine (34) (0.5 g, 4.8 mmol) was suspended In absolute 
methanol (20 ml). Concentrated H2SO4 (0.5 ml) was added and the solution was 
refluxed for 2 hr. The acid was neutralised by the addition of saturated NaHCOa (15 
ml), and methanol was removed in vacuo. The water phase was extracted with 
ethyl acetate (3 x 50 ml), the organic phases were pooled, washed with brine (2 x 
50 ml), dried (MgS04) and removed under reduced pressure to give methyl N- 
benzyl-(2S,3R)-threoninate (39a) as a yellow oil which was further purified by 
flash chromatography on silica gel (20% ethyl acetate in hexane) (2.7 g, 65%); m/z 
(Found: [M +  H]+224.128. C12H18O3N requires 224.129); §h (200 MHz; C^HCIa) 
1.20 (3H, d, CH3), 3.04 (1H, d, 2-H), 3.65-3.87 (2H, ABX, CHgPh), 3.68 (1H, m, 3-H), 
3.72 (3H, s, OCH3), and 7.31 (5H, m, aromatic); ôc (50 MHz; C^HCIs) 19.29 (CH3), 
51.96 (OCH3), 52.66 (£HgPh), 67.30 (C-2), 67.99 (C-3), 127.38-128.47 (aromatic),
139.08 (ipso) and 174.55 (COg); m/z (El) 224 ( [M+ H]+, 100%), 206 (8), 120 (5) and 
91(41).
Isopropyl A/-benzyl"(4S,5R)-1,2,3-oxathiazolidone-5-methy[-
4-carboxylate S-oxide (40) and (41):^42
Isopropyl A/-benzyi-threoninate (39) (2.0 g, 10.7 mmol) was dissolved in dry 
toluene (40 ml) and the solution was cooled to 0 °C under nitrogen. Freshly distilled 
triethylamine (2.4 g, 23,6 mmol, 2.2 eq) and thionyl chloride (11.8 mmol, 0.92 ml
1.1 eq) were added succesively over 20 min. The solution was then stirred for Ihr. 
at 0 °C and then for 1 hour at 20 °C. Ether (150 ml) was added, and the organic 
phase was washed with water (2 x 50 ml), dried (MgS04) and removed in vacuo to 
afford A/-benzyl-(4S,5R)-1,2,3-oxathiazolidone S-oxide (40) and (41) as a 3:2 
mixture of the two diastereomers on 8-2. The two compounds (40) and (41) were 
separated and purified by flash chromatography on silica gel using 10% ethyl 
acetate in hexane (2.11 g, 89%); m/z (Found: [M + H]+ 298.1113. C14H19O4NS  
requires 298.1113); m/z (Cl) 298 {[M + H]+, 100%), 252 (56), 210 (62), and 146 
(34).
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(2S,4S,5R)-isomer (40)
o.
H
‘P1O2C
BnN (S) p
-A— J ^ CHj
H
Rf 0.25 (10% ethyl acetate In hexane): [a]o -65.8 (c 0.61 In CHCI3); Vmax 
(neat)/cm-i 2986, 1741, 1279.5, 1205, 1168, 1103, and 1028; 8h (200 MHz; 
C^HCIa) 1.23 (6H, dd, J 1.8 Hz, (Cjd3)2CH), 1.47 (3H, d, J3  Hz, CH3), 3.48 (1H, d, J
3.7 Hz, 4-H), 4.49 (2H, ABX, J 4  Hz, PhCHg), 5.04 (1H, sept., (CH3)2CJ1), 5.37 (1H, 
dt., J  3 Hz, 5-H) and 7.26-7.37 (5H, m, aromatic); 5c (200 MHz; C^HCIg) 19.46 
(CH3), 22.13, 22.17 ((ÜHsjgCH), 49.71 (Ph^H), 67.59 (C-4), 70.32 ((CH3)2(1H), 
82.33 (C-5), 128.67,129.13, 129.30 (aromatic), 136.00 (quat. aromatic) and 168.76 
(00); m/z (El), 298 ([M+ H]+, 1%) 233 (57), 210 (73), 146 (82), 104 (37), 91 (100) 
and 43 (100).
(2R,4S,5R)-lsomer (41):
BnN (R) P
Rf 0.30 (10% ethyl acetate In hexane); [a]o +21.6 (c 0.65 In CHCI3); Dma% 
(neat)/cm-i 2986, 1741.5, 1277, 1208, 1157, 1103, 1030; 5h (200 MHz; C2HCI3) 
1.25 (6H, d, (CJd3)2CH)), 1.69 (3H, d , J 3  Hz, GH3), 3.93 (1H, d, J3.8  Hz, 4-H), 4.23 
(2H, ABX, PhGJd2), 4.79 (1H, m, ^ 3,3 3.8 Hz, 5-H), 5.05 (1H, sept, (GH3)2GH), and 
7.30-7.47 (5H, m, aromatic); 8c (200 MHz; G^HCIs) 22.14, 22.18 ((£H3)2GH), 22.58 
(GH3), 49.99 (PhûH), 67.58 (G-4), 70.54 ((GH3)2ÜH), 86.23 (G-5), 128.70, 128.12, 
128.92 (aromatic), 135.78 (quat. aromatic), and 168.76 (GO); m/z (El), 298 ([W + 
H]+, 1%) 233 (57), 210 (73), 146 (82), 104 (37), 91 (100) and 43 (100).
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Isopropyl iV-benzyl-(4S,5R)-1,2,3-oxathiazolidone-5-m ethyl-4- 
carboxylate S,S-dloxlde (33):142
The mixture of A/-benzyl-(4S,5R)-1,2,3-oxathiazolidone S-oxides (40+41) (2 g,
6.7 mmol) was dissolved in dry acetonitrile (30 ml) and the solution was cooled to 0 
°C in an ice-water bath. Ruthenium(lll) chloride monohydrate (8 mg), sodium 
periodate (2.15 g, 5 mmol, 1.5 eq), and water (40 ml) were then added 
successively. The solution was stirred for 30 min. at 0 °C and then allowed to warm 
up to room temperature. After Ihr. the solution was extracted with ether (3x100 ml), 
and the combined organic phases were pooled, washed with water (30 ml), brine 
(30 ml), dried (MgSO^), filtered through a silica pad and removed under reduced 
pressure to give a clear oil which solidified on standing. Recrystallization from ethyl 
acetate / hexane gave large transparent crystals of the isopropyl A/-benzyl-(4S,5R)- 
1,2,3-oxathiazolidone-5-methyl-4-carboxylate S,S-dioxide (33) (1.82 g, 80%), m.p. 
59-61 °C; (Found: 53.3; H, 6.4; N 4.4. Calc, for C14H19O5NS: C, 53.6; H, 6.1; N, 
4.5%); /77/z  (Found: [M + NH4]+331.1328. C14H19O5NS requires 331.1327.); [ajo 
-18.9° (c 0.62 in CH2CI2); Dmax (CHCl3)/cm-1 2986. 1747, 1356, 1160, 1103; 5h (200 
MHz; C2HCI3) 1.19-1.24 (6H, 2d, (CW zCH), 1.55 (3H, d, CH3), 3.66 (1H, d., 4-H), 
4.47 (2H, s, PhChb), 4.88 (1H, m, 5-H), 5.00 (1H, m, (CH3)2CH) and 7.32-7.40 (5H, 
m, aromatic); 5c (50 MHz; C^HCIs) 19.28 (CH3), 21.46, 21.52 (2 x CH3), 50.38 
(Ph£H2), 65.15 (C-4), 70.57 ((CH3)2ÜH), 77.52 (C-5), 128.7-129.3 (ar-C), 133.59 
(ipso-C) and 166.76 (CO); m/z (Cl) 331 ([M + H]+, 100%), 314 (35), 205 (11), 148 
(8), 108 (30) and 91 (22).
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Methyl A/-benzyi-(4S,5R)-1,2,3-oxathiazolidone-5-methyl-4- 
carboxylate S,S>dioxide (33a):
H3CO2C
Methyl oxathioazoiidine-carboxylate S,S-dloxide (33a) was prepared from 
methyl AZ-benzyl-threoninate (39a) (2g, 9.5 mmol) In an Identical manner to that 
described for (39) (2 steps, 1.95 g, 72%), m.p. 57-58 °C; m/z (Found: [M  + NH4]+ 
303.1015. G12H15O5NS requires 303.1014.); [a]o -17.5 (c 0.64 In CH2CI2); Dmax 
(CHCl3)/cm-i 2986. 1747, 1356,1160, and 1103; Ôh (200 MHz; C^HCIs) 1.53 (3H, d, 
CH3), 3.65 (3H, s, OCH3), 3.73 (1H, d, 4-H), 4.47 (2H, s. PhOidb), 4.90 (1H, m, 5-H) 
and 7.35-7.40 (5H, m, aromatic); 6c (50 MHz; C^HCb) 19.79 (CH3), 51.15 (O CH3), 
53.61 (Ph^Hg), 65.62 (0-4), 78.11 (0-5), 129.1-129.7 (aromatic 0), 134.01 (lpso-0) 
and 167.9 (OO2); m/z (El) 286 {[M+ H]+, 100%), 210 (25), 146 (18) and 91 (100).
1-lsopropyi Lithium N-Benzyl-Af-sulpho-2-am ino-fra/7S-but-2-enoate  
(45):
Oxathlazolldone S,S-doxide (33) (0.2 g, 0.6 mmol) was treated with lithium 
hydroxide (2 eq.) In watenethanol (50% v/v, 10ml) for 24 hr. The solvents were 
removed in vacuo and the residue was recrystallized from water / ethanol to give 1- 
Isopropyl A/-benzyl-2-amlno-trans-but-2-enoate (45) (0.12 g, 62%); m/z (Found: [M 
+ H]+ 322.1814. O14H18O5NSLI requires 322.1814); Ôh (200 MHz; ZHs-DMSO) 1.21 
(6H, d, (O W zCH), 1.62 (3H, m, OH3), 4.41-4.21 (2H, ABX q, PhOhb), 4.95 (1H.
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Sep., (CH3)2CJd), 6.73 (1H, q, C =C H (C H 3)), and 7.35-7.40 (5H, m, aromatic); 5c (50 
MHz; 2H6-D M S O ) 14.43 (CH3), 21.63 (ÛHsjaCH), 52.01 (PhfiH a), 68.49 (CHajaûH), 
(G H3O), 126.8-129.1 (aromatic 0), 132.38 (C-3), 138.03 (Ipso-C), 143.19 (C-2), and
172.1 (COa); m/z (Cl) 322 ([M + H]+, 100%), 234 (63, [ M - S 0 3 ll]+ ), 196 (92), 144 
(12), 108(54), 91 (14).
Isopropyl N-benzyl-N-sulpho-(2S,3S)-2-amino-3-azido>butanoate (46):
BnN
Methyl oxathiazolidone-carboxylate S,S-dioxide (33a) (100 mg, 0.32 mmol) 
was dissolved in water / acetone (50% v/v, 5 ml). NaNg (50 mg, 0.64 mmol) was 
added and the solution was stirred until no starting material could be detected by 
TLC (2 days). The solvents were removed in vacuo and the residue was dissolved 
In acetonitrile. The solution was filtered and the solvent was removed. The white 
residue was dried under vacuum for 4 hr. and then recrystallized from ethyl acetate 
/  hexane to give Isopropyl N-benzyl-2-amlno-3-azldo-butanoate (46) as white 
crystals (75 mg, 65%); m/z (Found: [M  -803]+ 249.135. C12H 16O 2N requires 
249.135.); [ah  -35.35° (c 0.52 In CH2CI2); 5h (200 MHz; C^HCIs) 1.03 (3H, d, CH3), 
3.67 (1H, m, 2-H), 3.71 (3H, s, OCH3), 4.05 (1H, m, 2-H), 4.35 (2H, ABX, PhChg) 
and 7.35-7.40 (5H, m, aromatic); 6c (50 MHz; C^HCb) 17.22 (CH3), 52.51 (Ph(lH2), 
53.18 (OCH3), 58.22 (C-3), 64.39 (C-2), 129.1-129.6 (aromatic C), 138.03 (Ipso-C) 
and 173.2 (CO2); m/z (El) 249 ([M- SO^^, 10%), 206 (12), 178 (37) and 91 (100).
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/V-benzyI-(4S,5R)-1,2,3-oxathlazolldone-5-methyl-4"[1'-allylJ-but-3*- 
en-1*-ol S,S-dioxide (47):
Isopropyl N-benzyl-oxathiazolidone-carboxylate S,S-dioxide (33) (260 mg, 
0.78 mmol) was dissolved In dry tetrahydrofuran (10 ml). Dilithium 
tetrachlorocuprate (II), as a solution in THF, (0.15 ml of 0.1 M solution, 0.02 eq.) 
was added and the solution was cooled to -78 °C. An etheral solution of allyl- 
magnesium bromide (1.5 mmol, 1.5 ml of 1.0 M solution in ether) was added and 
the solution was stirred overnight, at -78 °C. The reaction mixture was allowed to 
warm up to -20 °C, acetic acid (1 ml) was added and the solvents removed in 
vacuo. The residue was partitioned between water/ ethyl acetate (50:50 v/v, 20 ml). 
The aqueous phase was washed with ethyl acetate ( 2 x 1 0  ml), and the organic 
phases were pooled, dried (MgS04), and removed in vacuo. The off white residue 
was flash chromatographed on silica gel (50% ethyl acetate: DOM) to give the 
oxathiazolidone-4-buten-V-ol (47) (0.2 g, 77%); m/z (Found: [M + H]+338.1425 
C17H23O4NS requires 338.1425); 5h (200 MHz; C2HCI3) 1.22 (3H, d, CH3), 2.1-2.5 
(4H, m., (CH2CH=CH2)2), 3.31 (1H, d, 5-H), 4.52 (2H, ABX, PhOhb), 4.87 (1H, m., 6- 
H), 5.02-5.23 (4H, m., 2 x CH2CH=Ch2), 5.60-5.96 (2H, m., 2 x CH2CH=CH2) and 
7.29-7.48 (5H, m., aromatic); 6c (50 MHz; C2HCI3) 21.02 (GH3), 39.98, 41.34 
( i lH 2CH = C H 2), 55.20 (PhHH2), 70.75 (0-4), 77.73 (0-5), 120.17, 120.73 
(0 H2ÜH=0 H2), 129.19-130.20 (aromatic), 132.51, 132.54 (0 H20H=^H2), 135.09 
(quat. aromatic) and 183.5 (OO); m/z (01) 338 ([M + H]+, 100%), 258 (32), 168 (11), 
147 (64), 108 (96), 91 (100), 58 (45).
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//-Acetyl-(R,S)-alanine (55):19S
(S)-Alanine (2.5 g, 28 mmol) was dissolved in acetic acid (25 ml, 26 g, 0.44 mol) 
and the mixture was brought to the boil. After cooling for 2 min. at room 
temperature, distilled acetic anhydride (4.85 g, 47 mmol) was added in portions, 
the solution was brought again to the boil and reflux was continued for 2 min. The 
solution was allowed to cool and the volatile materials were removed in vacuo. 
Racemic A/-acetyl-alanine (55) was recrystallised from hot ethyl acetate (3.1 g, 
83%), m.p. 134-5 °C (Iit.,i98 134-136 °C); 6h (300 MHz; ZHg-DMSO) 1.35 (3H, d, 
CHa). 1.97 (3H, s, CH3CO), 4.3 (1H, q, 2-H), 8.24 (1H, d, NH) and 12.4 (1H, br., 
CO2H), 6c (50 MHz; ZHe-DMSO) 17.3 (CH3). 22.5 (^HaCO), 47.7 (a-C), 169.3 
(CONH) and 174.56 (CO).
A/-Acetyl-[2-2HHR,S)-alanine (55a);i98
CH3 CON H 
H0 2 C
oUi n
(S)-Alanine (2 g, 22 mmol) was dissolved twice in hot 2H2O (5 ml) and the 
solvent removed in vacuo. The amino acid was redissolved in acetic acid-^H (26,7 
g, 25 ml, 0.44 mol) and treated as described previously for (55), under a stream of 
nitrogen. The solvents were removed under reduced pressure. The residue was 
dissolved with heating in ^HgO (2 ml) and the solvent was again removed in vacuo. 
After drying for several hours A/-acetyl-[2-2H]-(R,S)-alanine (55a) was 
recrystallized from hot ethyl acetate, and dried at 60 °C (2.4 g, 81%), m.p. 134-135 
°C (lit.,198 134-136 °C); (Found: C. 45.7; H, 6.75; N, 10.4. Calc, for C3H6DO2N: C, 
45.8; H, 6.9; N, 10.7%); (Found: [M + H]+133.073. C5IH82HO3N requires 133.073); 
6h  (300 MHz; 2Hg-DMS0) 1.23 (3H, s, CH3), 1.83 (3H, s, CH3CO), 8.15 (1H, s, NH) 
and 12.4 (1H, br., CO2H), 6c (50 MHz; 2H6-DMSO) 17.32 (CH3), 22.54 (C.H3CO),
47.69 (C-2), 169.31 (CONH) and 174.56 (CO2H). The title compound contained >
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93% 2h as judged by iH-NMR, using the methyl group as internal integration 
reference.
(R)-Alanine (56);198
A/-Acetyl-(R,S)-alanine (55) (1.78 g, 13.5 mmol) was dissolved in water (80 ml) 
and the pH of the solution was adjusted to 7.3 with conc. ammonia soiution. 
Acylase I (4 mg) was added and the solution was incubated in awater-bath at 38 
°C. After 24 hr. acetic acid (1 ml) was added and the solution was heated to reflux 
for 1 min. The digested protein was filtered off through a celite pad and the volume 
was reduced in vacuo to 10 ml. On addition of alcohol (70 ml) and cooling at 5 °C, 
(S)-alanine precipitated as a white solid (0.44 g, 72%), m.p. 303-305 °C (lit.,198 3 1 4  
°C (dec.)); [a]D+13.3° (c 1 in 6 M HCI ) (Iit.,i98 +13.6° (c 1 in 6 M HCI).
Washings and filtrates were pooled and removed under reduced pressure. 
Water (10 ml) was added and the pH of the solution was adjusted to 3 using 3 M 
H2SO 4. The solvent was again removed in vacuo. N-Acetyl-(R)-alanine was 
extracted from the residue using hot acetone (5 x 20 ml). The pooled organic 
extracts were filtered and removed in vacuo to give a yellow syrup, which was 
suspended in 6 M HCI (20 ml). The suspension was refluxed for 2 hr., and the 
solvent was removed under reduced pressure. Excess acid was removed by 
treating the residue several times with water. Finally the crude amino acid was 
taken up in water (3 ml), and the pH of the solution adjusted to 4 with few drops of 
concentrated ammonia. On addition of ethanol (15 ml) (R)-alanine (5 6 )  
precipitated rapidly. Recrystallisation from hot water / ethanol gave the pure amino 
acid (0.39 g, 65%), m.p. 299-301 °C (Iit.,i96 314 °C); [a]o-13.0° (c 1 in 6 M HCI) 
(lit.,198 -13.6° (c 1 in 6 M HCI)); ôh (300 MHz; 2H2O) 1.25 (3H, d, CH3) and 3.55 (1H, 
q, 2-H); 6c (74 MHz; 2H2O) 19.45 (CH3), 53.20 (C-2) and 168.2 (CO2H).
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[2-2HHR)-Alanîne (56a)
CH3CONH
HO2C
CH3
(R)-[2-2H]-Alanlne (56a) was synthesized in an identical manner to (56) from 
(55a) (0.55 g, 62%), m.p. 291-293 °C, (lit.,i98 300 °C (dec.).); (Found: C, 40.4; H, 
8.02; N, 15.5. Calc, for C3H6DO2N: C, 40.4; H, 7.9; N, 15.7%); (Found: [M + H]+ 
91.062+0.001. C3H6DO2N requires 91.063); [ap] -13.1° (c 1 in 6 M HCI) (lit.,198 
-13.6° (c 1 in 6 M HCI)); ôh (300 MHz; 2H2O) 1.22 (H, s, CH3); 6c (50 MHz; 2H2O) 
17.58 (-CH3), 51.38 (C-2) and 178.23 (-CO2H); m/z (Cl) 91 (M+, 100%), 75 (5), and 
45 (20); The title compound contained > 93% 2H as judged by iH-NMR, using the 
methyl group as internal integration reference..
But-2-ynoîc acid (65)
BuLi (0.22 mol, 140 ml, 1.55 M in hexanes) was cooled to -50 °C and added via 
cannula to THF (400 ml) at -78 °C under a nitrogen atmosphere. The solution was 
purged with propyne for 10 min., strirred for 5 min., and then purged with carbon 
dioxide. Soon the solution became cloudy and a yellowish precipitate appeared. 
As soon as the colour changed to orange, the CO2 flow was stopped and the 
solution was stirred for an additional 10 min. at room temperature. The reaction 
was quenched with saturated NH4CI solution (200 ml), and the THF was removed 
under reduced pressure. The pH of the aqueous phase was adjusted to 1.5 (conc. 
HCI) and extracted with ether (3 x 200 ml). The organic phases were pooled, dried 
(MgS04) and removed in vacuo to afford a brown oil which, after distillation under 
reduced pressure, soiidified on standing. Recrystallization from ethyl acetate /  
hexane gave but-2-ynoic acid (65) as large white crystalls (14.5 g, 80%), m.p. 69- 
71 °C (lit.,196 70-72 °C); b.p. 115-120 °C/ O.ImmHg; (Found: C, 57.3; H, 4.9. Calc, 
for C5H6: C 57.1 H 4.9%); 6h (200 MHz; C2HCI3) 1.95 (3H, s, CH3), and 10.0 (1H, 
br., CO2H).
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Isopentyl but-2-ynoate (66a)
But-2-ynoic acid (65) (3 g, 35 mmol) was dissolved in dry isoamyl alcohol (40 
ml) and SOCb (8 ml, 0.1 mol, 3 eq.) was added over 5 min. at 0 °C. The reaction 
mixture was heated to 50 °C for 30 min. After 3 hr. at room temperature isoamyl 
alcohol was distilled off at 35 °C under reduced pressure (10 mmHg). The desired 
ester distilled between 60-64 °C. The purity of the but-2-ynoate at this stage was 
70% since an unidentified impurity with similar b.p. was co-dlstilling. 
Chromatography of the distillate on silica gel (5% ethyl acetate in hexane) afforded 
isopentyl but-2-ynoate (66a) as a clear oil of ~85% purity (2.8 g, 64%), b.p. 60-64 
°C /10 mmHg; m/z (Found: [M +  H]+ 155.1071. C9H14O2 requires 155.1072); ôh (200 
MHz; C2HCI3) 0.92 (6H, d, 2 x CH3), 1.55 (2H, m, OCH2CH2CH), 1.68 (1H, m, 
OCH2CH2CH), 1.97 (3H, s, (ChbCsC) and 4.25 (2H, t, OCH2CH2CHI; 6c (50 MHz; 
C2 HCI3 ) 4.23 (£HsC=C), 22.8 (G.H3)2CH), 25.58 (CH3)2i£H), 37.5 (OCH2ÜH2CH), 
64.9 (O IIH2CH2CH) 85.7 (CHaUsC) 117.3 (CH3C=(I) and 154.3 (CO2); m/z (Cl) 
155 ([M+ H]+, 12%), 103 (10) and 58 (3); Rf 0.35 (5% ethyl acetate in hexane).
Isopropyl but-2-ynoate (66b)
But-2-ynoic acid (65) (3 g, 35 mmol) was dissolved in dry isopropanol (40 ml) 
and SOCI2 (0.1 mol, 8 ml, 3eq.) was added over 5 min. at 0 °C. The solution was 
left at room temperature for 10 min. and then refluxed for 30 min. The volume was 
reduced in vacuo and the crude isopropyl but-2-ynoate (66b) was purified by flash 
chromatography on silica gel (ethyl acetate/ hexane 1:20) (2.2 g, 50%), b.p. 64-66 
° C /15 mmHg; m/z (Found: [M +  H]+ 127.0759. C7H10O2 requires 127.07589); 0)max 
(nu]ol)/cm-i 2985, 2253 (C=C), 1701 (CO), 1271, 1106, and 1072; Ôh (200 MHz; 
C 2HCI3) 1.25 (6H, d, (CJl3)2C H l), 1.97 (3H, s, Ci±3C=C) and 5.05 (1H, s, 
(C H 3)2CJi); ÔC (50 MHz; C 2HCI3) 4.27 ( iIH 3C=C), 22.1 (C.H3)2CH), 70.13 
((CH3)2ÜH), 85.36 (CH3G=C), 117.7 (CH3C = ^  and 153.8 (CO); m/z (El) 127 ([M +
H]+, 55%), 67 (7) and 58 (5). Rf 0.3 (5% ethyl acetate in hexane).
Chapter 4: Experimental 133
Isopentyl c/s-but-2-enoate (58a)
C O 2 C 5 H 1 1
Isopentyl but-2-ynoate (66a) (2 g, 16 mmol) was dissolved in ethyl acetate / dry 
pyridine (9:1), palladium on barium sulphate (5% palladium content, 10% per 
weight of the ester) was added and the solution was purged with Hafor 4 hr. After 
filtration through a celite pad the solution was partitioned between ethyl acetate (30 
ml) and 1 M HCI solution (100 ml). The aqeous phase was extracted with 
ethylacetate (2 x 20 ml), the organic phases were pooled, dried (MgS04) and 
removed in vacuo to afford a yellow oil which was chromatographed on silica gel 
(ethyl acetate/ hexane 1:9) to give isopentyl c/s-but-2-enoate (58a) as a clear oil 
(1.9 g, 77%); m/z (Found: [M +  H]+ 157.1229. C9H16O2 requires 157.1228); ôh (200 
MHz; C2HCI3) 0.92 (6H, d, (CH3)2CH), 1.52 (2H, m, OCH2CH2CH), 1.69 (1H, m, 
OCH2CH2CJI), 2.11 (3H, s, (CHsC^C), 4.13 (2H, t, OCH2CH2CHI. 5.79 (1H, dd, 
C H 3CH=CJ±) and 6.20 (1H, dq, CH3CH.=CH); ôc (50 MHz; C2HCI3) 15.8 
(I1H3CH=CH), 22.9 (& H 3)2C H ), 25.58 (C H 3)2& H ), 37.9 (O C H 2S .H 2C H ), 63.3 
(0 1^H2CH2CH) 121.2 (CH3ÜH=CH) 145.3 (CH3CH=£H) and 167.2 (CO2); m/z (El) 
157 {[M+  H]+, 2%), 121 (18), 103 (57), 70 (100) and 55 (73). Rf 0.55 (10% ethyl 
acetate in hexane).
Isopropyl c/s-but-2-enoate (58b)
CO2C3H7
But-2-enoic acid isopropyl ester (58b) was prepared from the isopropyl but-2- 
ynoate (66b) (2 g, 15 mmol) in an identical manner to that described for (58a) 
(1.73 g, 84%), m/z (Found: [M + H]+ 129.091. C7H12O2 requires 129.091); ôh (200
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MHz; C2HCI3) 1.22 (6H, d, (CH3)2CH), 2.13 (3H, dd, C il3CH=CH), 5.02 (IN , s, 
(CH3)2CH) 5.74 (IN , dd, CH3CH=Cjj), and 6.27 (1H, dq, CH3CH=CH); 3c (50 MHz; 
C2HCI3) 15.7 (Q.H3CH=CH), 22.4 (G.H3)2CH), 67.43 (CH3)2&.HO), 121.6 
(CH3CH=C.H), 144.95 (CH3£IH=CH), and 166.6 (CO2); m/z (01) 155 ([M + H]+, 
12%), 103 (10), and 58 (3). Rf 0.6 (10% ethyl acetate in hexane).
Methyl (5R,2S)-5-isopropyl-3,6-dimethoxy-2,5-dihydropyrazine-2- 
[(3'S)-3'-methyl]>-propanoate (60)
RO,
OR
BuLi (1.86 ml, 2.9 mmol, 1.6 M, 1.1 eq) In hexane was added (under nitrogen 
via syringe) to a solution of the P/s-lactlm ether (49) (0.5 g, 2.7 mmol) In dry THF 
(10 ml) cooled at -78 °G. After 15 min. a solution of methyl frans-crotonate (52) (0.4 
g, 4 mmol, 1.5 eq) in THF (5 ml) was added. After 3 hr. a solution of acetic acid 
(0.16 g, 2.7 mmol, 1 eq.) in THF (2 ml) was added, and the mixture was allowed to 
warm up to room temperature The solvent was removed In vacuo, and the residue 
was partitioned between ethyl acetate / water (50% v/v, 20 ml). The water phase 
was re-extracted with ethyl acetate (2 x 20 ml). The organic phases were pooled, 
dried (MgS04) and concentrated to afford the crude 2,5-dihydropyrazlne-2-[(3'S)- 
3’-methyl]-propanoate (60). The sample was applied on a silica gel coloumn and 
washed with neat hexane (1/2 the bed volume) in order to improve separation. 
Elution with a mixture of 4% ethyl acetate in hexane gave dihydropyrazin (60) 
(0.47 g, 62%); m/z (Found: [M + H]+ 285.1814. C14H24O4N2 requires 285.1814); [a]o 
+18.3 (c 0.61 in EtOH), D^ax (CHCW/cm 1 3154, 2960, 1702 (ester), 1644 (C=N), 
and 1485; Sn (300 MHz; C 2HCI3) 0.65 (3H, d, CJl3C H (C H 3)), 1.01 (3H, d, 
CH3CH(CJd3)), 1.05 (3H, d, CH3), 2.02-219 (2H, m, CH2CO2CH3), 2.20-2.25 (1H, m, 
3'-CH), 3.62 (3H, s, CH2CO2CH3), 3.65, 3.66 (6H, s, 2 x OCH3). and 3.9 (2H, m, 2
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and 5-H); 6c (75 MHz; C^HCIs) 16.38 (CH(aH3)2), 18.85 (-GH3), 31.53 (I1H(GH3)2), 
33.76 (G-3% 36.56 (G-4’), 51,25 (GO2G.H3), 52.18, 52.22 (2 x OGH3), 59.46 (G-5), 
60.46 (G-2), 162.49 (G-6), 163.81 (G-3) and 173.27 (GO2); m/z (El) 285 ( [M+  H]+, 
50%), 241 (84, [M -G 3H7M , 209 (100, [M-  G4H10OM, 184 (63, [M- G5H9O2M , 167 
(96), and 141 (92); (Rf 0.32 in 10% ethyl acetate In hexane).
Isopentyl (5R ,2S)-5-isopropyl-3,6-dim ethoxy-2,5-dihydropyrazine-2- 
[(3 'R )-3 '-m ethyl]-p ropanoate(61).
RO,
OR
Alkylpyrazine (61) was prepared and purified in an identicai manner to that 
described for the dihydropyrazine-2-propanoate (60), starting from the b/s-iactim 
ether (49) and the isopentyi c/s-but-2-enoate (58a) (0.25 g, 1.36 mmoi), (0.20 g, 
44%), m/z (Found: [M + H]+341.2440. C18H32O4N2 requires 341.2440); [œ]d +14.3 
(0 0.78 in EtOH): Omax (CHCi3)/cm-i 2961, 2873, 1738 (C=N), 1644 (ester) and 
1485; ÔH (300 MHz; C2HCi3) 0.68 (3H, d, CH3C H (C H 3)), 0.92 (6H, d, ester 
(CH3)2CHCH2), 1.04 (3H, d, CH3CH(CH3)). 108 (3H, d, CH3), 1.51 (2H, d. of t., 
O C H 2CJd2CH(CH3)2), 1.68 (1H, m, ester (CH3)2C ilC H 2), 1.98-2.15 (2H, m, 
CH2CO2R), 2.24-2.28 (1H, m, CJl-3'), 2.64 (1H, m, ester (CH3)2CHCH2), 3.689, 
3.696 (6H, 2s, 2 x OCH3)), 3.93 (2H, m, 3 and 6-H) and 4.08 (2H, t, OCH2); 8c (75 
MHz; C2H C I3) 16.40, 16.48 (ring CH(C.H3)2), 19.02 (CH3), 22.48 (ester 
((ÜH3)2CHCH2), 25.05 (ester (CH3)2ÜHCH2), 31.69 (ring jQH(CH3)2), 33.94 (C-3'), 
36.99 (C-4'), 37.32 (ester (CH3)2CH£.H2), 52.38, 52.36 (2 x OCH3), 59.73 (C-5),
60.61 (C-2), 162.49 (G-6), 163.81 (C-3) and 173.27 (CO2); m/z (Ei) 285 {[M+ H]+ , 
50%), 241 { [ M - C3H7]+, 84), 209 ( [ M - C4HioO]+, 100), 184 { [ M - CsHgOd*, 63), 167 
(96) and 141 (92)
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Isopropyl (5R,2S)-5-isopropyl-3,6-dlmethoxy-2,5-dihydropyrazine-2- 
[(3*R)-3’-methyl]-propanoate (61a)
RO,
OR
Alkylpyrazine (61a) was prepared and purified In an Identical manner as for 
the dlhydropyrazine-2-propanoate (60), starting from the Ws-lactim ether (49) and 
the Isopropyl c/s-but-2-enoate (58b) (0.20 g, 1.1 mmol), (140 mg, 40%), m/z  
(Found: [M + H]+313.2127. C16H28O4N2 requires 313.2127); "Umax (CHCI3) /  cm-i 
2961, 2873, 1738 (C=N), 1644 (ester) and 1485; 5h (300 MHz; C^HCIg) 0.68 (3H, d, 
ring CH3CH(Ch3)), 1.04 (3H, d, ring CH3CH(Cid3)). 1.06 (3H, d, 3'-CH3), 1.22 (6H, 
dd, ester (C W eC H ), 1.98-2.15 (2H, ABX, CÜ2CO2R), 2.24-2.28 (1H, m, ring 
(CH3)2CH), 2.64 (1H, m, 3'-H), 3.68, 3.69 (6H, 2s, 2 x OCH3), 3.93 (2H, m, 3 and 6-
H) and 5.01 (1H, s, ester (CH3)2CJ1); 5c (75 MHz; C2HCI3) 16.28, 16.44 (ring 
(£H 3)2CH), 19.02 (CH3), 21.71, 21.81 (ester ((dH3)2CH), 31.58 (ring (CH3)2£IH), 
33.89 (C-3'), 37.15 (0-4'), 52.31 (2 x OCH3), 59.72 (0-5), 60.49 (0-2), 67.38 (ester 
(0 H3)2£H), 162.5 (0-6), 163.8 (0-3) and 172.5 (OO2); m/z (El) 313 ([M + H]+, 16%), 
269 (48), 209 (77), 167 (42), 141 (82), 127 (79) and 43 (100).
(2S,3S)-3-Methylglutamlc acid (18)
H o N  CH3
A suspension of the pyrazine (60) (300 mg, 1.05 mmol) was stirred for 2 days 
in 0.25 M HCI (8 ml, 2 eq). The aqueous solution was extracted with ether ( 2 x 1 0  
ml) and the organic phases discarded. The pH was adjusted to 9-10 with
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concentrated ammonia and the aqueous phase extracted with ether ( 3 x 1 0  mi). 
The organic phases were pooled, dried (MgS04), and removed in vacuo. The 
residual oil, which was a mixture of the methyl pyrrolidone-2-carboxylate (63) and 
valine methyl ester (64 ), was separated on a silica gel using 10% ethyl acetate in 
hexane. Only pyrrolidone (63 ) elutes (Rf 0.6) (120 mg, 58%). The clear oil was 
refluxed in 6 M HCI for 2 hr. The solvent was removed in vacuo and the residue 
was dried thouroughly under high vacuum. Ethanol (5 ml) and propylene oxide (2 
mi) were added and the resulting solution was refluxed for 30 min. The white 
precipitate was centrifuged, the supernatant decanted, and the crystals of (2S,3S)- 
3-methylglutamic acid (18) were dried for 2 days in vacuo at 50 °C, (87 mg, 51%), 
m.p. 169-171 °C; (Found: C, 41.5; H, 6.6 ; N, 7.8. Calc, for C6H12O4N-O.75 H2O: C, 
41.24; H, 6.9; N, 8.0%); m/z (Found: [M + H]+162.0766. C6H 12O4N requires 
162.0766); [a]o +12.4° (c 0.34  in 6 M HCI); ôh (300 MHz; ^HgO) 0.93 (3H, s, CH3), 
2 .26  (1H, m , 3-H), 2.38-2.43 (2H, m, 4-CH2) and 3.66 (1H, s, 2-H); ôc (75 MHz; 
2H2O) 16.76 (CH3), 33.29 (C-3), 40.16 (C-4), 60.54 (C-2) and 175.07, 179.11 (2 x 
CO2); m/z (FAB) 162 ([M + H]+,23%), 144 (32, [M - H2O +H M  and 98 (40, [M - 
CH402N]+).
(2S,3R)-3-Methyfglutamic acid (17a)
H2N H
Alkylpyrazine (61) (180 mg, 0.53 mmol) was refluxed in 6 M HCI (5 ml) for 2 hr. 
The solvent was removed and the solution treated twice with water to remove the 
excess of the acid. The residue was dissolved in water (2 ml), the pH adjusted to 
1.5 and ethanol added (-70 ml) until the solution became cloudy. The mixture was 
kept at 5 °C for 2 days and then filtered to afford a white solid, which was 
recrystallized from water ethanol, dried for 2 days at 50 °C in vacuo, and identified 
as (2S,3R)-3-methylglutamic acid (17a) (36 mg, 42%), m.p. 166-168 °C; (Found:
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C, 40,05; H, 7.5; N, 7.6. Calc, for CeHii04N-H20: C, 40.22; H, 7.31; N, 7.82%) m/z 
(Found: [M - H20]+144.0661. C6H11O4N requires 144.0661); [a]o+10.2° (c 0.43 in 6 
M HCI); ÔH (300 MHz; 2H2O) 1.04 (3H, d, CH3), 2.30-2.65 (3H, m, CH(CH3)CH2) and 
3.80 (1H, d, 2-H); 6c (75 MHz; 2H2O), 17.11 (CH3), 33.63 (C-3), 40.50 (C-4), 60.89 
(C-2) and 175.44, 179.49 (2 x CO2H); m/z (El), 162 {[M+ H]+, 8%), 98 (100) and 55 
(95).
Methyl dibromoacetate (79)
Dibromoacetic acid (lOg, 45 mmol) was dissolved in dry methanol 100 ml, 
concentrated H2SO4 (5 ml) was added and the solution was ieft stirring overnight. 
Saturated Na2C03 (100 ml) was added, methanol was removed in vacuo and the 
ester was extraced from the aqueous phase with ether (2 x 150 ml). The organic 
phases were pooled, dried (MgS04), and removed in vacuo to give methyl 
dibromoacetate (79) (8.7 g, 82%); b.p. 179-181 °C (lit., 196 182-183 °C); ôh (200 
MHz; C2HCI3) 4.85 (3H, s, OCH3) and 5.82 (1H, s, CHBr2); ôq (50 MHz; C2HCI3) 
31.7 (CH3), 54.1 (CHBr2) and 165.0 (CO2).
Dimethyl 1-Bromo-c/s-cyclopropane-1,2-dicarboxylate (68) 174
H3CO2C
CO2CH3
A mixture of the dibromoacetate (79) (10 g, 43 mmol) and methyl acrylate (4.8 
g, 56 mmol, 1.3 eq) was added to a suspension of NaH (1.9 g, 47 mmol, 1.1 eq, 
60% in oil) in dry toluene. After 1 hr. at room temperature the solution was refluxed 
for 24 hr. The excess hydride was destroyed by the addition of water (5 ml). The 
volatile material was removed in vacuo and the oily residue was partitioned 
between water and ethyl acetate (1:1 v/v, 100 ml). After furter extraction with ethyl
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acetate (3 x 50 ml) the organic phases were pooled, dried (MgS04), and removed 
to give a yellow oil. The crude oil was a 10:1 mixture of the 1-bromo-c/s- (68) and 
1-bromo-fra/7s-cyclopropanedicarboxylate dimethyl ester (69). The cis isomer was 
purified with flash chromatography on silica gel (5% ethyl acetate in hexane) (5.6 g, 
55%); -Umax (neat)/cm-l , 3450, 3100, 1740, 1385, 1307, 1279, 1225, 1186, and 
1106; ÔH (200 MHz; C^HCIs), 1.69 (1H, dd, Hp), 2.12 (1H, dd., H«), 2.44 (1H, t, 
CHCO2), and 3.60, 3.73 (6H, 2s, 2 x OCH3); 6c (50 MHz; C^HCW 22.59 (CH2), 
29.35 KIHCO2), 30.88 (ÛBrC02), 52.55 (CHCO2ÜH3), 53.51 (CBrC02C.H3), and 
167.80, 169.08 (2 x CO2). (Rf 0.33, 5% ethyl acetate in hexane). The cis isomer 
(69) is a mixture of two enantlomers, namely the (1R,2S)- and (1S,2R)-bromo- 
dicarboxylates.
1-Bromo-c/5-cyc[opropane-1,2-dicarboxylic acid (80)^74
Dimethyl 1 -bromo-c/s-dicarboxylate (79) (0.5 g, 2.1 mmol) was suspended in 6 
M HCI (20 ml) and the solution was refiuxed for 2 hr. The soiution was baslfied with 
potassium hydroxide (2 M) until pH 9-10. The aqueous phase was washed with 
dichloromethane (2 x 20 mi), acidified to pH 1 (6 M HCI), and extracted with ethyl 
acetate (3 x 20 ml). The organic phases were pooled, dried (MgS04) and removed 
in vacuo to give 1 -bromo-c/s-cyclopropane-1,2-dicarboxyiic acid (80) as a white 
solid which was recrystailized from ethyl acetate / petrol ether (290 mg, 67%), m.p. 
139-141 °C; m/z (Found: [M + NH4]+225.9715. CsH504Br requires 225.9715); Vmax 
(nujol)/cm-f 1700 (b), 1302,1263 and 1211; ôh (200 MHz; 2H2O), 1.80 (1H, dd, Hp) 
2.02 (1H, dd, H«) and 2.60 (1H, t, CHBr); ôc (75 MHz; SHgO, CH3OH) 23.48 (CH2),
31.62 (CBr), 32.41 (CH) and 171.86, 173.67 (2CO2), m/z (Cl) 249 ([M + NH4]+, 
38%), 148 (100), 105 (17), 62 (15), 52 (12) and 39 (18).
Chapter 4: Experimental 140
1-Bromo-fra/75-cyclopropane-1,2-dicarboxyfic acid (81)
A mixture of dibromoacetate (82) (3.5 g, 15 mmoi) and methyi acrylate (1.7 g, 
20 mmol, 1.3eq) was added to a suspension of NaH (0.66 g, 47 mmol, 1.1 eq, 60% 
in oil) in dry dimethylformamide (25 ml). The solution was heated to 80 °C for 5 hr. 
The excess of hydride was destroyed by the addition of water (20 mi). The resuiting 
solution was partitioned between water and ethyl acetate (1:1 v/v 100 ml). After 
further extraction with ethyl acetate (3 x 50 ml) the organic phases were pooled, 
dried (IVIgSO^), and removed to give a yellow oil. The crude oil was a 2:3 mixture of
1-bromo-c/s-(68) and 1-bromo-frans-cyclopropanedicarboxylate dimethyl ester 
(69) (both isomers 2.80 g, 79%); An analytical sample of the 1-bromo-frans-diester 
(69) was obtained by collecting only the initial fractions after silica gel 
chromatography (5% ethyl acetate in hexane); (Rf 0.36, 5% ethyl acetate in 
hexane); Dmax (neat)/cm-f 3462, 3104, 1749, 1377, 1316, 1283 and 1225; 6h (200 
MHz; C2HCIa) 1.85-2.05 (2H, m, Hp and HJ, 2.60 (1H, t, CHCO2) and 3.77, 3.80 
(6 H, 2s, 2 X OCH3); 6 c  (50 MHz; C^HCIa) 23.58 (CH2), 29.93 (C.HCO2), 30.43 
(£BrC02), 52.69 (CHCO2ÜH3), 34.09 (CBrCOaQHa) and 166.76, 168.67 (2 x CO2).
The above mixture (1.5 g, 6.3 mmol) was suspended in 6 M HCI (20 ml) and 
refluxed for 2 hr. The pH of the solution was adjusted to 9-10 with potassium 
hydroxide (2 M). The aqueous phase washed twice with dichloromethane, acidified 
again, and re-extracted with ethyl acetate (3 x 20 ml). The organic phases were 
pooled, dried (MgS0 4 ), filtered, and removed to give a mixture of the free 
bromodiacids (80), (81) (0.95g, 72%).
The mixture of the free acids from the previous step (0.95 g, 4.5 mmol) was 
dissolved in dry isopropanoi (20 ml), concentrated H2SO4 (0.2 ml) was added, and 
the solution was stirred for 8 hr. ar room temperature. After addition of saturated
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Na2COs (5 ml) the solution was extracted with dichloromethane ( 2 x 1 0  ml). The 
aqueous phase was then acidified, and re-extracted with ethyl acetate (3 x 30 ml). 
The organic phases were pooled, dried (MgS04), and removed to give an oily 
residue which contained the trans and cis bromo-cyclopropane-dicarboxylate 
isopropyl diesters in a ratio of 8:1. Fiash cromatography on silica gel (5% ethyl 
acetate in hexane) gave diisopropyi 1-bromo-fra/7s-1,2-isopropylcyclopropane- 
dicarboxylate (69). Hydrolysis and work-up in an identical manner to that 
described for (80), afforded, after recrystallization, the pure trans diacid (81) (140 
mg, 38%). m/z (Found: [M + NH4]+225.9715. CsH504Br requires 225.9715); Dmax 
(nujOl)/cm-i 1699 (b), 1290, 1242, and 1139; ôh (200 MHz; 2H2O) 1.73, 1.94 (2H, 
dd, CH2) and 2.61 (1H, t, CHBr); ôc (50 MHz; 2H2O) 25.68 (CHg), 32.21 (CH), 34.70 
(CBr) and 174.80, 174.90 (2 x CO2), m/z (Cl) 249 ([M + NH4]+, 226, 38%), 148 
(100), 105 (17), 62(15), 52 (12) and 39 (18). The trans isomer (81) is a mixture of 
two enantiomers, namely the (1R,2R)- and (1S,2S)-bromo-cyclopropane-1,2- 
dicarboxylates.
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B) Purification Protocois
The cells used in this study were cultured in the Department of Biological 
Sciences at the University of East Anglia. The fermentation service provided 
batches of 450 g of frozen cell paste of Clostridium tetanomorphum (Strain H I) 
from a 150 L fermentation.
For the purification of the two components of glutamate mutase four types of 
chromatographic techniques were used. Anion exchange chromatography of the 
crude protein extract was performed on DEAE-52 cellulose. The chromatographic 
media was dissolved in a 10 mM K2PO4, pH 7.0, left for 24 hours, packed (300 x 26 
mm) and used as such during the whole study.
Gel exclusion chromatography was performed using Sephadex G-150-120. The 
gel was suspended in the appropriate buffer and allowed to settle several times to 
remove fine particles. The column was repacked (150 x 26 cm) every time before 
use to achieve maximum flow rates (20-25 ml hr.-i).
Anion exchange FPLC chromatography was performed on a TSK DEAE-5PW 
(75 X 8  mm). A hydrophobic interactions TSK Phenyl-PW (75 x 8  mm) high 
performance column was employed for the purification of component S.
SDS-PAGE was performed following the procedure of Laeml|i99 on a 
discontinuous medium. A Mini-Protean II Dual Slab Cell apparatus was used.
The centrifugations were carried out on a CENTRICON 0-124 centrifuge. 
Pooled fractions from various steps (see below) were concentrated by ultrafiltration. 
Ultrafiltration was performed using an AMIGON apparatus (43 or 76 mm diameter), 
through a YM10 or a YM30 membrane, under N2.
The purification was carried out between 0-4 °C. The FPLC steps were 
conducted at room temperature. All materials used were of AR quality. AN 
procedures involving coenzyme B12 were performed under reduced light or in dark 
room.
Finally the amount of protein present was determined by the method of Lowry et 
a/.2oo Appropriately diiuted samples of the protein solution was mixed with 
Coomasie blue dye reagent (100 mg of Coomasie brilliant blue dissolved in 50 ml 
of 95 % ethanol to which 100 ml of 85 % of phosphoric acid has been added and
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the whole diluted to 1 L with water). After 5 min. the absorbance was measured at 
595 nm. Standard curves were prepared by using bovine serum albumin.
Buffers for the Purification of Glutamate Mutase
1) Sonication buffer: 50 mM potassium phosphate, pH 7.6.
2) Protamine sulphate solution: 50 mM potassium phosphate pH 7.0, 1% 
protamine sulphate.
3) Dialysis Buffer: 2 mM Potassium phosphate, pH 7.6, 10 mM 2- 
mercaptoethanol, 2 mM EDTA.
4) Ion Exchange Chromatography - DEAE-52 cellulose.
Equilibration Buffer: 10 mM potassium phosphate, pH 7.6, 10 mM 2- 
mercaptoethanol, 2 mM EDTA. Elution Buffer: 80 mM potassium phosphate, pH 7.0, 
10 mM 2-mercaptoethanoi, 2 mM EDTA.
5) G-150 gel exclusion chromatography column. Elution buffer: 50 mM 
Potassium phosphate, pH 5.8,10 mM 2-mercaptoethanol, 2 mM EDTA
6) ion exchange TSK DEAE-5PW
Low Salt: 10 mM potassium phosphate, pH 7.6;
High Salt: 10 mM potassium phosphate, 0.5 M KCI, pH 7.6
7) Hydrophobic interactions TSK Phenyl-PW 
Low Salt : 10 mM potassium phosphate pH 7.4;
High Salt : 10 mM potassium phosphate, 1 M ammonium sulphate, pH 7.4; 
Purification of Component E and S: Steps 1-6
Step 1: Sonication
Frozen Clostridium Tetanomorphum cell paste (Hi strain) (50 g), was thawed in 
100 mi of 50 mM potassium phosphate buffer, pH 7.6. The suspension was 
sonicated for 15 min. at <6 °C, in bursts of 1 min. using a Uitrasonic W-220F 
sonicator (150W). The resulting suspension was centrifuged (20,000 g, 30 min.). 
The precipitate was discarded and the suspension including a slimy grey layer was 
used immediately for the next step.
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Step 2: Protamine Sulphate
To the 145 ml of the sonic extract (15.3 mg/ ml) was added 50 ml of 1% 
protamine sulphate solution in 50 mM potassium phosphate buffer, pH 7.0 at 4 °C. 
After stirring for an additional 10 min. the soiution was centrifuged (20,000 g, 30 
min.) and the precipitate discarded.
Step 3: Ammonium Sulphate Fractionation
To 170 ml of the protamine extract (5 mg/mi) was added precrushed ammonium 
sulphate to 45% saturation at 4 °C. After stirring for an additional 20 min., the 
precipitate was separated by centrifugation (20,000 g, 30 min.) and discarded. 
Ammonium suiphate was added again to a final saturation of 85%. The resulting 
precipitate was separated by centrifugation (30,000 g, 45 min.) and then dissolved 
in 36 ml of 10 mM potassium phosphate, pH 7.6.
The resulting solution was then diaiysed for 6-8 hr against 5 L of 2 mM 
potassium phosphate, pH 6.8 containing 10 mM 2-mercaptoethanol and 2 mM 
EDTA. The conductivity of the diaiysate was checked to be less than that of the 
equilibration buffer for the DEAE-celiulose.
Step 4: DEAE-Cellulose Fractionation
The above solution was applied to a column of DEAE-cellulose equilibrated 
with 10 mM potassium phosphate pH 7.6. The coiumn was then eiuted 
successively with 400 ml of 10 mM pH 7.6, and 500 mi of 80 mM potassium 
phosphate pH 6.8 at a flow rate of 3 ml min. % 15 mi fractions of were collected and 
assayed. The fractions containing active protein (13-20, -120 ml) were pooled and 
concentrated (6-8 ml) using uitrafiltration. Alternatively the enzyme was precipitated 
by saturation to 80% in the presence of 2 mM EDTA. The precipitate was recoverd 
as a peilet by centrifugation (30,000 g) and stored at -80 °C.
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Step 5: Sephadex-G-150
The cloudy concentrated solution from the previous step was centrifuged 
(10,000 g, 10 min.) and then applied to a G-150 column equilibrated with 50 mM 
potassium phosphate, pH 6.8. The protein was eluted with the same buffer at a flow 
rate of 20 mi hr.-i (fractions of 10 ml were collected). The major peaks were those 
containing component E, (3-methylaspartase, and component S.
Fractions containing component E (35-48, 200-300 mi), and component 8  (70- 
90, 320-420 ml) activity were concentrated respectively to a volume of 2-3 ml by 
ultrafiltration. Residual 2-mercaptoethanol was removed by addition of 20 mM 
potassium phosphate buffer pH 7.0 (10 ml) for component E and of 50 mM 
potassium phosphate buffer pH 7.0 (10 ml) for component S. The volume was 
again reduced by ultrafiltration and the solutions containing component E and 8  
were stored at -80 °G in aliquots of 0.7 mi.
Step 7: FPLC for Component E:
An aliquot from the above step was thawed, diluted with water to 2 ml, filtered 
through a 2 nm filter, and applied to T8K DEAE-PW ion exchange column 
equilibrated with a 10 mM potassium phosphate buffer, pH 7.6. The protein was 
eluted with a gradient of 0-500 mM KCI in the same buffer at a flow rate of 1 ml 
min.-i, and fractions of 1.5 ml were collected. Gradient: 0% (5 ml); 0-8% (20 ml); 8- 
20% (40 ml); 20-100% (5 mi); 100% (5 ml); 100-0% (5 ml). The fractions (15-18, 15- 
20 ml), which contained component E without any p-methylaspartase activity, were 
concentrated to 2 ml. Potassium phosphate buffer (50 mM, pH 7.4, 5 ml) was 
added, the volume reduced again to 1 mi. The resulting protein solution was 
assayed (4 units mM) and used for kinetic experiments and incubations. The half- 
life of this preparation at -25 °C is -20 days.
To obtain a completely homogenous sample of component E, the fractions from 
two consecutive runs were pooled, concentrated and immediately reapplied on the 
FPLC system. Gradient: 0% (5 ml); 0-20% (60 ml); 20-100% (5 mi); 100% (5 ml); 
100-0% (5 ml). Fractions containing the pure monomer form of component E (18-
22) were concentrated (1 ml) and stored at -80 °C. Typically the activities obtained 
were 1.5-2 units mi'i
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Step 6: FPLC for Component S
An aliquot from Step 5 was thawed, diluted with water to 2 ml, brought to 800 
mM ammonium suiphate, filtered and applied to a TSK Phenyl-5PW hydrophobic 
interaction column, which had been equilibrated with 1 M ammonium sulphate in 
10 mM potassium phosphate pH 7.6. The protein was eluted with a gradient of 1 -0 
M (NH4)2S04 (1 mi min.-i) and fractions of 1.5 ml were collected. Gradient: 100% 
(10 ml); 100-0% (60 ml); 0 (10 ml); The fractions containing component S 
activity.(48-52), were concentrated by ultrafiltration (2 mi), potassium phosphate 
buffer (50 mM, pH 7.0, 5 mi) was added, and the volume reduced to afford a protein 
solution that contained -10 units ml-'* (1 unit mg-i) of component S activity. The 
half-life of this preparation at -25 °C was -30 days. Completely homogeneous 
protein was obtained with re-application of the above soiution on the coiumn.
C) Experiments with Giutamate Mutase
Assay Buffers
1 M Tris-CI, pH 8.3
0.5 M Sodium (2S)-glutamate, pH 8.3
0.5 M KCI, 0.1 M MgCl2
0.3 M (3-mercaptoethanol
3 mM AdoCbl
Solution of (3-methyiaspartase 500 units ml-"*
2-Mercaptoethanol and glutamate solutions were prepared always fresh. The 
rest were stocked at 4 °C, and fresh aliquots used every 4-5 days.
Procedure
In a 1 ml quartz cell (10 mm path) were added the following reagents: 50 ixl Tris 
buffer, 10 jil (2S)-glutamate solution, 10 |xl KCi, MgCl2, and 10 |jlI 2- 
mercaptoethanol. The solution was incubated at 37 °C with the appropriate amount 
of component S (10-50 [xi, depending on concentration and purpose), together 
with a precalculated volume of water. The solution was usually equilibrated for 7- 
10 minutes to allow component S to be fully reduced. Component E (10-50 \x\,
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depending again on concentration and purpose) was added. 30 Seconds iater the 
reaction was initiated by adding 5 ixl of coenzyme solution (total volume of the 
assay solution 1 ml). The absorption at 240 nm was followed at 37 °C for 2-3 min. 
One unit of mutase activity causes a 3.85 change in absorbance units per minute at 
240 nm, corresponding to 1 nmol of mesaconate per minute.
In order to obtain reproducible results it was necessary to degas the water used 
to dilute the reagents. For the early stages of the purification the reduction of 
component S seems to be not reproducible, resulting in the problems discussed 
previously (see § 4.7).
Inhibition Buffers
All the inhibitors were prepared as 40 mM solutions at pH 8.2 (sodium 
hydroxide was used to adjust pH when necessary). The soiution was then filtered 
through 2 nm filter, and stored at 4 °C. Appropriate volume of the inhibitor solution 
was used to obtain concentrations ranging from 0.5 mM (12.5 nO to 20 mM (500 
nl).
Inhibition studies
The inhibition studies were performed under the same conditions as the assay 
described above. The appropriate amount of inhibitor solution was incubated with 
component S and the precalculated volume of water (total volume 1 ml). The 
amount of protein used was typically -0.02 units. Two or three assay were always 
performed initially to establish the range of concentrations to be used and the 
amount of time necessary to fully reduce the specific batch of component S, since 
there obviously were different amounts of the oxidised form in every preparation.
In the case of the 1 -bromo-cyclopropane-1,2-diacids (the molecules absorb at 
240 nm), 5 mm path cells (1 ml) were used. The assays performed for 1-bromo- 
cyclopropane-frans-1,2-dicarboxylic were followed for a longer period of time, 
usually 10-12 min. The compounds not identified as inhibitors were incubated with 
the enzyme with concentrations up to 20 mM (substrate concentration 1 or 0.5 mM).
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The values of the rate used for kinetic analysis were always corrected (divided by 
the units of the enzyme present in the assay solution).
Incubation Studies - General method
The possible substrate (2-3 mg, 1-2 x 10-6 mol) the appropriate volume of water, 
and potassium phosphate buffer (50 jxl, 1 M, pH 8.3) were added in small (5 ml) 
pyrex test tube and sealed. The solution (-1.5 mi) was flushed with nitrogen 
through a syringe for 5 min. 2-Mercaptoethanol (20 |il, 0.3 M), and component S 
(0.3-0.8 units) was added and the resulting solution was incubated at 37 °C for 10 
min. Component E (0.3-0.8 units), and coenzyme (20 |xi) were added last. A typical 
assay was always performed using 20 |il of the resulting incubation solution to 
verify the presence of the expected activity. Incubation times ranged from 8-15 hr. 
The solvents were removed in vacuo and the residue analysed by "^H-NMR 
spectroscopy.
Incubations Containing Labelled Compounds
A typical incubation containing labelled 3-alkylaspartic acids (see p. 97) 
proceeded as follows: A mixture of [3'-2H3]-(2S,3S)-3-methylaspartic acid (2a) (2 
mg, 1.36 x 10-6 moi) and 3-(2S,3S)-ethylaspartic acid (82) (5 mg, 3 x 10-6 mol) 
together with the appropriate volume of water, and potassium phosphate buffer (50 
[xi, 1 M, pH 8.3) were sealed in small (5 mi) pyrex test tube. The solution (-1.5 mi) 
was flushed with nitrogen through a syringe for 5 min. 2-Mercaptoethanol (20 txl, 
0.3 M), and component S (0.3-0.8 units) were added and the resulting solution was 
incubated at 37 °C for 10 min. Component E (0.3-0.8 units), and coenzyme (20 |xl) 
were added last. Incubation times ranged from 8-15 hr. The solvents were removed 
in vacuo and the residue was analysed by ‘*H-NMR spectroscopy (see Fig. 3.12, p.
98). The above experiment was performed using different ratios of the two 
alkylaspartates.
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Other 3-alkylaspartates mixtures that were treated with glutamate mutase in a 
similar manner are listed below.
i) (2S,3S)-3-methylaspartic acid (2) / [3',4'-2Hs]-(2S,3S)-3-ethylaspartate (82).
ii) (2S,3S)-3-methyiaspartic acid (2) /  [4'-2H3]-(2S,3S)-3-ethylaspartate (82c).
iii) (2S,3S)-3-methylaspartic acid (2) / [3'-2H2]-(2S,3S)-3-ethylaspartate (82d).
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